Text

Rev 18 to Odcm
	ML20203H270
Person / Time
Site:	Limerick
Issue date:	04/30/1997
From:	Boyce R; PECO ENERGY CO., (FORMERLY PHILADELPHIA ELECTRIC
To:	;
Shared Package
ML20203H137	List: ML20203H133; ML20203H191; ML20203H220; ML20203H250; ML20203H270;
References
	PROC-970430, NUDOCS 9803030187
	Download: ML20203H270 (198)
	v • d • e

l I

i I

i PoRc nS SQR YES NQA NO

, 50.59 US

_RFSP.MGR. YES LIMERICK GENERATING STATION UNITS 1 AND 2 OFFSITE DOSE CALCULATION MANUAL 1

l Revision 18 W

4 PhCO ENERGY COMPANY i

DOCKET NOS. 50-352 AND 50-353 '

Approval. \ th '

'y Plant Handjer s

osO3030187 990226 DR ADOCK 0 y2

.m- -

c --

r * - -

- _ . _ - - . _ ~ _ . _ _ . _ . . _ . _ _ _ _ _ _ _ _ _ . _ . _ _ _ - - _ . . - _ _ _

t ODCM Rev. 18

- 4/97 Table of Contents Page trart I + RADIOLOGICAL EFFLUENT CONTROLS

.0 DEFINITIONS 1 2.0 BASIS FOR EFFLUENT MONITORING CONTROIA 6 2.1 METEOROLOGICAL MONITORING INSTRUMENTATION 6 i

2.2 MAPS DEFINING UNRESTRICTED AREAS AND SITE BOUNDARY FOR RADIOACTIVE GASEOUS AND LIQUID EFFLUENTS 6 2.3 RADIOACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTATION 6 2.3.1 Concentration 9

< 2.3.2 Dose 9 2.3.3 Liquid Radweste Treatment System 10 2.4 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION 10 1.4.1 Dose Rate 10 2.4.2 Dose - Noble Gases 11 2.4.3 Dose - Iodine 131, Iodine 133, Tritium, and Radionuclides in Particulate Form 12 2.4.4 Ventilation Exhaust Treatment System 12 2.4.5 Venting and Purging 13 2.4.6 Total Dose 13 2.5 MONI'1VRING PROGRAM 13 2.5.1 Land Use Census 14 2.5.2 Interlaboratory Comparison Program 14 2.6 APPLICABILITY 14 3.0 METEOROLOGICAL MONITORING INSTRUMENTATION CONTROLS 16 3.1 METEOROLOGICTL MONITORING INSTRUMENTATION 16 i

- .. . . . . - . _ _ ~ _ _ _ _ - . . . _ _ . . - _ - - - - _ . . . . _ - - -- . -- . . . . . -

ODC34 Rev.18 4/97 Page 3.2 RADIOACTIVE LIQUID EFFLUENT MONITORING INS *RPANTATION 20

3.2.1 Radioactiva "ffluent Monitoring

Instrumentation Controls 21 3.2.2 Concentration 24 >

3.2.3 Dose 28 3.2.4 Liquid Radwaste Treatment System 29 3.3 GASBOUS EFFLUENTS i

3.3.1 Radioactive Gaseous Effluent Monitoring Instrumentation 30 ;

3.3.2 SITE BOUNDARY Dose Rate 35 3.3.3 Dose - Noble Gases . 39 3.3.4 Dose - Iodine 131, Iodine-133, Tritium, and Radionuclides in Particulate Form 40 3.3.5 Ventilation Exhaust Treatment Systera ' 41 3.3.6 Venting or Purging 42 3.3.7 Total Dose 43 3.4 RADIOLOGICAL ENVIRONMENTAL MONITORING 3.4.1 Monitoring Program 44 3.4.2 Land Use Census 57 3.4.3 Interlaborato!.y Comparison Program 58 3.5 ANNUAL RADIOLOGICAL ENVIRONMENTAL OPERATING REPORT 59 3.6 ANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT 60 3.7 MAJOR CHANGES TO RADIOACTIVE WASTE TREA7 MENT SYSTEMS 62 ii

- - - ,4, e , w + . , , - - ;--- , ---__,,,y -

-,,-n , . . , . , _ , , ,,__.,m, - -

, , , , , , , - , ,_m y ,.- , , .-- y,w, , ,,y- yog a..

ODCH R0v. 18 4/97 LIMERICK GENERATING STATION

, OFFSITE DOSE CALCULATION MANUAL TABLE CONTENTS Page Part II - CALCUIATION METHODOLOGIES 1.0 LIQUID EFFLUENTS 63 1

1.1 RADIATION MONITORING INSTRUMENTATION AND CONTROLS 63 1.2 LIQUID EFFLUENT MONI'IVR SETPOINT DETERMINATION 64 1.2.1 Radwaste Discharge Monitor 64 1.2.2 Service Water Radiation Monitor 67 1.2.3 RHR Service Water Monitor 68 1.3 LIQUID EFFLUENT DOSE CALCULATIONS - 10 CFR 50 69 1.3.1 Member of the Public Dose - Liquid Effluents 69 ,

1.4 LIQUID EFFLUENT DOSE PROJECTION 74

2.0 GASEOUS EFFLUENTS 75 2.1 RADIATION MONITORING INSTRUMENTATION AND CONTROLS 75

', 2.2 GASROUS EFFLUENT MONITOR GETPOINT DETERMINATION 76 2.2.1 North Vent Noble Gas Effluent Monitors 77 j 2.2.2 South Vent Noble Gas Effluent Monitors 79 2.2.3 Noblo Gas Effluent Fractional Contribution 81 2.2.4 Noble GLs Effluent Default Setpoints 82 2.2.5 WRAM Noble Gas Effluent Monitor 87 2.3 GASBOUS EFFLUENT DOSE EVALUATIONS 90 2.3.1 Site Boundary Dose Rate - Noble Gases 91 2.3.2 Site Boundary Dose Rat e - Radiciodine and Particulates 93 2.3.3 -Noble Gas Air Dose 94 2.3.4 Radiciodine and Particulate Dose Calculations 10 CFR 50 95 iii i

)

ODCH Rev. 18 4/97

Page 2.3.5 Annual Dose Evaluation 98 2.4 GASEOUS EFFLUENT DOSE PROJECTION 101 3.0 SPECIAL DOSE ANALYSIS 102 ,

3.1 TOTAL DOSES M MEMBERS OF THE PULLIC 102 3.2 DOSES DUE TO ACTIVITIES INSIDE THE SITE BOUNDARY 104 i

4.0 RADIOLOGICAL ENVIRONMENTAL MONIM RING PROGRAM 105 4.1 SAMPLING PROGRAM 105 4.2 INTERuABORATORY COMPARISON PROGRAM 105

/ /PENDICES t

Appendix A Technical Specification /ODCM 157 Appendix B - Radiological Environmental Monitoring 160 Program Sample Type, Locatie7 and Analysi,s l Appendix C Requirements for ODCM Revision 167 iv p- py - ,- ;w s - * . - i-y , - - - , - - m,w- ,,e- .,

_.__________m _ _ _ _ _ _ _ . . . _ _ - - _ _ _ _ . . . _ _ _ . . _ . _ . _ . _ _ _ _ _

r i ODCM rov. 18 l 4/97 ;

LIST OF TABLES 7 I 1.1 Surveillance Frequoney Notation ;

I 3.1 1 Meteorological Monitoring Instrumentation i

I ?.1+ 2 Meter.' alogical Monitoring Instrumentation Surveillance Requir ments I 3.2 1 Radioactive Liquid Effluent Monitoring Instnunentation I 3.2 2 Radioactive Liquid Effluent Monitoring Instrumentation Surveillance Requirements I 3.2 3 Radioactive Liquid Waste Sampling and Analysis Program I 3.3 1 Radioactive Gaseous Effluent Monitoring Instrumentation I 3.3 2 Radioactive Gaseous Effluent Monitoring Instrumentation Surveillance Requirements j I 3.3 3 Radioactive Gaseous Waste Sampling and Analysis Program i I 3.4 1 Radiological Environmental Monitoring Program

! I 3.4 2 Reporting Levels for andioactivity Concentratisas In Environmental Samples

I 3.4 3 Detection Capabilities For Environmental Sample Analysis i II 1.1 Ingestion Individual Done Factors (Daipj) For Liquid Effluent's II 1.2 Assumptions Used In Limerick Effluent Dose Evaluations II 2.1 Dose Factors for Noble Gases II 2.2 Ingestion Individual Dose Factors (DFk,1,n) For Gascous Effluent II 2.3 Assumptions Used In Limerick Gaseous Effluent Dose Evaluation II 2.4 Nearest Gaseous Effluent Dose Receptor Distances (Meters)

A.1 Technical Specification /0DCM Matrix B.1 Radiological Environmental Monitoring Program v

-l l

l

,,w .~,,,-,,,,.a n, e- n , . , . ~ . . -- - . . . . , - ....n .. . , , . , . , . . - - - - - - , ,

4 ODCM Rev. 18 l 4/97 LIST OF FIGURES '

I 2.2 la Map Defining Exclusion Aress for Radioactive Gaseous and Liquid Effluents

)

I 2.2-1b Map Defining Low Population Areas for Radioactive '

Gaseous and Liquid Effluents

~

I 3.1-1 Meteorological Tower Location 1

II 1.3.1 1 LGS Dilution vs River Flow (Outfall) i II 1.3.1-2 LGS Dilution vs River Flow (Citizen's Utility)

II 1.3.1-3 LGS Dilution vs River Flow (Phoenixville) i II 1.3.1-4 ISS Dilution vs River Flow (Philadelphia Suburban)

II 1.3.1-5 LGS Dilution vs Ri%er Flow (Crew Course)

II 1 1 Liquid Effluent Flow Diagram II 2-1 Gaseous Effluent Flow Diagram - North Stack II 2 2 Gaseous Effluent Flow Diagram - South Stack

, II 2-3 Gaseous Effluent Flow Diagram - Hot Maintenance Shop i

B1 Environmental Sampling Location on site or Near the Limerick Generating Station j B2 Environmental Sampling Locations at Distances Less Than j Five Miles from the Limerick Generating Station >

'. s Environmental Sampling Locations at Distances Greater Than Five Miles from the-Limerick Generating Station I

i 1

vi- !

v -.<-wa, w, ,- a . , - - <- .- ,-,,-r.r,-w,-,---,,,-.~,.. ,,,n-,.--c,--,a,----- ,,- ,- - us , ..,,----nx-- - e---,-

l l

l e i 3

Fliposs The purpose of the offsite Dose Calculation Manual is to establish methodologies and procedures for calculating doses to individuals in areas at and beyond the SITE BOUNDARY due to radioactive affluents from Limerick Generating Station.

I

- - - - - - - -- a - - .a .-_.--- - -- - - , , n -----

PART I RADIOLOGICAL EFFLUENT CONTROLE I

i ODCM RON. 18 Paga 1 l 4/97 1.0 DEFINITIONS The following terms are taken from LGS Unit 1, Unit 2 Tech Specs.

1.1 ACTION ACTION shall be that part of a specification which prescribes remedial measures required under designated conditions.

1.2 CHANNEL CALIBRATION A CHANNEL CALIBRATION shall be the adjustment, as necessary, of the channel output such that it responds with the necessary range and accuracy to known values of the parameter which the channel monitors. The CHANNEL CALIBRATION shall encompass the entire channel includ%g the sensor and alarm and/or trip functions, and shall nelude the CHANNEL FUNCTION TEST. The CHANNEL CALIBRATION m y be perfortned by any series of sequential, overlapping or total channel s*;eps such that tra entire chanael is calibrated.

1.3 CHANNEL CHECK A CHANNEL CHECK shall be the qualitative assessment of channel behavior during operation by observation. This determination shall include, where possible, comparison of the channel indication and/or status with other indications and/or status derived from independent instrument channels measuring the same parameter.

1.4 CHANNEL FUNCTIONAL TEST A CHANNEL FUNCTIONAL TEST shall bei

a. Analog channels - the injection of a simulated signal into the channt.: as close to the sensor as practicable to verify OPERABILITY including alarm and/or trip functions and channel failure trips.

b. Bistable channels - the injection of a simulated signal into the sensor to verify OPERABIT.ITY including alain.

and/or trip functions.

The CHANNEL FUNCTIONAL TEST may be performed by any series of sequential, overlapping or total channel steps such that the entire channel is tested.

l ODCM Rev. 18 Page 2 l 4/97 1.5 CONTINUOUS SAMPLING Per ASTM Standard (1987)Section II (Water and Environmental Technolog), Volume 11.03, Article D1356; is defined as' sampling without interruptions throughout an operation or for a predetermined time.' A CONTINUOUS SAMPLE is the opposite of a GRAB SAMPLE. The time period involved to secure (shut-down) ventilation or re establish sampling of the release pathway shall meet the intent of CONTINUOUS SAMPLING.

Consistent with irdustry standards, the time allowance shall not excee6 6 burJ.

1.6 DOSE EUTIVALEF. I-131 DOSE EQUIVALENT I-131 shall be that concentration of I 131, ndcrocuries per gram, which alone would produce the same thyroid dose as the quantity and isotopic mixture of I 131, I-132, I-133, I-134 and I 135 actually present. The thyroid dose conversion factors used for this calculation shall be those listed in Table III of TID-14844, ' Calculation of Distance Factors for Power and Test Reactor Sites."

1.7 FREOUENCY NOTATION The FREQUENCY NOTATION specified for the performance of Surveillance Requirements shall correspond to the intervals defined in Table 11.1.

1.8 MEMBER (S) OF THE PUBLIC MEMBER (S) OF THE PUBLIC shall include all persors who are not occupationally associated with the plant. This category does not include employees of the utility, its contractors, or vendors. Also excluded from this category are persons who enter the site to service equipment or to make deliveries.

This category does include persons who use portions of the site for recreational, occupational or other purposes not associated with the plant.

1.9 OFFSITE DOSE CALCULATION MANUAL The OFFSITE DOSE CALCULATION MANUAL (ODCM) shall contain the methodology and parameters used in the calculation of offsite doses resulting from radioactive gaseous and liquid effluents, in the calculation of gaseous and liquid effluent monitoring Alarm / Trip Setpoints, and in the conduct of the Radiological Environmental Monitoring Program. The ODCM shall also contain (1) the Radioactive Effluents Controls and Radiological Environmental Monitoring Programs required by Technical Specification 6.8.4 and (2) descriptions of the

I ODCM R0v. 18 Pago 3 l 4/97 information that should be included in the Annual Radiological Environmental Operating and Annual Radiological Effluent Release Reports required by Technical Specifications 6.9.1.7 and 6.9.1.8. (3) description of meteorological monitoring Controls.

1.10 OPERABLE - OPERABILITY A system, subsystem, train, component or device shall be OPERABLE or have OPERABILITY when it is capable of performing its specified functions (s) and when all necessa g attendant instrumentation, controls, electrical power, cooling or seal water, lubrication or other auxiliary equipment that are required for the system, subsystem, train, component or device to perform its function (s) are alr.o capable of performing their related support function (s).

1.11 OPERATIONAL CONDITION - CONDITION An OPERATIONAL CONDITION, i.e., CONDITIOF., shall be any one inclusive combination of mode switch position and average reactor coolant temperature as defined in the Technical Specifications.

1.12 PURGE - PURGING PURGE or PURGING shall be the controlled process of discharging air or gas from a confinement to maintain temperature, pressure, humidity, concentration or other operating condition, in such a manner that replacement air or gas is required to purify the confinement.

1.13 RATED THERMAL POWER See current LGS Tech Spec definition.

1.14 }tEPORTABLE EVENT A REPORTABLE EVENT shall be any of those conditions specified in Section 50.73 of 10 CFR Part 50.

1.15 SITE BOUNDARY The SITE BOUNDARY shall be that line as defined in Figure I2.2-la.

i l ODCM Rev. 18 Page 4 '

l 4/97 I t 1.16 SOURCE CHECK A SOURCE CHECK shall be the qualitative assessment of channel ;

, response when the channel sensor is exposed to a radioactive

. source.

1.17 THERMAL POWER THERMAL POWER shall be the total reactor core heat transfez rate to the reactor coolant.

1.18 UNRESTRICTED AREA

- An UNRESTRICTED AREA shall be any area at or beyond the SITE

'0UNDARY access to which is not controlled by the licensee for 4

ptrposes of protection of individuals from exposure to radiation and radioactive materials, or any are within the SITE r BOUNDARY used for residential quarters or for industrial, consnercial, institutional, and/or recreational purposes.

1.19 VENTILATION EXHAUST TREA'IMENT SYSTEM i A VENTILATION EXHAUST TREA'INENT SYSTEM shall be any system designed and installed to reduce gaseous radiciodine or

~

radioactive material in particulate form in affluents by passing ventilation or vent exhaust gases through charcoal absorbers and/or HEPA f11ters for the purpose of removing s

lodines or particulates from the gaseous exhaust stream prior to the release to the environment (such a system is not considered to have any effect on noble gas effluents).

Engineered Safety Feature (ESP) atmospheric cleanup systems are not considered to be VENTILATION EXIC.UST TREA'IMENT SYSTEM 4

components.

1.20 VENTING '

i VENTING shall be the controlled process of discharging air or gas from a confinement to maintain temperature, pressure, humidity, concentration or other operating condition, in such a manner that replacement air or gas is not provided or required during VENTING. Vent, used in system names, does not imply a VENTING process.

s t

v,-----ve,-c -- ~ -3 --..,4, . , , . - , - ,e,, -- +.-4.-,w.. -rm.wr-,.---%--, ,e..r.we- - , - -.mw -r- . --,s- --- -- - - - - -- -r---- vw,, - , m ---r- .--r-e----- r - - - - -

- - - - . . _ _ . - . . . . - . . - - . . . - . . . . - _- . - - - . . - - ~ . . _ - _ . . - . . - - _

i ODCM R;v. 18 l

Pag 3 5 4/97 ;

TABLE I1.1 SUEVIILLANCE FREQUENCY NOTATION B

NOTATION FREQUINCY S (Shift) At least once per 12 hours1.388889e-4 days 0.00333 hours 1.984127e-5 weeks 4.566e-6 months .

D (Daily) At least once per 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months . ,

t W (Weekly) At least once per 7 days.

M (Monthly) At least once per 31 days.

Q (Quarterly) At least once per 92 days.

SA (Semi annual) At least once per 184 days.

A (Annual) At least once per 366 days. ,

E At least once per 18 months (550 days) .

R At least once per 24 months (731 days) .

S/U Prior to each reactor startup.

P Prior to each radioactive release.

N . A ., Not applicable.

ti

i 4

l ODCM Rev. 18 Page 6

) l 4/97 2.0 BASIS FOR EFFLUENT MONITORING CONTROLS 2.1 ' METEOROLOGICAL INSTRUMENTATION The OPERABILITY of the meteorological monitoring I

instrumentation ensures that sufficient meteorological data is available for estimating potential radiation doses to the .

public as a result of routine or accidental release of '

radioactive materials to the atmosphere. This capability is required to evaluate the need for initiating measures to protect the health and safety of the public. This instrumentation is consistent with the reccannendations of Regulatory Guide 1.23 'Onsite Meteorologeeal Programs,'

February, 1972.

I Site data compiled since January 1972 provide correlation between Elevation 1 (Tower 1) and Elevation 1 (Tower 2), and between Elevation 2 (Tower 1) and Elevation 2 (Tower 2). This correlation serves u justification for the use of the appropriate Tower 2 instrument as a back-up to the Tower 1 instrument as shown in Table I3.1 1 and Table I3.1 3.

2.2 MAPS DEFINING tynuCTRICTED inne AND SITE BOUNDARY FOR RADIOACTIVE GASEOUS AND LIOUID EFF M Information r'egarding radioactive gaseous and liquid offluents, l' which will allow identification of structures and release points as we'.1 as definition of UNRESTRICTED AREAS within the SITE BOUNDARY that are accessible to MEMBER (S) OF THE PUBLIC,

, shall be shown in Technical Specifications Figures 5.1.3-la and 5.1.3-1b.

I The exclusion area and low population zone shall be as shown in Figures I2.2 la and I2.2 1b.

2.3 RADIOACTIVE LIOUID EFFLUENT MONITORING INSTRUMENTATION The radioactive liquid effluent instrumentation is provided to monitor and control, as applicable, the releases of radioactive

' materials in liquid effluents during actual or potential releases of liquid effluents. The alarm / trip setpoints for these instruments shall be calculated in accordance with the procedures in the ODCM part II to ensure that the alarm / trip will occur prior to exceeding the limits of 10 CFR Part 20.

The OPERAB hITY and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63, and 64 of Appendix A to 10 CFR Part 50, i

i

_ . . _ _ . . - _ . . . _ _ . . _ . _ . _ . - _ . - - _ . . , _ . _ . . . . . - , , - . - . . ~ . _ . . _ . . _ . , _ - . . -__

l ODCM Rov. 18 Page 7 l 4/97 FIGURE 12.2 la EXCLUSION ZONE hvnru.~ur..* ~ - 3 g , pg ~ ' ~ ~ s ~ r < r. .L M in3 ; k *y ' 7 g p , . . .

. -h= . . k f'yp\.l.

. . . .-l:

se ; 4. r M ' j f

r K( Q,.- ' K

. ,,1h,qu,, p. . .6 y: ' .c;. .t Q
.e.

gb . . -c'. .' i ,Q'GQ' t y :' ~y))\

_3:

}I' 'u, ,{a e~.ekp ,Q $

%.. #gagg,, $1.: 4%..

'p.... / . : .

a y=' "

"bwic, r %h' ,r e_ -ne~ .

=

p e , -S'Q, -

n

~. /

_ s \ ' 'T #.. w b- <

vj,,,,,

g.

~ g/v . i m

y =5 Q

~

-n9 '

., ,v*'t-. ,7 .

m<Ag> k\;::: \ '

4t ;- 4 ' ' 2 f..' ..W*i ..,6(

.\ .

i

]8tg 9/\S %gs.. +B&i

'r b ; g ( Wa %.:..k:y <T4 1

&mm po, 42, 4 < y p w QM bb2klE..k 2. h..,. Kir -

l ODO4 Rev. 18 Page 8 l 4/97 FIGURE I2.2-1b LOW POPULATION ZONE i

f ___o

[ ' YI '

's .T ,

1 -

= _r3), . -

{ .4 <

! q k ,

i e

Q l T '

p y y-

... m -

2[1 u _

{3N,.,, n .

$ );l

. . _ - . . - - . _ . . -- - __ .=. - . - . . .-. - - - - . - . _ . - -. .

l ODCM Rsv. 18 Page 9 l 4/97 2.3.1 CONCENTFAT1QN This control is provided to ensure that the concentration of radioactive materials released in liquid waste effluents to UNRESTRICTED AREAS will be less than the concentration levels

, specified in 10 CFR Part 20, Appendix B. Table II, Column 2.

, This limite, ion provides additional assurance that the levels of radioactive materials in bodies of water in UNRESTRICTED AREAS will result in exposures within (1) the Section II.A design objectives of Appendix I, 10 CFR Part 50, to a MEMBER OF THE PUBLIC, and (2) the limits of 10 CFR 20.1301(e) to the population. The concentration limits for dissolved or entrained noble gases are based upon the assuruption that Xe-135 is the controlling radioisotope and its MPC in air was converted to an equivalent concentration in water using the ntethods described in the International Comission on Radiological Protection (ICRP) Publication 2.

The required detection capabilities for radioactive materials in liquid waste samples are tabulated in terms of the lower

, limits of detection (LLDs). Detailed discussion of the LLD, and other detection limits can be found in HASL Procedures Manual, HASL-300 (revi9ed annually), Currie, L.A., " Limits for Qualitative Detection and Quantitative Determination -

Application to Radiochemistry,* Anal. Chem. 40, 586-93 (1968) and Martwell, J.K. " Detection Limita for Radioanalvtical Countina Technicues.' Atlantic Richfield panf ord Cnmnany Reoort ARH-SA-215 (June, 1975).

2.3.2 DOSE This Control is provided to implement the requirements of Sect. ions II. A, III.A, and IV.A of Appendix I, 10 CFR Part 50.

The Control implements the guides set forth in Section II.A of Appendix I. The ACTION statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive matorial in liquid effluents will be kept 'as low as reasonably achievable". Also, for fresh water sites with drinking water supplies which can be potentially affected by plant operations, there is reasonable assurance that the operation of the facility wil? Nt result in a radinnuclide concentrations in the fin. .3 drinking water that are in excess of the requirements of 40 CFR Part 141. The dose calculation methodology and parameters in the ODCM implement the requirements in Section III.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on models and data, such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathwaye is unlikely to be sucstantially underestimated. The equations specified in the ODCM for 4

calculating the doses due to the actual release rates of radioactive materials in liquid effluents are consistent with the methodology provided in Regulatory Guide 1.109,

' Calculation o_ Annual Doses to Man from Routine Releares of Reactor Effluents for the Purpose of Evaluating Compliance with

l ODCM Rev. 18 Fige 10 l 4 '97 10 CFR Part 50, Appendix I,

Revision 1, October, 1977 and Regulatory Guide 1.113, " Estimating Aquatic Dispersion of Effluents from Accidental and Routine Reactor Releases for the Purpose of Implementing Appendix I,* April, 1977.

2.3.3 LIOUID RADWASTE TREAMENT SYSIEM The requirement that the appropriate portions of *.his system be used when specified provides assurance that the releases of radioactive materials in liquid effluents will be kept 'as low as reasonably achie/able". This specification implements the requirements of 10 CFR 50.35a, General Design Criterion 60 of Appendix A to 10 CFR Part 50 and the design objective given in Section II.D of Appendix I to 10 CFR Part 50. The specified limits governing the use of appropriate portions of the liquid radwaste treatment system were specified as a suitable fraction of the dose design objectives set forth in Section II.A of Appendix I, 10 CFR Part 50, for liquid effluents.

2.4 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION Th2 radioactive gaseous effluent instrumentation is provided to monitor and control, as applicable, the releases of radioactive materials in gaseous effluents during actual or potential releases of gaseous effluents. The alarm / trip setpoints for these instruments shall be calculated in accordance with the procedures in the ODCM to ensure that the alarm / trip will occur prior to exceeding the limits of 10 CFR Part 20. The OPERABILITY and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63, and 64 af Appendix A to 10 CFR Part 50, 2.4.1 DOSE RATE This control is provided to ensure that the dose at any time at and beyond the SITE BOUNDARY from gaseous effluents from the site will be within the annual dose limits of 10 CFR Part 20 to UNRESTRICTED AREAS. The annual dose lim:.:.s are the dose associated with the concentrations of 10 CFR Part 20, Appendix B, Table II, Column I. These limits provide reasonable assurance that radioactive material discharged in gaseous effluents will not result in the exposure of a MEMBER OF THE PUBLIC in an UNRESTRICTED AREA, either within or outside the SITE BOUNDARY, to annual average concentrations exceeding the limits specified in Appendix B, Table II of 10 CFR Part 20 (10 CFR 20.106 (b) (1) ) . For MEMBERS OF THE PUBLIC who may at times be within the SITE BOUNDARY, the occupancy factor for that MEMBER OF THE PUBLIC will usually be sufficiently low to compensate for any increase in the atmospheric diffusion far: tor for above that for the SITE BOUNDARY. Examples of calculations for such MEMBERS OF THE PUBLIC, with the appropriate occupancy factuts, are given in the ODCM. The specified releare rate limits restrict, at all times, the corresponding gamma and beta dose rates above background to a MEMBER OF THE PUBLIC at or beyond the SITE BOUNDARY to less than or equal to 500 mrems/ year to the total

l ODCM R3v. 18 PO93 11 l 4/97 body or to less than or equal to 3000 mrems/ year to the skin.

These release rate limits also restrict, at all times, the corresponding thyroid dose rate above background to a child via the inhalation pathway to less than or equal to 1500 mrems/ year.

This Contrni applies to the release of radioactive materials in gaseous efflucnts from all reactors at the site.

The required detection capability for radioactive materials in gaseous waste samples are tabulated in terms of the lower limite of detection (LLDs). Detailed discussion of the LLD, and other detection limits can be found in EASL Procedures Manual, HASL-300 (revised annually), Currie, L.A., "Liedts for Qualitative Detection and Quantitative Detennination -

Application to Radicchemistry," Anal. Chem. 40. 586-93 (1986)

Lad Hartwell. J.K. ' Detection Limits for Radioanalvtical Countina Technicues." Atlantic Richfield Hanford Comnany

ReDort ARH-SA-215 (June 1975).

2.4.2 DOSE - NOBLE GASES This control is provided to implement the requirements of Sections II.B, III.A, and IV.A of Appendix I, 10 CFR Part 50.

The control implements the guides set forth in Section II.B of Appendix I. The ACTION statements provide the required operating flexibility and at the same tins implement the guides set forth in Section IV.A of Appendix I to assure that the releases of . radioactive material in gaseous effluents will bc kept 'as low as reasonably achievable". Tae Surveillance Requirements implement the requirements in Section III.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on appropriate pathways in unlikely to be substantially underestimated. The dose calculation established in the ODCM for calculating the doses due to the actual release rates of radioactive noble gases in gaseous effluents are consistent with the methodology provided in Regulatory Guide 1.109, " Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Costpliance with 10 CFR Part 50, Appendix I,"

Revision I, October 1977 and Regulatory Guide 1.111, " Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routing Releases from Light-Weter Cooled Reactors," Revision 1, July 1977 with site specific dispersion curves and deposition methodology. The OLCM equations provided for determining the air doses at an beyond the SITE BOUNDARY are based upon the historical average atmospheric conditions.

l ODCM Rev. 18 Page 12 l 4/97 2.4.3 DOSE - IODINE-131. IODINE-133. TRITIUM, AND RADIONUCLIDES IN PARTICULATE FORM This control is provided to implement the requirements of bections II.C, III.A, and IV.A of Appendix I, 10 CFR Part 50.

The controls are the guides set forth in Section II.C of Appendix I. The ACTION statements provide the required operating flexibility and at the same time implcment the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive mater:lais in gaseous effluents will be kept "as low as is reasonably achievable.' The ODCM calculational methods specified in the Surveille.nce Requirements implement the requirements in Section III.A of Appendix I be shown by calculational procedures based on models and data, such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated. The ODCM c,alculational methods for calculating the doses due to the actual release rates of the subject materials are consistent with the methodology provided in Regulatory Guide 1.109, Calculation of Anaual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I," Revision 7, October 1977 and Regulatory Guide 1.111,

" Methods for Estimating Atmospheric Transpor". and Dispersion of Gaseous Effluents in Routine Releases from Light-Water-Cooled Reactors," Revision 1, July 1977 with site specific dispersion curves and deposition methodology. These equations also provide for determining the actual doses based upon the historical average atmospheric conditions. The release rate specifications for iodine-131, iodine-133, tritium, and radionuclides in particulate form with half-lives greater than 8 days are dependent on the existing radionuclides pathways to man in ar9as at and beyond the SITE BOIniDARY. The pathways which were examined in the development of these calculations t

were: (1) individual inhalation of airborne radionuclides, (2) i deposition of radionuclides onto gceen leafy vegetation with subsequent consumption by man, (3) deposition onto grassy areas where milk animals and meat-producing animals graze with consumption of the milk and meat by man, and (4) deposition on the ground with subsequent exposure of man.

2.4.4 VENTILATION INMAUST TREA'INENT SYSTEM The requirement that the appropriate portions of this system be used, when specified, provides reasonable assurance that the releases of radioactive materials in gaseous effluents will be kept "as low as is reasonably achievable." This control implements the requirements of 10 CFR 50.36a, General Design j- Criteria 60 of Appendix A to 10 CFR Part 50, and the design l objectives-given in Seccion II.D of Appendix I to 10 CFR Part 50. The specified limits governing the use i

l l

l- ODCM Rtv. 18 Pags 13

l 4/97 of appropriate portions of the systems were specified as a i suitable fraction of the dose design sbjectives set forth in Section II.B and II.C of Appendlic I. 10 CFR Part 50, for gaseous effinents.

2.4.5 VENTING OF PURGING This control provides reasonable assurance that releases from drywell purging operations will not exceed the annual dose limits of 10 CFR Part 20 for UNRESTRICTED AREAS.

2.4.6 TOTAL DOSE This control is provided to meet the dose limitations of 40 CFR Part 190 that have been incorporated into 10 CFR Part 20 by 46 CFR 18525. The control requires the preparation and submittal of a Special Report whenever the calculated doses

from plant radioactive effluents exceed twice the design objective doses of Appendix I.

For sites containing up to four

. reactors, it is highly unlikely that the resultant dose to a MEMBER OF THE PUBLIC will exceed the dose limits of 40 CFR 190 if the individual reactors remain within the reporting 4

requirement level.

The Special Report will describe a course of action that should result in the limitation of the annual dose to a MEMBER OF THE PUBLIC to within the 40 CFR Part 190 limits. For the purposes of the Special Report, it may be assumed that the dose commitment to the MEMBER OF THE PUBLIC from other uranium nel cycle sources is negligible, with the exesption that dose

-contributions from other nuclear fuel cycle facilities at the same site or within a radius of 5 miles must be considered. If 2

the dose to any MEMBER OF THE PUBLIC is estimated to exceed the reqcirements of 40 CFR Part 190, the Special Report with a nquest for a variance (provided the release condition

resulting in violation of 40 CFR Part 190 have not already been corrected), in accordance with the provisions of 40 CFR 190.11 l and 10 CFR 20.2203, is considered to be a timely request and

. fulfills the requirements of 40 CFR Part 90 until NRC-staff action is completed. An' individual is not considered a MEMBER OF THE PUBLIC during any period in which he/she is engaged in carrying out any operation that is part of the nuclear fuel i cycle.

2.5 RADIOLOGICAL ENVIRONMENTAL MONITORINC PROGRAM 4

The Radiological Environmental Monitoring Program (REMP) required by this control provides representative measurements of radiation and of radioactive materials in those exposure-

, pathways and for those radionuclides that lead to the highest

, potential radiation ~ exposures of MEMBER OF THE PUBLIC resu'. ting

from the station operation. This monitocing program implementsSection IV.B.2 of Appendix I to 10 CFR Part 50 and thereby supplements the radiological effluent-monitoring program by verifying that the measurable concentrations of radioactive materials r.nd levels of radiation are not higher than expected-l 1

l l i ODCM Rev. 18 l

Page 14 l 4/97 on the basis of the effluent measurements and modeling of the environmental exposure pathways.

The required detection capabilities for environmental sample analyses are tabulated in terms of the lower lindts of detection (LLDs). The LLDs required by Table I3.4-3 are considered optimum for routine environmental measurements in industrial laboratories. It should be recognized that the LLD is defined as an a nriori (before the fact) lbmit representing the capability of a measurement system and not an af ter the fact limit for a particular measurement.

Detailed discussion of the LLD, and other detection limits, can be found in HASL Procedures Manual, HASL-300 (revised annually); Currie L.A., " Limits for Qualitative Detection and Quantitative Determination - Application to Radiochemistry,*

Anal. Ch,em. 40, 586-93 (1968) and Hartwell, J.K., " Detection Limits for Radionnalvtical Countino Technicues." Atlantic Richfielt Hanford Cnmnany ReDort ARH-SA-215 (June, 1975) 2.5.1 LAND USE CENSUS This control is provided to ensure that changes in the use of areas at and beyond the SITE BOUNDARY are identitled and that modifications to the monitoring program are made if required by the results of the census. The best information fram the door-to-door survey, aerial survey or consulting with local agricultural authorities or any combination of these methods shall be used. This census satisfies the requirements of Section IV.B.3 of Appendix I to 10 CFR Part 50. Restricting the census to gardens of greater than 500 square feet provides assurance that significant exposure pathways via leafy vegetables will be identified and monitored since a garden of this size is the minimum required to produce the quantity (26 Kg/ year) of leafy vegetables assumed in Regulatory Guide 1.109 for consumption by a child. To determine this minimum garden size, the following assumptions were used: (1) that 20% of the garden was used for growing broad leafy vegetation (i.e.

similar to lettuce and cabbage), and (2) a vegetation yield of 2 kg/ Square meter.

2.5.2 INTERLABORATORY COMPARISON PROGRAM The requirement for participation in an Interlaboratory Cceparison Program ensures that independent checks on the precision and accuracy of the measurements of radioactive material in environmental sample matrices are performed as part of the quality assurance program for environmental monitoring in order to demonstrate that the results are reasonably valid for the purpose of Section IV.B.2 of Appendix I to 10 CFR Part bO.

2.6 APPLICABILITY #

2.6.1 Compliance with the controls contained in the succeeding controls section is required during the OPERATIONAL CONDITIONS

l l

} l ODCM Rov. 18 Pega 15 l 4/97 or other conditions specified therein; except that upcn failure to meet the controls, the associated ACTION requirements shall be met.

2.6.2 Non compliance with a control shall exist when the requirements of the control and associated ACTION requirements are not performed within the specified time intervals. If the control is restored prior to expiration of the specified time intervals, completion of the ACTION requirements is not required.

2.6.3 There are no actions in the ODCM which would require an operational condition change.

2.6.4 There are no restrictions on changing operating conditions in any of the controls on the ODCM.

2.6.5 Surveillance Requirements shall be met during the OPERATIONAL CONDITIONS or other conditions specified for individual controls unless otherwise stated in an individual Surveillance Requirement.

2.6.6 Each Surveillance Requirement shall be performed within the specified interval with a maximum allowable extension not to exceed 25% of the surveillance interval.

2.6.7 Failure to perform a Surveillance Requirement within the allowed surveillance interval defined by control 2.6.6, shall constitute noncompliance with the OPERABILITY requirements for a centrol. The time limits of the ACTION requirements are applicable at the time it is identified that a Surveillance f Requirement has not been performed. The ACTION requirements may be delayed for up to 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months to permit the completion of the surveillance when the allowable outage time limits of the ACTION requirements are less than 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months . Surveillance requirements do not have to be performed on inoperable equipment.

The associated bases from the LGS Technical Specifications applies to this section.

(

. . - - .- .-_ . - . _ _ - - ._ ... - . _ = . _ _ . - - . . - .. _ .-

l ODCM Rev. 18 Page 16 l 4/97 3.0 METEOROLOGICAL MONI'IDRING INSTRUMENTATION CONTROLS

3.1 The meteorological monitoring instrumentation channels shown in Table I5.1-1 shall be OPERABLE.

APPLICABILITY: At all times.

ACTION:

With less chan the mininum required instrumentation channels 3merable for more than 7 days, prepa.:e and submit a special Report to the Commission pursuant to LGS Technical Specification 6.9.2 within the next 10 days outlining the cause of the malfur.ction and the plans for restoring the instrumentation to OPERABLE status.

SURVEILLANCE REQUIREMENTS 3.1-1 Each of the above required meteorological monitoring instrumentation channels shall be demonstrated OPERABLE 3

by the performance of the CHANNEL CHECK and CHANNEL CALIBRATION operations at the frequencies shown in Table I3.1-2.

i

l ODCM R0v. 18 Pago 17 l 4/97 TABLE I3.1_1 METEOROLOGICAL MONITORING INSTRUMRNTATION MINIMUM Tower 1 Tower 2 INSTRUMENT INSTRUMENT (Primary) (Backup) _ OPERABLE

1. Wind Speed

a. Elevation 1 30 feet 159 fest 1

b. Elevation 2 175 feet 304 feet 1

2. Wind Direction

a. Elevation 1 30 feet 159 feet 1

b. Elevation 2 175 feet 304 feet 1

3. Air Temperature Difference (AT)

a. Elevations 266 feet- 300 feet-26 feet 26 feet 1 4

Tanta I3.1-2 METEOROLOGICAL MONITORING INSTRUMENTATION SURVEIf,TANCE REOtIREMENTS Channel Channel INSTRUMENT Check CALIBRATION

1. Wind Speed

d. Elevation 1 (Tower 1 and Tower 2) D SA

b. Elevation 2 (Tower 1 and Tower 2) D SA

2. Wind Direction

a. Elevation 1 (Tower 1 and Tower 2) D SA

b. Elevation 2 (Tower 1 and Tower 2) D SA

3. Air Temperature Difference (AT)

a. Elevations 266 - 26 ft (Tower 1) D SA

b. Elevatiens 300 - 26 ft (Tower 2) D SA NOTE:-

The meteorological towers shall be located as shown on Figure I3.1-1. For backup sources of data retrieval, rofer to Table I3.1-3.

l ODCM Rev. 18 Dage 18 l 4/97 TABLE I3.1-3 METEOROLOGICAL 'IDWER DATA RETRIEVAL INSTRUMENT TOWER 1 TOWER 2 DATA LOGGER DATA RM-21A Channel #

Wind Speed 1 (TWR1)

a. Elev. 1 Strip Chart Strip Chart RM-21A 14 (TWR2)

Wind Speed 5 ("IWRI)

b. Elev. 2 Strip Chart Strip Chart RM-21A 21 (TWR2)

Wind Dir. O (TWR1)

a. Elev. 1 Strip Chart Strip Chart RM-21A 13 (TWR2)

Wind Dir. 4 ('IWR1)

b. Elev. 2 Strip Chart Strip Chart RM-21A 20 (TWR2)

DELTA T Multi-pt Rec Multi-pt Rec RM-21A 7 (TWR1) 23 (TWR2)

PRIMARY OPTION:

A) lE DATA IS UNAVAILABLE FOR TOWER 1 THEN verify corresponding data available for Tower 2 !

B) DATA IS AVAILABLE FROM RM-21, DATA LOGGER OR STRIP CHARTS. THE SOURCES OF DATA IN ORDER OF PREFERENCE ARE THE RM-21, DATA LOGGER OR STRIP CHARTS. DATA LOGGER AND STRIP CHARTS ARE LO('ATED IN THE CONTROL ROOM.

6

l ODCM Rsv. 18 P ga 19 l 4/97 Picure 13.1-1 i Meteorological Tower Location

~

t \ .

.' Y\s.,,X $h -

.., s k,hY .

1/ ,1 \ ,\ .t i y # '._ .

, 3 *

.. ?.*"

h.g::.~ , .y.:, 3 .-

Sy 4 \'t \ \

8 3 S '. T "}' . ) '. " ' NEIEOROLOGICALfM .

\\N . h, ./ 'h =Efi,?c' $ '. .

2:0\ \ \ \ \* T b'k '#!)' ,, _-

< h' >C 4hw qs ogsvo; q.e.- .u 'w

.-( y } s. 'g;g 1 u.K\ u{M,':.?% s a// a yy, e\

-- ~

\ \. .

COOLING,

-e

/ \ Q ' L'+ !, h' ~ t

'\ g4 TOWERS m m p q w .

7 * \ k \ P,4 220KV ,. _ Q_K' q; ,.gJ

'js\

/ : 1 eSUESTAil0Hi

'%g-w .,.* r~

b'f

\ y !

p h, -a ,

\\ ~\

1

\ _.

= rr=ne.w_

~

W e:

wn

.., \i y411 p - r i,i

e. c sr < _ . -

/

y,. c '.

m . _ % _ _ __ oJ=_

~ -

a s ' uw \. A -

.::- [ 'f \g i .. D i;L If h-u'

, .:,c""sm T~ aJ;f',L, 4

,k wcs k %

C ,% kcwtJ" i\Sp" F % y e -

G

\

14 '

N. .

R. y, K =. # % j, ' ' '.t %w.m

-. ~_.1g a

) . n ..d -

g%. .._

NN ,ill::':"j) - g.U. N' ,.f _ ',k j i + ~ If

% ~

\ .

7 .' ' .

y

l l ODCM Rev. 18 Page 20 l 4/97 3.2 RADIOACTIVE LIOUID EPPUIRNT MONITORING INSTRUMENTATION CONTROLS 3.2.1 The radioactive liquid effluent monitoring instrumentation channels shown in Table 13.2-1 shall be OPERABLE with their alarm / trip setpoints set to ensure that Control I3.2.2 is not exceeded. The alarm /setpoints* of these channels shall be datermined and adjusted in accordaace with the methodology and parameters in the ODCM - Part II, Section 1.2.

APPLICABILITX: At all times.

ACTlQH:

a. With a radioactive liquid ef fluent monitoring instrument =1 tion channel alarm / trip setpoint less conservative than required by the above control, ie-M stely suspend the reler.ae of radioactive liquid efflue.u monitored by the affected channel, and declare the channel inoptcable.

b. With less chan the minimum number of n dioactive liquid effluent monitoring instrumentation cl.annels OPERABLE, take the ACTION shown in Table I3.2-1. Restore the inoperable instrumentation to OPERABLE stat.us within the time tjecified in the ACTION or explain in the next Anaual Rad:.oactive Effluent Release Report why this inoperability was not corrected within the time specified.

SURVEILLANCE REOUIREMENTS 3.2.1 1 Bach radioactive liquid effluent monitoring instrumentation channel shall be demonstrated OPERABLE by performance of the CHANNEL CHECK, SOURCE CHECK, CHANNEL CALIBRATION and CHANNEL FUNCTIONAL TEST performance at the frequencies shown in Table I3.2-2.

Excluding the flow rate measuring devices which are not determined and adjusted in cccordance with the ODCM.

l ODC24 Rsv. - 18 Page 21 4 l 4/97 TABLE 13.2-3 kJIOACTIVE LIOUID EFFLUENT MONITORING INSTRUMENTATION MINIMUM CHANNELS INSTRUMENT OPERABLE ACTION

1. Gross Radioactivity Monitors Providing

Automatic Termination of Release

a. Liquid Radwaste Effluent Line 1 100

b. A/B RHR Service Water Effluent Line 1/ loop 101 Gross Radioactivity Monitors Not Providin;.'

Automatic Termination of Release

a. Service Water Effluent Line 1 101

3. Flow Rate Measurement Devices

a. Liquid Radwaste Effluent Line 1 102

b. Discharge Line 1 102 4

1 t

i a

w - ~ * ^

w -

M m m o

l l ODCM Rev. 18 '

Page 22 l l 4/97 ACTION ST8LTEMENTS Action 100- With less than the Minimum Required Channels operable, effluent releases may continue for up to 14 days provided that prior to initiating a releases 4

a. At least two independent samples are analyzed in

. accordance with Table I3.2-3, and

b. At least two technically qualified members of the l facility staff dependently verify the release rate calculatic snd discharge line valving;

, Otherwise, suspend relwase of radioactive effluents via this pathway.

Action 101- With less than the Minimum Required Channels operable, of fluent releases via this pathway may continue for up to 30 days provided that, at least once per 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months , grab

samples art, collected and analyzed for radioactivity by

gamma isotopic analysis (Principal Gamma Emitters, I-131, and Dissolved / Entrained Gases) as a Lower Limit of .

1 Detection an specifie d in Table I3.2-3 or gross radioactivity (beta and gamma). Gross Beta is analyzed at an LLD of at least 1N7 pCi/ml. Gross Gamma is j analyzed at an LLD of at least SN7 pCi/ml.

If the A or B RHRSW Process Rad Monitor should become inoperable, sampling is required at least once every eight (8) hours at a sample point common with the inoperable A and/or B RERSW Process Rad Monitor (s) whether or not the respective 1C/2C and/or 1D/2D AHRSW i

Process Rad Monitors are operable. However, there are no additional sampling requirements when the 1C/2C and/or 1D/2D RHRSW Process Rad Monitors are inoperable since monitoring requirements are satisfied through the operable A and/or B RERSW Process Rad Monitors or the inop sampling of those points.

If a monitor is inoperable but will still continuously sample and annunciate on high activity, i.e. rad monitor bypass switch placed in " Bypass", Chemistry sampling is not required as the continuous monitor sampling complies

-with the periodic sampling requirement.

Action 102- With lesk than the Minimum Required' Channels operable, ef fluent releaser via this pathway- may continue for up to 30 days provided the flow rate is estimated at least once per 4 hours4.62963e-5 days 0.00111 hours 6.613757e-6 weeks 1.522e-6 months during actual releases. Pump curves

. generated in situation may be usect to estimate flow.

ODCM Rev. 18 l

Page 23 l 4/97 ,

TABLE I3.2-2 RADIOACTIVE LIOUID EFFLUENT MONITURING INSTRL""TATION SURVEIf fAMCE RROUTD35ussa As CHAKMEL CHANNEL- SOUFCE CHANNEL FUNCTIONAL INSTRUMENr- CHECK CHECK CALIBRATION TEST

1. Gross Radioactivity Monitors Providing Automatic Termination of Release

a. Liquid Radwaste Effluent Line D* D* R(3) Q(1)

b. RHR Service Water System Effluent Line D M R(3) Q (1)

2. Gross Radioactivity Monitored Not Providing Automatic Termination of Release

a. Service Water System Effluent Line D M R(3) Q(2)

3. Flow Rate Measurement Devices

a. Liquid Radwaste Effluent Line D(4) N.A. R Q ,

b. Discharge Line D(4) N.A. R Q

Daily when in use i

t 1

.l ODCM Rev. 10 .

Page 24 ;

I 4/97 2'ARLE I3. 2 2 (Continued)

TABLE. NOTATIONS (1) The CHANNEL. FUNCTIONAL TEST shall also dem.ustrate that automatic isolation of this pathway and concrol room alarm annunciation will occur if any of the following conditions exists:

1. Instrument indicates measured levels above the alarm / trip setpoint.

2. Circuit failure.

3. Instrument indicates a downscale failure.

(2) The CHANNEL FUNCTIONAL TEST shall also demonstrate that control room alarm annunciation occurs if any of the following conditions exists:

1. Instrument indicates measured levels above the alarm setpoint.

2. Circuit failure.

3. Instrument indicates a downscale failure.

(3) The initial CHANNEL CALIBRATION shall be performed using reference standards certified by the National Institute of Standards and Technology (NIST) obtained from suppliers that

! participate in measurement assurance activities with NIST.

These standards shall permit calibrating the system over its intended range of energy and measurements range. For subsequent CHANNEL CALIBRATION, sources that have been i

related to the initial calibration shall be used.

(4) CHANNEL CHECK shall consist of verifying indication of flow during periods of release. CHANNEL CHECK shall be made at least once per 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months on days on which batch releases are made.

l l

l

l ODCM Rev . 18 POga 25

l. 4/97 CONCENTRATION CONTROLS 3.2.2 The concentration of radioactive material released in liquid effluents to UNRESTRICTED AREAS (see Figure I2.2-la,b) shall be limited to the concentrations specified in 10 CFR Part 20, Appendix B, Table II, Column 2 for radionuclides other than dissolved or entrained nobles gases. For dissolved or entrained noble gases, the ;

concentration shall be limited to 2E 4 microcuries/ml total activity.

APPLICABILITX: At all times.

ACTION:

With the concentration of radioactive ma':.erial released in liquid effluents to UNRESTRICTED AREAS cxceeding the above limits, imediately restore the concentration to within the above limits or terminate the release.

SURVEILLANCE REOUIREMENTS 3.2.2-1 Radioactive liquid wastes shall be sampled and analyzed according to the sampling and analysis program of Table I3.2-3.

3.2.2-2 The results of the radioactivity analyses shall be used in accordance with the methodology and

, rameters in the ODCM Part II. Section 1.3 to assure that the conecntrations at the point of release are maintained within the limits of Control I3.2.2.

?

l ODCM Rev. 18 Page 26 l 4/97 IABLE 13.2-3 RADIOACTIVE LIOUID WASTE SAMPLING AND ANALYSIS PROGRAM Lower Limit Minimum Type of of Detection niquid Release Sampling Analysis Activity (LLD)'

Type Frequency Frequency Analy. mis (uCi/M1)

A. Batch Waste P P Principal Gamma SE 7 Release Each Batch Each Batch Emitters' Tanks

I-131 1E-6

1. Floor or P M Dissolved and IE-5 Equip. Drain One Batch /M Entrained Gases Sample Tanks (Gamma Emitters)'

2. Laundry P M H-3 1E-5 Drain Sample Each Batch Composite d Tank Gross Alpha 1E-7 l

l P Q Sr-89, Sr-90 SE-8 Each Batch Composite d Fe-55 1E-6

8. Continuous W W Principal Gamma SE-7 Release' Grab Sample Emitters' I-131 1E-6

1. RHR Service W W Dissolved and 1E-5 Water System Grab Sample Entrained Gases Effluent Line' (Gamma Emitters)'

2. Service Water W M H-3 1E-5 System Grab Sample Composite d Effluent Line' Gross Alpha 1E-7 W Q Sr-89. Sr-90 SE-8 Grab Sample Composite d Fe-55 1E-6 l

l

___ _ _ _ . _ m__.._ ._.._ _ _ _ _ _ _ _ . _ _ . . . _ . . ._

ODQ4 Re' . 18 Page 27 l 4/97 TABLE T3.2-3 (Continued)

TABLE NOTATIONS

a. The LLD is defined as the smallest concentration of radioactive material in a sample that will yield a net count, above system background, that will be detected with 95% probability with only 5% probability of falsely concluding that a blank observation represents a "real' signal.

For a measurement system, which may include radiochemical separation:

(2.71 + 4.66s ) (1-exp (- AAt ) )

LLp . __.

E V 2.2236 Y- [exp (- AAt ))i ( AAta)

(2.71 + 4. 66 si)

LLD (Grab Samples).

E* V- 2.22E6

Y (exp AAt i )

. Where:

LLD is the a oriori lower limit of detection as defined a'.ove .

t ar microcuries per unit mass or volume),

se is the standard deviation of the background counting rate or of the counting rata of blank sample as appropriate las counts j per minute),

E is the counting efficiency, as counts per disintegration, V is the sample size, in unit of mass or volume, 2.22E6 is the number of di' cions per minute per microcurie, Y is the fractional radiochemical yield, when applicable, J

A is the radioactive decay constant for the particular radicnuclide, and At for the plant effluents is the elapsed time between the end of the sample collection and the time of counting.

At: for the plant efiluents is the elapsed time between the end of the santple collection and the start of sample collect. ion.

4 Typical values of E, V, Y, Ati and Ar2 Phould be used in Calculation.

It should be recognized that the LLD is defined as an a oriori (before the fact) limit representing the capability of a measurement system

and not as an after the tact limit for a particular measurement.

4 l

l ODCM Rev. 18 Page 28 l 4/97 TABLE 13.2-3 (Continued)

TABLE NOTATIONS

b. A batch release is the discharge of liquid wastes of a discrete volume. Prior to sanpling for analyses, each batch shall be isolated, and then thoroughly mixed to assure: representative sampling.

c. The principal gamma emitters for which the LLD specification applies include the following radionuclides: Mn-54, Fe-53, Co-58, Co-60, Zn-65, Mo-99, Cs-134, Cs 137, Ce-141 and Ce-144.

The dissolved and entrained noble gases (gamma emitters) for which the LLD specification applies include the following radionuclides: Kr-87, Kr-88, Xe-133, Xe-133m, Xe-135, Xe-135m, Xe138. This list does not mean that only these nuclides are to be considered. Other gamma peaks that are identifiable, together with those of the above nuclides, shall also be analyzed and j reported in the Annual Radioactive Effluent Release Report pursuant to Control 3.6.

d. The term " Composite Sample" means a combination of individual samples obtained at regular intervals over a time period. Either the volume of each individual sample is proportional to discharge flow rates, or the sampling interval (for constanc volume samples) is proportional to flow rates over the time period used to produce the composite,

e. A continuous release is the discharge of liquid wastes of nondiscrete volume, from a Volume of a system that has an input flow during the continuous release.

f. Whenever effluent releases are in excess of the monitor's setpoint.

. _ . . _ . . _ _ _ _ . _ _ . -. _____.___._.__..m..._____ _ _ _ . _ _ _ .

l ODCM Rsv. 18

, 29 i

Fog4 /97 l

DQSE CONTROLS 3.2.3 The dose er dose cou2nitment to a MEMBER OF THE PUBLIC from 4 radioactive materials in liquid effluents released from the site to UNRESTRICTED AREAS (See Figure 12.2-la) shall be limited:

l

) a. During any calendar quarter to less than or equal to j 3 mrems to the total body and to less than or equal to j 10 mrams to any organ, and

b. During any calendar year to less than or equal to 6

mrems to the total body and to less than or equal to 20 l mrems to any organ.

APPLICABILITY: At all times.

ACTION:

With the calculated dose from the release of radioactive materials in liquid effluents exceeding i any of the above limits, prepare and submit to the Con 1 mission within 30 days, pursuant to Technical Specification 6.9.2, a Special Report which identifies the cause(s) for exceeding the limit (s) and defines the corrective actions that have been taken to reduce

the releases and the proposed corrective actions to be taken to assure that subsequent releases will be in compliance with the above limits. This Special Report aball also include the radiological impact on finished drinking water supplies at the nearest downstream drinking water source.

SURVEILLANCE REOUIREMENTS 3.2.3-1 Cumulative dose contributions from liquid effluents 1 for the current calendu quarter and the current

! l calendar year shall ha :Jatermined at least once per 31 days.

1 i

i i-

s l ODCM Rev. 18 Page 30 l 4/97 LIOUID RADWASTE TREATMENT SYSTEM CONTROLS 3.2.4 The liquid radwaste treatment system shall be IN SERVICE and appropriate portions of the system shall be used to reduce the radioactive materials in liquid waste prio: to tneir discharge when the projected doses due to the liquid effluent, from the site, to UNRESTRICTED AREAS (See Figure I2.2-la) would exceec 0.06 mrem to the total body or 0.; mrem to any organ in a 31-day period.

APPLICABILITY: At all times.

ACTION:

a. With radioactive liquid waste being discharged without treatment or in excess of the above limits, pursuant to Technical Specification 6.9.2, prepare a Special Report which includes the following information:

1. Explanation of what liquid radwaste was being discharged without treatment, identification of any inoperable equipment or subsystems, and the r'eason for the inoperability.

. 2. Action (s) taken to restore the inoperable equipment to OPERABLE status, and

3. Sumary description of action (s) taken to prevent a recurrence,

b. Submit report to Commission within 30 days.

SURVEILLANCE REOUIREMENTS 3.2.4-1 Dose due to liquid releases from the site to UNRESTRICTED AREAS shall be projected at least once l per 31 days.

4 l

l w- - - -

. -~ . . - .- - - .. .- -- ._ . - - . - - - . .. .-- - - . . _ . _ . - .

l ODCM Rsv. 18 l Pcgs 7' i

l 4/>,

3.3 RADIOAC"PIVE GASEOUS EFFLUENT MONITORING INSnUMENTATION CONTROLS 3.3.1 The radioactive gaseous effluents monitoring instrumentation l channels in Table I3.3-1 shall be OPERABLE with their alarm / trip setpoints-set to ensure that the limits of ODCM l Control Part I Section 3.3.2 are not exceeded. The alarm / trip j setpoints of the applicable channels shall be determined in accordance with the methodology and parameters in the ODCM Part II, Section 2.2.

APPLICABILITY: As shown in Table I3.3-1.

ACTION:

a. With a radioactive gaseous effluent monitoring instrumentation channel alarm / trip setpoints less

conservative than required by Part II Section 2.2, inmediately suspend the release of radioactive gaseous effluents monitored by the affected channel or declare the channel inoperable,

b. With less than the mininum number of radioactive gaseous effluent monitoring instrumentation channels OPERABLE, take the ACTION shown in Table I3.3-1.

Restore the inoperable instrumentation to OPERABLE

. status within the time specified in the ACTION: If the inoperable instrumentation is not restorec within the time specified in the ACTION statement: create an AR in PIMS to ensure an explanation is written by the responsible System Engineer and is included in AERR by the Effluent Physicist.

! SURVEILIX4CE REOUIREMENTS 3.3.1-1 Each radioactive gaseous effluent monitoring instrumentation channel shall be demonstrated OPERABLE by performance of the CHANNEL CHECK, SOURCE CHECK, CHANNEL CALIBRATION AND CHANNEL FUNCTIONAL TEST operations at the frequencies shown in Table 23.3-2.

j 4

-. . . . ~ . . _ - . . - ..

.l' ODCM.~v. 18 Page.32

, l 4/97 TABLE I3.3-1 RADIOACTIVE GASEOUS EFFLUENT BONI*IORING INSTRIBIENTATION MINIMUM CHANNELS-INSTRIBEENT OP m mu APPLICABTLTTY ACTION l~ See Note Below' '

. l 1. SOUTH STACK EFFLUENT MONITORING SYSTEM '

a. Noble Gas Activity Monitor 1

111

'b.' Iodine Sampler 1

112 ;

c. Particulate Sampler 1

112 i

d. Effluent System Flow Re.te Monitor 1 *- 113. ,

e. Sampler Flow Rate Monitor 1 + 113-l.2. NORTH STACK EFFLUENT MONITORING SYSTEM +

1

114 I

a. Noble Gas Activity Monitor ;

b. Iodine Sampler 1

112 j

c. Particulate Sampler 1

112. t

d. Effluent System Flow Rate Monitor 1

113 ,

e. Sampler Flow Riate Monitor 1

113: ;

l 3. HOT MAINTENANCE SHOP VENTILATION EXHAUST RADIATION MONITOR

a. Iodine Sampler 1 ** 112 i

b. Particulate Sampler 1 ** 112- !

c. Effluent System Flow Rate Monitor 1 ** 113 l

d. Sampler Flow Rate Monitor 1 ** 113 E

+ The (A or B) North Stack Normal Range Radiation Monitors OR the Wide Range Accident Monitor (Low Range) may be used to satisfy requirements for the North Stack Effluent Monitoring ,

System.

i NOTE: With regard to Actions 111, 112, 113, and 114; with less than the minimum Required Channels operable for greater than 30 days prepare and submit a Special Report to the Effluent Physicist within the next 10 days outlining the cause of the malfunction and the plans for l restoring the instruments.to OPERABLE Status. Sampling shall continue until the minimum ;

channel operability requirement is met. l 5

At all times. *

- During operation of the hot maintenance shop ventilation system. !

l ODCN R0v. 18 )

PCga 33 1 i

l 4/97 j IABLE 13.3-1(Continued)

TABLE NOTATIONS ACTION STATEMENTS ACTION 111 -

With less than the minimum Required Channels (SS Noble Gas) OPERABLE, effluent releases via this pathway may continue for up to 30 days provided grab l samples are taken at least once per 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months and these saaples are analyzed for gross activity within 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months .

ACTION 112* -

With less than the minimum Required Channels (Iodine & Part.) OPERABLE, effluent releases via this pathway ,

may continue for up to 30 days provided samples are continuously collected with auxiliary sampling equipment as required in Table 13.3-3.

IE the Sample Pump is operable, a particulate and iodine sample can be obtained;

&lg2 the Minimum Channels Operable requirements are satisfied.

ACTION 113* -

With less than the minimum Required Channels (Eff & Smpl. OPERABLE, effluent releases via NS, SS or HMS Flow Rate) may continue for up to 30 days provided the flow rate is estimated by adding the nominal flow rates indicated in P&ID M-26 for each 1

in-service fan. This shall be documented in the MCR operations Shift Log at least once per 4 hours4.62963e-5 days 0.00111 hours 6.613757e-6 weeks 1.522e-6 months .

ACTION 114 -

With less than the minimum Required Channels (NS Noble Gas) OPERABLE, effluent releases via this pathway may continue for up to 30 days provided grab l samples are taken at least once per 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months and these samples are analyzed for gross activity within 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months . The Mechanical Vacuum Pumps may not be operated while in this action statement.

If release point is the Hot Maintenance Shop, Then secure ventilation because no means exist to alternately sample the ventilation.

ODCM Rev. 18 l Page 34 4/97 l

TABLE I3.3-2 RADIOACTIVE GASEOUS EFFLUENT MONITORING It{STRUMENTATION SURVEILLANCE REOUIREMENTS CHANNEL MODES IN WHICH CHANNEL SOURCE CHANNEL FUNCT. SURVEILLANCE CHECK CHECK CALIBR. TEST IS REQUIRED INSTRUMENT

1. 'OUTH STACK EFFLUENT MONITORING SYSTEM *

a. Noble Gas Activity Monitor D M R (2) Q(1)

N.A. *

b. Iodine Sampler W(3) N.A. N.A.

N.A. *

c. Particulate Sampler W(3) N.A. N.A.

d. Effluent System Flow Rate Monitor D N.A. R Q

e. Sampler Flow Rate Monitor D N.A. R Q

2. NORTH STACK EFFLUENT MONITORING SYSTEM N *

a. Noble Gas Activity Monitor D M R(2) Q(1)

W(3) N.A. N.A. N.A.

b. Iodine Sampler *

c. Particulate Sampler W(3) N.A. N.A. N.A.

d. Effluent System Flow Rate Monitor D N.A. R Q

e. Sampler Flow Rate Monitor D N.A. R Q

3. HOT MAINTENANCE SHOP VENTILATION EXHAUST RADIATION MONITOR N.A. **

a. Iodine Sampler W(3) N.A. N.A.

N.A. N.A. **

b. Particulate Sampler W(3) N.A.

c. Effluent System Flow Rate Monitor D N.A. R Q

d. Sampler Flow Rate Monitor D N.A. R Q

Wide Range Accident Monitor (WRAM) surveillance is specified in Technical )

Specification 3.3.7.5 l

At all times.

- During operation of the hot maintenance shop ventilation exhaust system.

1 l

l l ODCM rov. 18 P ga 35 l 4/97 TABLE T3.3-2(Continued)

TABLE NOTATIONS (1) The CHANNEL FUNCTIONAL TEST shall also demonstrate that control room alarm annunciation occurs if any of the following conditions exists:

s

1. Instruments indicate measured levels above the alarm / trip setpoint.

2. Circuit failure.

3. Instrument indicates a downscale failure.

4. Instrument controls not set in operate mode.

(2) The initial CHANNEL CALIBRATION shall be performed using one or more of the reference standards certified by the National Institute of Standards and Tebcing (NIST) oc using standards that have been obtained from suppliers that participate in measurement assurance activities with NIST.

These standards shall permit calibrating the system over its intended range of energy and measurement range. For subsequent CHANNEL CALIBRATION, sources that are traceable to the initial calibration shall be used.

(3) The iodine cartridges and particulate filters will be changed and analyzed at least once per 7 days.

s

- - -- ___-------_--______.____----___-_._--__-__-___.-_._-----_________--_-_-__---_______-__---_a

s l ODQ4 Rev. 18 Page 36 i

l 4/97 QASEOUS EFFLUENTS

_COfCROLS 3.3.2 The dose rate due to radioactive materials released in gaseous effluents from the site to areas at or beyond the SITE BOUNDARY (See Figure I2.2-la) shall be limited tot

a. For noble gases: less than or equal to 500 mrems/yr to the total body and less than or equal to 3000 mrems/yr to the skin, and

b. For iodine-131, iodine-133, tritium, and for all radionuclides in particulate form with half-lives greater than 8 days: less than or equal to 1500 mrems/yr to any organ. (Inhalation pathways only.)

APPLICABILITY: At all times.

ACTION:

With the dose rate (s) exceeding the above limits, innediately restore the release rate to within the above limits.

SURVEILLANCE REOUIREMEfES 3.3.2-1 The dose rate due to noble gases in gnseous effluents shall be determined to be within the l above limits. w 3.3.2-2 The dose rate due to iodine-131, iodine-133, tritium, and all radionuclides in particulate form with half-lives greater than 8 days in gaseous effluents shall be determined to be within the l above limits by obtaining representative samples and performing analyses in accordance with the sampling and analysis program specified in Table I3.3-3.

- . . -- - . _ - . ~ . _ _ . . . - - - . _ . - . - . - ~ - . . - . .

a l ODCM R0v. 18

- P:go 37 l 4/97

'ABLE T 3 . 3 - 3

! RADIOACTIVE GASEOUS WASTE SAMPLING AND ANALYSIS PROGRAM i 4 l

\

Lower Limit l

Minimum Type of of Detection a Gaseous Release Sampling Analysis Activlty (LLD)*

Type Frequency Frequency Analysis (uC1/M1)

! A. North Stack / Continuound Q Gross Alpha 1E 11 i South Stack Coop. Part. Sr-89, Sr-90 1E-11 Sant' e i i l M' t Grab Smpl. M6 Nnble Gas .E-4 q H3 3E 6 i

Continuous' M'

Char. Smp1. I 131 1E 12

I 133 1E-10 Part. Smp1. Principal Gama i l Emitters' 1E-11 Continuousd Continuous Noble Gas i Noble Gas Beta or Gamma 1E 6 Monitor (Based on Xe 133)

B. Hot Mainten. Continuous' Q Gross Alpha 1E 11 Shop Vent Comp. Part. Sr-89, Sr-90 1E-11 Exhaust' Smpl.

Continuousd W Char. Smyl. I-131 1E-12 I 133 1E 10 Part. Smpl. Principal Gama l Emitter 6' 1E 11 e ._ _ _ _ _ . . _ . - - _ , _ . . - _ . . - . . . _ _ _ _

i )

1 l

l ODCM Rev. 18 Page 38 l 4/97 TABLE I3.3 3 (Continuedl TABLE NOTATIONS

a. The LLD is defined, as the smallest concentration ot radioactive material in a sample that will yield a net count, above system background, that will be detected with 95%

probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal. It should be recognized that the LLD is defined as an a oriori (before the fact) limit representing the capability of a measurement system and not as an af ter the f act limit f or a particular measurement.

For a particular measurement system, (which may include radiochemical separation): ,

(2.71 + 4.66ss ) (1 exp( Aatis))

LLD =

EV 2.22E6 ' Y - [exp (- AAt i )) ( AAts)

( 2 . 71 + 4 . 6 6 so)

LLD (Grab Samples) =

E- V- 2.22E6 - Y (exp - AAt i)

Where LLD is the a oriori lower limit of detection as defined above (uCi/cc or uCi/mL) ,

se is the standard deviation of the background counting rate or of the counting rate of blank sample as appropriate (as epm), shall be based on the actual observed variance of the background counting rate or of the counting rate of the blank samples (as appropriate) rather than on an unverified theoretically predicted variance.

E is the counting efficiency, as cpdis, V is the sample site, in units of cc or mi, 2.22E6 is the number of dpm/uCi Y is the fractional radiochemical yield, wnen applicable, A is the radioactive decay constant 'ar the particul.ar radionuclide, and At i for the plant effluents is the elapsed time between the end of the sample collection and the time of counting.

At: for the plant ef fluents is the elapsed time between the end of the sample collectior. and the start of sample collection.

Typical values of E, V, Y Ati and At: should be used in calculation.

l ODCM Rov. 18 7

Pago 39 l 4/97

TABLE 13.3 3 (Continued)

TABLE NOTATIONS

b. Sampling and analyses shall also be performed following

shutdown, startup, or a THERMAL POWER change exceeding 15% of l the R/.TRD THERMAL POWER within a 1 hour1.157407e-5 days 2.777778e-4 hours 1.653439e-6 weeks 3.805e-7 months period. This '

requirement does rat apply if (1) analysis show that the DOSE EQUIVALENT I 131 concentration in the prirary coolant has not increased more than a f actor of 3; and (2) the main condenser of fgas pre treatment radioactivity monitor shows that ef fluent activity has not increased more t h a factor of 2.

c. Samples shall be changed at least once per 7 days and analyses shall be completed within 40 hours4.62963e-4 days 0.0111 hours 6.613757e-5 weeks 1.522e-5 months af tnr changing, or af ter removal from sampler. Sampling shall also be performed at least once per 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months for at least 7 days following each shutdown, startup or THERMAL POWER change exceeding 15% of RATED THERMAL POWER in i hour and analyses completed within 48 hours5.555556e-4 days 0.0133 hours 7.936508e-5 weeks 1.8264e-5 months of changing. When samples collected for 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months are i

analyzed, the corresponding LLDs may be increased by a factor of 10. This requirement does not apply if (1) analysis shows that the DOSE BQUIVALENT I-131 concentration in the primary coolant has not increased more than a f actor of 3; and (2) the noble gas monitor shows that effluent activity has not

, increased more than a factor of 3.

4

d. The ratio of the sample flow rate to the sampled stream flow i

rate shall be known for the time period covered by each dose or dose rate calculation made in accordance with Controls 3.3.2, 3.3.3, and 3 3.4.

e. The principal gamma emitters for which the LLD specification applies include the following radionuclides: Kr-87, Kr 88, Xe-133, Xe 133m, Xe-135, Xe-135m and Xe 1!8 for gaseous emissions l and Ma-54, Fe 59, Co 58, Co 60, En 65, I-131, Cs 134, Cs 137, Ce-141 and Ce-144 for particulate amissions. This list does not mean that only these nuclides are to be considered. Other gamma peaks which are identifiable, together with the above i nuclides, shall also be analyzed and reported in the Annual l Radioactive Effluent Release Report, pursuant to Control 3.6 l f. Required for the hot maintenance shop ventilation exhaust only during operation of the hot maintenance shop ventilation exhaust syster.

4 a--,,n_,- ,, - -, , ,sw-.s ,,-+-~e .grww-s++ v

i l

0D04 Rcv.18 Page 40 l

4/97 DOSE - NOSLE GASES CONTROLS 3.3.3 The air dose due to noble gases released in gaseous effluents, ;

from the site to areas at and beyond the SITE BOUNDARY (See '

Figure 12.2 la) shall be limited to the followings

a. During any calendar quarter: less than or equal to 10 mrads for ganna radiation and less than or equal to 20 mrads for beta radiation, and L

b. Durin' any calendar year: less than or equal to 20 mrads for ganna radiation and less than or cqual to 40 mrads for beta radiation.

APPLICABILITY: At all times.

ACTION:

A. With the calculated air dose from radioactive nob',e gases in gaseous offluents exceeding any of the above

, limits, prepara and rubmit to the Comission within 30 l days, pursuant to Technical Specification 6.9.2, a l Special Report which identifies the cause(s) for l exceeding the limit (s) and defines the corrective actions that have been taken to reduce the releases and the proposed correceive actions to be taken to assure that subsequent releases will be in compliance with the above limits.

SURVEI'.*ANCE REOUIREMENTS l

3.3.3-1 Cumulative dose contributions for the current quarter l

t and current calendar year for noble gases shall be l detemined every 31 days.

4

___ _ _ _ . . _ - - _ _ _ _ _ _ _ . . . . _ . , - . ._ ~ _ . _ . _ _ __ ~.,_ -_ _.

l ODCM rov. 18 Paga 41 j 4/97 DOSE - IODINE - 133. TRITIUM, AND RADIONUCLIDES IN PARTICULATE FORM UNTROLS 3.3.4 The dose to a MEMBER OF THE PUBLIC from isdine 131, iodine-133, tritium and all radionuclides in particulate form with half-lives greater than 8 days in gaseous effluents released from the site to areas at or berund the SITE BOUNDARY (See Figure I2.2-la) shall be limited to the followings

a. During any calendar quarters less than or equal to 15 mrems to any organ and,

b. During any calendar year: less than or equal to 30 mrems to any .cgan.

APPLICABILITY: At all times.

ACTION:

a. With the calculated dose from the release of iodine-131, iodine-133, tritium and all radionuclides in particulate form with half-lives greater than 8 days in gaseous effluents exceeding any of the above limits, prepare and submit to the Commission within 30 days, pursuant to Technical Specification 6.9.2, a Special Report which identifies the cause(s) for exceeding t'ne limit and defir.es tha corrective actions that have 1,een taken to reduce the releases and the proposed corrective actions to be taken to assure that subsequent releases will be in compliance with the above limits.

SURVEILLANCE REOUIREMENTS 3.3.4-1 Cumulative dose contributions for the current calendar quarter and current calendar year for iodiae-131, iodine 133, tritium and radionuclides in particulate form with half-lives greater than 8 days shall be l determined once per 31 days.

i l ODCM Rev.-18 Page 42 l l 4/97 VENTILATION EXHAUST TREA'IMENT SYSTEM CONTROLS 3.3.5 The VENTILATION EXHAUST TREA'IMENT SYSTEM shall be ZN SERVICE and appropriate portions of the system shall be used to reduce

! radioactive material in gaseous waste prior to their discharge when the projected doses due to gaseous effluent releases, from the site to areas at and beyond the SITE BOUNDARY (See Figure I2.2.la) when averaged over 31 days would exceed 0.6 mrem to

!. any organ in a 31 day period.

APPLICABILITY: At all times.

ACTION:

a. With gaseous waste being discharged without treatment, or

, in excess of the above limits, prepare' and substit to the Commission within 30 days, pursuant to Technical Specification 6.9.2, a Special Report which includes the foliowing informetion:

1. Explanation of why gaseous radwaste was being discharged without treatment, identification of any

inoperable equipment or subsystens, and the reason for the inoperability.

i

2. Action (s) taken to restore the inoperable equipment to OPERABLE status, and

3. Sumary description of action (s) taken to prevent a recurrence.

, SURVEILLANCE REOUIREMENTS 3.3.5-1 Doses due to gaseous releases from the site to areas at and beyond the SITE BOUNDARY shall be projected at l least once per 31 days.

l

_, , . .-.- - _,. m, , - . - . . . . _ . . . . . - . . - - - - - - - - , _ ,, ~ _. . ..-. ,_ 4-. ---

l l ODCM R v. 18 Pag 3 43 l 4/97 VENTING OR PURGING CONTROLS 3.3.6 The VENT 1.dG or PURGING of the Mark II containment shall be through the standby gas treatment system.

APPLICABILITY: Whenever the containment is vented or purged.*

ACTION:

a. With the requirements of the above specification not satisfied, suspend all VENTING and PURGING of the containment.

'31DG911LLMLC]LJLMSUIREMIDrIR 3.3.6-1 The containment thil be determined to be aligned for VENTING or PURGING through the standby gas treatment system within 4 hours4.62963e-5 days 0.00111 hours 6.613757e-6 weeks 1.522e-6 months prior to start of and at least once per 12 hours1.388889e-4 days 0.00333 hours 1.984127e-5 weeks 4.566e-6 months during VENTING or PURGIN1 of the containment.

3.3.6-2 Prior to use of the purge system through the standby gas treatment system assure that:

a. Both standby gas treatment system trains are OPERA 3LE whenever the purge system is in use, and

b. Whenever the purge system is in use during OPERATIONAL CONDITION 1 or 2 or 3, only one or the standby gas treatment system trains shall be used to prevent damage to both trains should a LOct. occur (LCO 3.6.5.3 q M ION a applies during this configuration).

Except after Containment is deinerted and purged while the reactor is in OPCON 4 or 5 QE for the one inch /two inch vent valves to the Reactor Enclosure Equipment Compartment Exhaust Filters when used for -

containment pressure control and nitrogen make-up operations.

s

.,,._...,m..._. .

l l !

! ODCM Rev. 18 !

Page 44 I i l 4/97 :

I l KADIDACTIVE EFFLUENTS i TOTAL DOSE .

j CONTROLS {

i

! 3.3.7 The annual (calendar year) dose or dose commitment to any MEMBER.0F THE PUBLIC, due to releases of radioactivity and !

i radiation, f rom uranium fuel cycle sources shall be limited to .

less than or equal to 25 mrams to the total body or any organ, !

except the thyroid, which shall be limited to less than or equal to 75 mrams.

APPLICABILITY At all times.

p ACTION:

a. With the calculated doses from the release of radioactive materials in liquid or gaseous effluents exceeding twice the limits of ODCM Controls I3.2.3.a, 13.2.3.b, 13.3.3.a, I3.3.3.b, i 13.3.4.a or 13.3.4.b, calculations shall be nade including >

direct radiation contributions from the reactor units and from ,

outside storage tanks to determine whether t.te above limits of ODCM Control 3.3.7 have been exceeded. If such is the case, i prepare and submit to the Commission within 30 days, pursuant to

Technical Specification 6.9.2, a Special Report that defines the correct.ive action to be taken to reduce subse@ent releases to prevent recurren'ce of exceeding the above 1Mts and includes the schedule for achieving conformance with the above limits.

This Special Report, as defined in 10 CFR 20.2203, shall include an analysis that estimates the radiation exposure (dose) to a MEMBER OF THE PUBLIC from the uranium fuel cycle sources, including all effluent pathwaye and direct radiation, for the calendar yekr that includes the release (s) covered by this report. It shall also describe levels of radiation and +

concentration of radioactive material involved, and the cause of the exposure levels or concentrations. If the estimated dose (s) exceeds the above limits, and if the release condition resulting in violation 40 CFR Part 190 has not already been corrected, the Special Report shall include a request for a variance in accordance with the provisions of 40 CFR Part 190. Submittal of the report is considered a timely request, and a variance is granted until staff action on the request is complete.

SURVEILLANCE REOUIREMENTS 3.3.7-1 Cwmulative dose contributions from liquid and gaseous l effluents shall be determined.

3.3.7-2 If the cumulative dose contributionn exceed the Ibnits defined in 3.3.7a, Cumulative dose contribut$en from direct radiation from unit operation shall be 1 determined.

)

l ODCM Rev. 18 Pago 45 j 4/97 3.4 RADioicarcAL 31gv1101e(El(TAL MONITORING PROGRAM (REMP).

cotrr10Ls 3.4.1 The monitoring program shall be conducted as specified in Table I3.4 1.

APPLICABILITY: At all times.

Acriod

a. With the radiological environmental monitoring program not being conducted as specified in Table 13.4 1, prepare and submit to the Commission, in the Annual

adiological Ruvironmental Operating Report per OD N Control 3.5, a description of the reasons for not conducting the program as requirwd and the plans for preventing a recurrence,

b. With the level of radioactivity as the result of plant offluents in an environmental sampling medium at a specified location exceeding-the reporting levels of Table I3.4 2 when averaged over any calendar quarter, prepare and submit to the Commission within 30 days, pursuant to Technical Specification 6.9.2, a Special Report that identifits the cause(s) for exceeding the limit (s) and defines the corrective actions to be taken to reduce radioactive offluents so that the potential annual dose to a MEMBER OF THE PUBLIC is less than the calendar year limits of OD N Controls I3.2.3, 13.3.3 and I3.3.4. When more than one of the adienuclides in Table I3.4-2 are detected in the sat.pling medium, this report shall be submitted ift concentration (1) _, concentration ui . ,,,,a reporting level (1) reporting level (2)

When radionuclides other than those in Table I3.4 2 are detected and are the result of plant effluents, this report shall be submitted if the potential annual dose to a MEMBER OF THE PUBLIC is equal to or greater than the calendar year limits of ODCM Controls 13.2.3, 13.3.3 and I3.3.4. This report is not required if the measured level of radioactivity was not tne result of plant effluents; however; in such an event, the condition shall be reported and described in the Annual Radiological Environmental Operating Report.

! ODCM Rev. 18 '

Page 46 l 4/97 i

RADIOLOGICAL ENVIRO)tipNTAL MONITORING (Continued) i c.- With milk or iresh leafy vegetable samples unavailable from one or more of the sample locations required by Tablo I3.4 1, identify locations for obtaining replacement samples and add them to ther radiological environment.a1 monitoring program within 30 days. The i specitic locations from which samples were unavailable may than bu deleted from the monitoring program.

Pursuant to Technical Specification 6.14, submit as a part of or concurrent with the Annual Radioactive Effluent Release Report, a complete, legible copy of the entire ODCM, including a revised figure (s) and ,

~

table for t.he ODCN reflecting the new location (s) .

SURVEILLANCE REOUIR]DGENTS 3.4.1-1 The radiological environmental monitoring samples

.l shall be collected pursuant to Table I3.4 1 f rom t.he specific locations given in the tt.ble and fAgure(s) in .

the ODO2 and shall be analyzed pursuant to the requirements of Table I3,4-1, the detection !

capabilities required by the Table 13.4-3.

F l

l

ODCM Rev. 18 l Fage 47 4/97 l

TABLE I3.4-1 RADIOLOGICAL ENVIROhMENTAL DamrwRING PRONM NUMBER OF REPRESENTATIVE SAMPLES AND SAMPLING AND TYPE AND FREQUENCY EXPOSURE PATHWAY OF ANALYSIS SAMPLE' LOCATION" COLLECTION FREQ.

AND/OR SAMFLE' 1.D:'dECT RADIATION" 40 routine monitoring stations At least Quarterly Gasuna dose at least either with twc or more dosi- quarterly.

meters or with one instrument for measuring and recording dose rate cont nuously placed as follows:

(1) An innsr' ring of stations, I' .

one in each meteorological sector, in the general area of the SITE BOUNDARY: (2) An outer ring of stations, one in each meteorological sector, in the 3-9 mile range from the site; (5) The balance of the stations placed in special interest areas such as population centers, nearby residences, schools and in 1 or 2 areas to serve as control stations. .

l ODO4 Rev. 18 Page 48 l 4/97 TABLE I3.4-1 (Continued) l RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM ,

i NUMBER OF REPRESENTATIVE EXPOSURE PATHWAY SAMPLES AND SAMPLING AND TYPE AND FREQUENCY AND/OR SAMPLE SAMPLE LOCATION" COLLECTION FREQ. OF ANALYSIS

2. AIRBORNE i Radioiodine and Samples from 5 locations: Continuous sampler Radiciodine canisters:

Particulates a.3 samples from close to the operation with sample I-131 analysis 3 SITE BOUNDARY locations (in collection weekly, or weekly.

different sectors) of the more frequently if highest calculated annual required by dust Particulate Samoler:

average ground level x/Q. loading'. Gross beta radic activity analysis b.1 sarple from the vicinity following filter community having one of the highest calculated annual change:'

ground level x/Q. Gamma isotopic 1 sample from a control loca- analysis' of tion, as for example 15-30 km composite (by ,

distant and in the least pre- location) at least valent wind direction. .ruarterly

. _ .-. -- - _ - - _ . . . _ _ _ _ _ _ _ _ - - - . _ . - - - - . _. _ . ~ _ - - . - _ . _ _ . . . . _-._. . . _ . -

1

, i i.

l L ;

j. ODCM Rev. 18 j Page 49 !

j. 4/97 j TABLE I3.4-1 (Continued) [

4 RADIOLOGICAL ENVIROleEENTAL BONI1DRIEG PROGRAM r I

, NUDE 3ER OF' REPRESENTATIVE !

EXPOSURE PATHWAY - SAMPLES AND SAMPLING AND - TYPE AND FREQUENCY [

AND/OR SAMPLE SAMPLE . LOCATION ** COLLECTION FREQ. OF ANALYSIS [

4 3.WATMBORNE- .

a . Surf ace' . I sample upstream Coraposite sample Gammaa isotopic analysis

j 1 sample downstream over 1-month neonthly. Composite for ;

period'. tritium analysin :

quarterly. l i- ,

s b. Ground Samples from 1 or 2 sources Quarterly. !

only if likely to be affected" l l

i

- c. Drinking 1 sample of each on 1 to 3 of Monthly. I-131 analysis on each j l

of the nearest water supplies (Composite) cosposite when the dose j that could be affected by its calculated for the con- i discharge. sumption of the water is

> greater than 1 mrem per lt I sample from a centrol year.' Composite for gross i location beta and ganum isotopic

.wnalysis monthly. Comp- !

- usite for tritium analysis !

i quarterly. I i

4

d. Sediment from i suple from downstream area - Semiannually. Ga==== isotopic analysis' f; shoreline with existing or potential semiannually.

r :

' r I

i i

i l

l ODCM R w. 18 Page 50 i

l 4/97

TARLR I3.4-1 (Continued) i RADIOLOGICAL ENVIROlGENTAL DEMI'IORING PROGRAM j NUMBER OF REPRESENTATIVE I

EXPOSURE PATHWAY SAMPLES AND SAMPLING AND TYPE AND FREQUENCY l AND/OR SAMPLE SAMPLE LOCATION" COLLECTION FREQ. OF ANALYSIS i

)

4. INGESTION t 1 a. Milk Samples from milking animals Semimonthly when Gasuna isotopic" and I-131 !

in 3 locaticas within 5 km animals are on analysis semimonthly when [

distance having the highest pasture, monthly animals are on pasture i dose potential. If there are at other times. (April 1 - Oct. 1):

none, then 1 sample from monthly at other times.

l l milking animals in each of :

3 areas between 5 to 8 km distance where dor? are cal-culated to be greatec than 1 mrem per year.'

!. 1' sample from milking animalc [

t at a con *rol location (15- j 30 km di, stance) and in the ;

j i

! least wind direction. I t

! l 1 sample of two recreationally Sample in season, f:=- isotopic' l b. Fish and l Invertebrw.es important species in vicinity or semiannually analysis on editte

j. of plant discharge area. 1 if they are not portions. l sample of same species in area seasonal. l not influenced by plant discharge. l t

i I

I f

l

[

i. !

4

i 4

i 2 l ODCM Rev. IR I Page 51 l l 4/97 i

TABLE I3.4-1 (Continued}

\~

RADIOLOGICAL EN7IROlWENLL 10NITORING PROGRAN l

i NUMBER OF REPRESENTATIVE !

'EXPOSURF PATHNAY SAMPLES AND SAMPLING AND TYPE AND FRsvunm.x ;

AND/OR SAMPLE SAMPLE LOCATION'" C7LLECTION FREQ. OF ANALYSIS !

i

! t

4. INGESTION (Continued)

c. Food Products Samples of 3 different kinds of Monthly when avail- Gamna isotopic" and ,

broad leaf vegetation grown able, if milk sa g ling I-131 analysis. j 4

nearest each of 2 different is not preformed.

offaite locations of highest predicted annual average !

ground level D/Q if milk sampling is not preformed.

i sample of each of-the similar Monthly when avail- Ganuna isotopic" and '

broad leaf veget.ation grown able, if milk sampling I-131 analysis.

i 15-30 km distance in the least is not performed. ,

prevalent wind direction if milk

sampling is not performed.

[

i i

3

l ODCM Rtv. 18 Page 52 l 4/37 RADIOLOGICAL FINIRONMENTAL MONITORING T_ABLE 13.4 1 (Continued)

TABLE NOTATIONS

c. Specific parzmeters of distance and direction sector form the centerline of the two reactors and additional description where pertinent, shall be provided for each and every sample location in Table I3.4-1 in a table and figure (s) in the ODCM. Deviations are perndtted f rom the required bampling schedule if specimens are unobtainable due to hazardous conditions, seasonal unavailability, malfunction of automatic sampling equipment and other legitivate reasons. If specimens are unobtainable due to sampling equipment nalfunction, every ef fort shall be made to complete corrective action prior to the end of the next sampling period. All deviations from the sampling schedule shall be documented in the Annual Radiological Environmentkl Operating Report pursuant to ODCM Centrol 3.5. It is r3 cognized that, at times, it may not be posstole or practicable to continue to obtain samples of the media of choice at the most desired location or time. In these instances suitable alternative media and locations may be chosen for the particular pathway in question and appropriate substitutions made within 30 days in the radiological environmental monitoring program. Pursuant to Technical Specification 6.14, submit as a part of or concurrent with the next Annual Radioactive Effluent Release Report a complete legible copy of the ODCM including a revised figure (s) and table for the ODCM reflecting the new location (s).

b. One or more instrumentw, such as a pressurized ion chamber, for measuring and recoding dose rate continuously may be used in place of, or in addition to, integrating dosimeters. For the purpose of this table, a thermoluminescent dosimeter (TLD) is considered to be one phosphor; two or more phosphors in a packet are considered as two or more dostmeters. Film badges shall not be used as dosimeters for measuring direct radiation,

c. Methodology for recovery of radioiodine shall be described in the ODCM.

d. Airborne particulate sample filters shall be analyzed for gross beta radioactivity 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months or more after sampling to allow for radon and thoron daughter decay. If gross beta activity mi air particulate samples is greater that 10 times the yearly mean of control samples, gamma isotopic analysis shall Le performed on the individual samples,

e. Gamma isotopic analysis means the identification and quantification of gamma-emitting radionuclides that may be attributable to the effluents from the facility.

i

l ODCM Rcv. 18 Page 53 l 4/97

f. The ' upstream sample' shall be caken at a distance beyond significant influence of the discharge. The ' downstream sample' shall be taken in an area beyond but near the mixing zone.

g. A composite sample is one in which the quantity (aliquot) of liquid sampled is proportional to the quantity of flowing liquid and an which the method of sampling employed results in a specimen that is representative of the liquid flow. In this program composite sample niiquots shall be collected at time intervals that are very short (e.g., hourly) relative to the compositing period (e.g. , monthly) in order to assure obtaining a representative sample,

h. Groundwater samples shall be taken when this source is tapped for drinking or irrigation purposes in areas where the hydraulic gradient or recharge properties are suitable for contamination.

l 1. The dose chall be calculated for the maxinum organ and age group.

e

+

d 1 l l ODCM Rev. 10 l Page 54 ,

l 4/97 i Tnta 13.4 2 REPORTING LEVELS FOR RADIOA MTVITY CONCENTRAT70NS IN EFVIRONMENTAL SAMPLES l Ranortina Levels AIRBORNE FOOD WA'11R PARTICULATE or FISH MILK PRODUCTS ANALYSIS (pCi/L) GASES (pCi/n/) (pCi/kg, wat) (pCi/L) (pCi/kg, wet) t H3 20,000$

Mn 54 1,000 30,000 Fe 59 400 10,000 Co 58 1,000 30,000 Co-60 300 10,000 Zn-65 300 20,000 Zr Nb 95 400**

I 13* 2 0.9 3 100 Co 134 30 10 1,000 60 1,000 Co-137 50 20 2,000 70 2,000 Bs-La-140 200** 300

For drinking water samples. This is 40 CFR Part 141 value. If no drinking pathway exists, a value of 30,000 pCi/L may be used.

- Total for parent and daughter.

, _ . _ _ . . - . _ ._.2. _ .,_..--_ _..- _ __ _ . _.

l ODCM Rov. 18 Pago 55 l 4/97 TABLE T3.4 3 DETECTION CAPABILITIES FOR ENVIRONMENTAL SAMPLE ANALYCIS'*)

Lower limit of Detection (LLD)**)

AIRBORNE FOOD WATER PARTICUU.TE or FISH MILK PRODUCTS SEDIMEITTS ANALYSIS (pCi/L) GASES (pCi/m ) 8 (pCi/kg, (pCi/L) (pCi/kg, (pCi/kg, wet) wet) dry)

Gross Beta 4 0.01 H3 2,000 Mn-54 15 130 Fo-59 30 260 Co-58,60 15 130 Zn 65 30 260 Zr 95 30 Nb 95 15 I 131 1* 0.07 1 60 Ca-134 15 0.05 130 15 60 150 4

Co-137 18 0.06 150 18 80 180 Bc-140 60 60 La 140 15 15

I l

l ODCM Rev. 18 l page 56 l l

4/97 ,

TABLE T3.4-3 (Continued)

TABLE NOTATIONS (a) This list dose not mean that only these nuclides are to con. dered. Other peaks that are identifiable at 95% confidence lev . together with those of the above nuclides, shall also be ana4j.ed and reported in the Annual Radiological Environmental Operating report pursuant to ODCM Control 3.5.

(b) Required cetection capabilities for thermoluminescent dosimeters used for environmental measurements are given in Regulatory Guide 4.13.

(c) The LLD is defined, for purposes of these controls, as the smallest concentration of radioactive material in a sample that will yield a net count (above system background) that will be detected with 95% probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal.

For a particular measurement system (which may include radiochemical separation):

4,.66s, LLD-E V 2.22 Y exp ( AAt)

Where:

LLD is the a nriori. lower lindt of detection as defined above (as picoeuries per unit mass or volume),

s, is the standard deviation of the background counting rate or of the counting rate of blank sample as appropriate (as coints per minute),

E le the counting efficiency (as counts per disintegrat!on),

V is the sample size (in units of mass or volume),

2.22 is the number of disintegrations per minute per picoeurie, Y is the fractional radiochemical yield (when applicable),

K is the radioactive decay constant for the particular radionuclide, and At for the environnsntal samples is the elapsed time between sample collection (or end of the sample collection period 11 time of counting.

Typical values of E, V, and At should be used in calculation.

l l ODO4 Rev. 18 Paga 57 l 4/97 IABL:t 13.4-3 (Continued)

TABLE NOTATIONS i

It should De recognized that the LLD is defined as an a orf ori (before the fact) limit representing the capability of a measurement system and not as an after the fact limit for a particular measurement. Analyses shall be perfomed in such a manner that the stated LLDs will be achieved under routine i conditions. Occasienally background fluctuations, unavoidably '

omall sample sizes, the presence of interfering nuclides, or other uncontrollable circumstances may render these LLDs unachievable. In such cases, the contributing factors shall be identifiec and described in the Annual Radiological Environmental Opsrating Report pursuant to ODCM Control 3.5.

(d) LLD for drinking water samples.

+

9

l ODCM Rev. 18 )

Page 58 l 4/97 RADIOLOGICAL ENVIRONMENTAL MONITORING LAND USE CENSUS CONTROL 3.4.2 A land use census shall be conducted and shall identify within a distance of 8 km (5 miles) the location (in each of the 16 nateorological sectors) of the nearest garden

of greater than 50 m' (500 fts) producing broad leaf or vegetables.

APPLICABILITY At all times.

ACTIONt_

a. With a land use census identifying a location (s) which yields a calculation dose or dose comnidment greater than the values currently being calculated in ODCM Control 3.3.4.1, identify the new location (s) in the next Annual Radioactive Effluent Release Report, pursuant to ODCM Control 3.6.

b. With a land use census identifying a location (s) that yields a calculated dose or dose commitment (via the same exposure pathway) 20% greater than at a location from which samples are currently being obtained in accordance with ODCM Control 3.4.1, add the new location (s) to the radiological environmental monitoring program within 30 days. The sampling location (s), excluding the control station location, having the lowest calculated dose or dose ec+snitment (s) (via the same exposure pathway) may be deleted from this monitoring program after October 31 of the year in which this land use census was conducted. Pursuant to Technical Specificatiou 6.14, submit as a part of or concurrent within the next Annual Radioactive Effluent Release Report a complete, legible copy of the entire ODCM including a revised figure (s) and table (s) for the ODCM reflecting the new location (s).

SURVEILLANCE REOUIREMENTS 3.4.2-1 The land use census shall be conducted during the growing season at least once per 12 months using that information that will provide the best results, such as by a door-to-door survey, aerial survey, or by consulting local agriculture authorities. The results of the land use l Census are included in the Annual Radiological Environmental Operating Report pursuant to ODCM Control 3.5.

Broad leaf vegetation sampling of at least 3 different kinds of vegetation may be performed at the SITE BOUNDARY in each of 2 differect direction sectors with the highest predicted D/Qs in lieu of the garden census. ODO4 Controls for broad leaf vegetation sampling in Table I3. 4-1 item 4.c. shall be followed, including analysis of control samples.

l l

i l ODCM R;v. 18 Pago 59 l 4/97 EADIOLOGICAL_ENVIE N AL_MQNITORING INTERLaBORATORY COMPARISON PROGRAM CONTROL 3.4.3 In accordance with LGS Technical Specification 3.12.3, analyses ;

4 shall be performed on radioactive materials supplied as part of an Interlaboratory Comparison Program which has been approved ;

j by the conmission.

APPLICABILITY: At all times.

ACTION:

With analyses not being perfonned as required above, report the

corrective actions taken to prevent a recurrence to the conmission in the Annual Radiological Environmental Operating Report pursuant to ODCN Control 3.5. ;

Ell]LVEILLANCE P.EOUIREMENTS 3.4.3 1 The Interlaboratory Comparison Program shall be l described in the ODCM part II, section 4.2. A sunnary of the results shall be included in the Annual Radiological Environmental Operating Report pursuant to ODCM Control 3.5.

l ODCM Rev. 18 Page 60 l 4/97 ANNUAL RADIOLOGICAL EINIRONMENTAL OPEPJtTING REPORT

3.5 Routine Annual Radiological Environmental Operating Report covering the operation of Unit 1 and Unit 2 during the previous calendar year shall be suhrtitted prior to May I for each year. The initial report was submitted prior to May 1 of the year following initial criticality (1984) . A single report is submitted for a multiple unit station. The Annual Radiological Environmental Operating Report shtl1 include summaries, interpretationb, and an analysis of trends of the results report period, including a comparison (as appropriate), with preoperational studies, operational controls and previous environmental surveillance reports and an assessment of the observed impacts of the plant operation on the environment. The reports shall also include the results of land use census required by ODCM Control 3.4.2. The Annual Radiological Euvironmental Operating Report shall include the results of all radiological environmental samples and of all environmental radiation measurements taken during the report period pursuant to the locations specified in the tables and figures in the OFFSITE DOSE CALCUIATION MANUAL, as well as summarized and tabulated results of .

these analyses and measurements in the format of the table in the Radiological Branch Technical Position, Revisior. 1, November 1979.

In the event that some individual results are not available for inclusion with the report, the report shall be submitted noting and explaining the reasons for the missing results. T% missing data shall be submitted as soon as possible in a supplementary report.

The report shall also include the following: a summary description of the radiological environmental monitoring program and at least two legible maps. One map shall cover stations near the SITE BOUNDARY; a seccnd shall include the more detailed distant stations.

Covering all sampling locations keyed to a tably giving distances and directions from the centerline of the reactor plant; the results of licensee participation in the Interlaboratory Comparison Program, required by ODCM Control I3.4.3 discussion of all deviations from the Sampling Schedule of Table I3.4 1; and discussion of all analyses in which the LLD required by Table I3.4 3 was not achievable.

l ODCM Rw. 18 j Page 61 l 4/97 ADMINISTRATIVE COITTROLS 3.6 ANNUAL RADIOACTIVE EFFLUENT RELEASE REPDRT A Routine Annual Radioactive Efflua.nt Release Report covering the operation of Unit i and Unit 2 during the previous 12 months of operation shall be submitted within 60 days after January 1 of each year. The period of the first report shall begin with the date of initial criticality. A recurring action request shall be used to generate the report. A single unit submittal is made for the 2 unit station. The submittal combines those sections that are common to all units at the station. The Annual Radioactive Effluent Release Report shall include a summary of the quantities of radioactive liquid and gaseous effluents and solid waste released from the facility as outlined in Regulatory Guide 1.21,

' Measuring, Evaluation, and Reporting Radioactivity in Solid Wastes and Releases of Radioactive Materials in Liquid and Gaseous Effluents from Light-Water-Cooled Nuclear Power Plants,*

Revision 1, June 1974, with data summarized on a quarterly basis following the format of Appendix B thereof.

The Annual Radioactine Effluent Release Report to be submitted 60 days after January 1 ti each year shall include an annual summary ,

of hourly meteorological data collected over the previous year.

This annual summary may be either in the form of an hour-by-hour listing on magnetic tape of wind speed, wind direction and atmospheric stability, and precipitation (i.f measured), or in the form of joint frequency distributions of wind speed, wind direction, atmospheric stability. The licensee has the opticn of retaining this summary of required meteorological data on site in a file that shall be provided to the NRC upon request. This same report shall include an assessment of the radiation doses due to the radioactive liquid and gaseous effluents released from both '

units during the previous calendar year. This same report shall also include an assessment of the radiation doses from radioactive liquid and gaseous effluents to MEMBER OF THE PUBLIC due to their activities inside the SITE BOUNDARY (Figures I2.2-la and I2.2-1b) during the report period. All assumptions used in making these assessments shall be included in these reports. The assessment. of radiation doses shall be performed in accordance with the methodology and parameters of the OFFSITE DOSE CALCULATION MANUAL (ODCM).

L i

l ODCM Rev. 10 Page 62 l 4/97 The Annual Radioactive Effluent Ra'mase Report to be submitted 60 days af ter January 1 of each year L.all also include an assessment of radiation doses to the hypethetically highest exposed MEMBER OF THE PUBLIC from reactor releases and other nearby uranium fuel cycle sources (including doses from primary effluent pathways and direct radiation) for the previous calendar year to show conformance with 40 CFR Part 160, Environmental Radiation Protection Standards for Nuclear Power Operation. Dose contribution from liquid and gaseous effluents is calculated based on Regulatory Guide 1.109, Rev 1, October 1977.

The Annual Radioactive Effluent Release Reports includes the following information for each type of solid waste (as defined in 10 CPR Part 61) shipped offsite during the report period

1. Total volume, activity and estinated total % error for each waste types

a. Spent resins filter sludges, evaporator bottoms, etc.

b. Dry compressible waste, contamitiated equipment, etc.

c. Irradiated components, control rods, etc.

d. Others (describe).

2. Activity and percentage of each principle radionuclide (>1%),

for each individual waste type as defined in

1. (a d) above.

3. The disposition of solid waste shipments (identify the number of shipments, the mode of transport, and the destination).

4. The disposition of irradiated fuel shipments (identify the number of shipments, the mode of transport, and the destination.

The Annual Radioactive Effluent Release Report includes a list and description of unplanned releases from the site to UNRESTRICTED AREAS of radioa7?ive raterial in gaseous and liquid ef fluents made during the reporting period.

l Changes mace during the reporting period to procedure RW-C-100 (formerly the PROCESS CONTROL PROGRAM) and to the ODCM, as well as a listing of new locations for dose calculations and/or environmental monitoring identified by the land use census pursuant to C0CM Control 3.4.2. shall be submitted in the form of a complete, legible copy of the entire ODCM as part of or concurrent with the Annual Radiological Effluent Release Report for the period of the report in which any change to the ODCM was made.

The Annual Radioactive Effluent Release Reports includes an explanation as to why the inoperability of liquid or gaseous effluent monitoring instrumentation was not corrected within the time specified in ODCM Controls 3.2.1 or 3.3.1, respectively; and description of the events leading to liquid holdup tanks or gas storage tanks exceeding the Control limits.

l ODCM Rev. 18 Page 63 l 4/97 3.7 MAJOR CHANGES TO RADIOACTIVE WASTE TREMMENT SYSTEMS Licensee-initiated major changes to the radioactive waste systems (liquid, gaseous, and solid) :

a. Shall be reported to the Comnission in the Annual Radioactive Effluent Release Report for the period in which the change was made effective. The discussion or each change shall contain:

1. A sammary of the evaluation that led to the determination that the change could be made in accordance with 10 CFR 50.59;

2. Sufficient detailed information to totally support the reason for the change without benefit of additional or supplemental infornacion;

3. A detailed description of the equipment, components, and processes involved and the interf ace with other plant systens;

4. An evaluation of the change which shows the predicted releases of radioactive materials in liquid and gaseous effluents and/or quantity of solid waste that dif fer f ran those previously predicted in the license application ind amendments thereto;

5. An evaluation of the change which shows the expel:ted maximum exposures to individual in the UNRESTRICTED AREA and to the general population that differ from those previously estimated in the license application and amendments thereto;

6. A comparison of the predicted releases of radioactive naterials, in liquid and gaseous effluents and in solid waste, to the actual releases for the period prior to when the changes are to be made:

7. An estimate of the exposure to plant operating personnel as a result of the change; and

8. Documentation of the fact that the change was

, reviewed and found acceptable by the PORC.

b. Shall be reviewed and accepted by the PORC prior to implementation.

c. Shall be dacumented by a recurring action request.

PART II CALCULATION METHODOLOGIES

l ODQ4 Rev.18 Page 64 l 4/99 1.O LIOUID EFFLUElfrS 1.1 RADIATION MONITORING INSTRUMENTATION AND CONTT.0LS The liquid etfluent monitoring instrumentation and controls at Limerick for controlling and monitoring normal radioactive material releases in accordance with the Limerick *echnical Specifications are summarized as follows.

1) Licuid Radwaste Dystem: The liquid radwaste discharge monitor (RISH63-0K604) prov4 des an alarge and automatic termination of radioactive material releases from the lig. tid radwaste syatem as required by Technical Specification 6.8.s.d.1. Additional design features of the liquid radwaste system which prevent inadvertent releases to the environment include 1) redundant discharge val es, 2) single discharge line with loop seal and siphon a.reaker to sc.iminate probability of inadvertent d'.scharges, 3) Low Cooling Tower Blowdown flow interic',k which isolates the radwaste discharge line.

2) Service Water System: The Service Water discharge monitor (RISH10-1K605 kND RISH10- 1605) prova. des an alarm upon indication of ar**, ..a the service water -

system as required by Tcno. A acification 6.8.4.d.1, While the s v. .r system is not a normal release pathway -

ur provides an indication of potentik. acms due to e,xcessive leakage of the heat excuangers. In addition, the service water side of the fuel pool heat exchz.ngers is kept at a higher pressure than the shell side to prevent pott >**al radioactive contamination of the service wr.+

3) RHR Service Water System: The RHR Service WatLr Radiation (RHRSW) Monitors (RISH12-CK619A. RISH12-OK6192, RISH12-1K619C, RISH12-1K619D, RI.9H12-2Kfl9C AT RISH12-2K619D) provide alarm and automatic termination of radioactive teaterial release from the RHRSW system, as required by technical Specification 6.8.4.d.1. While the RHRSW system is not a normrJ.

release pathway, the monitors provide indication of potential problems due to excessive leakage of the heat exchangers.

l

l ODCM rov. 18 Page 65 l 4/97 1.2 LIOUID EFFLUENT MONITOR SETPOINT DE""ERMINATION

, Per the requirements of Technical Specification 6.8.4.d.1, i

alarm setr,oints shall be established for the liquid effluent monitoring instrumentation to ensure that the release concentration limits of Specification 6.8.4.d.2 and 6.8.4.d.3 are met (i.e., the concentration of radioactive material released in liquid effluents to UNRESTRICTED AREAS shall be limited to the concentrations ,

specified in 10 CFR 20, Appendix B, Table II, Column 2,

)

for radionuclides and 2.0E-04 pCi/ml for dissolved or entrained noble gases).

1.2.1 Radwaste Discharce Monitor and Disqhg*1oe Flow Rate

- RISH63-OK604 The setpoint for the liquid radwaste discharge 1 monitor and flow rate element are determined by ,

the following equations. The radwaste discharge monitor high-high alarm / isolation setpoint is evaluated at least monthly based on isotopes detected in the liquid radwaste sample tanks released during the previous month or on any specific sample tank being released (I;C ), the required minimum cooling tower blowdown flow at t.ime of discharge (CIBD), and average liquid radwaste discharge flow (RR). The flow rate determination is calcul.ted for each release and the MPC fraction calcu?ated includes, in the concentration mix, ' most recent results from

1) the quarterly composite for SR-89, SR-90 and Fe-55, and 2) the monthly composite for H-3, anc

3) the sample (s) for dissolved and entrained noble gases.

If the calculated setpoint is less than the existing setpoint, the setpoint will be reduced to the next value. If the calculated setpoint is grnter than the existing setpoint, the cetpoint may remain at the lower value or increased to the calculated value.

The actual setpoint may be reduced to a value less than the calculated setpoint at the riiscretion of Superv sion. i If there were no sample tanks released or no activity detected during the previous month, then the calculation is performed using release data from the most recent month during which isotopes were detected. In addition, if there were no sample tanks released during the previour month, chemistry supervision may substitute more restrictive values (e.g., tritium) based on the plant sampling data.

i

' ODCM Rev. 18 i l Page 66 4/97 l 1

)

1. 2 '.1 - 1 Satooint Detern._ gen - RTEH63-0K604 1 The setpoint for the liquid radwaste l discharge monitor is determined by the following equation:

CPMgm s

~' '

(9) (RR) [E ( Cmn) /NPCmu) ) ( E Cs,_) (RR+CTBD) ,ggg'" (1 1) iRR+ CTBD) ,

(S) (E) (RR) (ECj,/NP(, ],

where:

CP % = Calculated liquid radwaste discharge monitor (RISH63-0K604) count rate

' attributable to the gamma emitting radionuclide, epm IC - = the sum of the concentration of the identified gamma emitting nuclidt.s (gC1/ml),

l CTBD = the required minimum cooling tower blowdown rate at time of discharge (gpm),

I RR = average liquid radwaste discharge flow (gpm),

BKGamm

= background count rate of liquid radwaste discharge monitor (CPM),

E = the gross detection efficiency of the liquid radwaste discharge monitor (pCi/ml/ cpm), and S = 2; margin of safaty factor to assure that the release is terminated prior to 10 CFR 20 limits being exceeded.

Included in this factor are errors associated with monitor uncertainty, sampling uncertainty, flow rate uncertainty, and tha contribution of other release paths (Service Water a ad RHRSW) which are not normally contaminsted.

E(C /MPC - ) = the effective gamma MPC ratio for the mixtura-of radionuclides in the liquid radwaste diLharge line (unitiess) .

L __ . . _ _ --. .

- . -- - - - . - _= - - .___ - - - _-... . - - _ - . . - - - - .

l ODCM rov. 18 Pace 67 l 4/97 4

where i C- = the concentration of each identifiec ganna emitting radionuclide - i in the liquid effluent (undiluted) (pCi/ml)

MPC , = the MPC value corresponding to radionuclide i from 10 CFR 20 Appendix B, Table II, Column 2 (dissolved and d

entrained noble gases MPC = 2.0E yCi/ml) l (pci/rl).

I(Ci w /MPCw,) = the effective nongamma MPC ratio for the i mixture of radionuclides in the liquid radwaste discharge line (unitiess) where:

1 Cw = the concentration of each identified

nonganna radionuclide i in the liquid i

effluent (undiluted) (pCi/ml)*

MPCw - The MPC value corresponding to radionuclide i form 10 CFR 20, Appendix B, Table II, Column 2 (dissolved and entrained noble gases MPC = 2Ed pCi/ml)

(pCi/ml)

NOTE: The concentration mix must include the most recent sample data for H-3, Sr-89, Sr-90, Fe-55 and gross alpha.

1.2.1-2 Flow Rate Determitiation

NOTE: H the effective MPC ratio for the mixture of radionuclides (I(C /MPCY) i ] is s1.0, THEN a flow rate setpoint determination is not required, AtlD there is no limit on discharge flow rate.

H a flow rate determination is required, THEN the setpoint for the liquid radwas 7 = flow rate is determined for each release by the following equation:

N%um 5 (1-2)

(SF) [E ( M C,) E where:

FLOWm = flow limit for radwaste discharge line (gpm).

CTBD = required minimum cooling tower blowdown-flow for time of. release (gpm).

SF = 2; margin of safety factor to assure that the release does not-exceed 10 CFR 20 limits.

j l'

e l ODCM Rev.18 Page 68

_l 4/97 E (C i /MPC 3) = . the effective MPC ratio for the mixture of radionuclides in the liquid radwaste discharge line (unitiess) ,

I where:

l C, = the concentration of each identified radionuclide i i in the liquid effluent (undiluted) (pci/ml)*

MPCi = the MPC value ccrresponding to radionuclida i from 3

10 CFR 20 Appendix B, Table II, Column 2, d

, (dissolved and entrained nob).e gases MPC = 2E

! pCi/ml) (pCi/ml) .

NOTE: The concentration mix must include the most recent sample data

for H-3, Sr-89, Sr-90, Fe-55 and dissolved and entrained noble i gases.

1.2.2 Servicte Water Radiation Wnitor - RIEH10-1K605. .

2K605 The Service Water Radiation Monitor maximum high-4 high setpoint is determined by the following equation. The setpoint is evaluated every 24 months to assure that a high background count rate does not prevent adequate monitor senritivity in order to meet the requirements of Technical Specifications 6.8.4.d.2 and 6.7.4.d.3.

1.2.2-1 Setpoint Determination The maximum setpoint for the Service Water Radiation Monitor is determined by the following equation:

CPM,,, = 0.5 (2.0E-05pci/ml) (CF) where:

CPM,, = Calculated Mar 4 - = Service Water Radiation Monitor (RISE 12-1K605, -

21t605) count rate, CEM.

2.0E-05 pCi/ml = MPC limit for Cs-137 CF = Monitor calibration factor - in cpm /pCi/ml 0.5 = Safety Factor E __e.__. -a A m __me. gg ,.

m A - .= yew a w,m .m vr' *T F'F _r*" ' ' ' ' 'fn'F T

.- .~ ._ . . _ . . _ . . . . . _. , _ _ . . _ . . _ . _ . . . _ _ _ _ _ . . _ . . _ _ _ . __ _

l l ODCM RCV. 18 l P3g3 69 i

l. 4/97 1.2.3 RHR Service hater Monitor -P;SH12-OK619A. -0K(19B,

-1K619C. -1K619D. -2K619C, .3K619D The RHR Service Water Radiation Monitor marin e high-high setpoint is determined by the following equation. The setpoint is evaluated every 24 4

months to assure that a high background count does not prevent adequate monitor sensitivity in order to meet the Technical Specifications 6.8.4'.d.2 and 6.7.4.d.3.

! 1.2.3-1 Setpoint Determination l

! The setpoint for the RER Service Water Radiation Monitor is determined by the following equation:

Ch = 0.5 (2.0E-05pCi/ml) (CF) where:

CPM w = Calculated ==vi='-dtHR Service W',ter Radiation Monitor (RISK 12-0K619A, -0K619B, -

1K619C, 1K619D, -2K619C, -

2K619D) count rate, CPM.

2. 0E-5f!Ci/ml = MPC limit for Cs-137 CF = Monitor calibration factor -

in cpm /pci/ml.

i 0.5 = Safety Factor i

i 1

i-i ODCM Rtv. 18 f- l Page 70 l

-4/97

-1.3 Liould Effluent Lose-cmiculation - 10 ClrR 50 i 1.3.1: ' "ers of ' the Public Dome ODO( I3.2.3 limits the dose or dose conunitment to-MEMBERS OF THE PUBLIC from radioactive materials in liquid effluents from Limerick Generating

+ Station to:

- during any-calendar quarter, l

s 3 mrem to total body s10 mram to any organ l

- during any-calendar year.

s 6 mrem to total uody s20 mram to total organ.

Per ODCM I3.2.3.1 the cumulative dose contribution from liquid effluents for the current calendar quarter year shall be determined at least once per 31 days in accordance with the follcwing ,

calculation methods. These equations-are for the three aquatic environment exposure pathways (potable-water, fish, shoreline exposure) in the Limerick aquatic environment. Only real pathways are addressed for each receptor. .The receptors and associated pathways are listed below. Doses from each real pathway are summed to give dose at the recaptor. The monthly results are accumulated to give the quarterly dases and the quarterly results are accumulated to give the annual doses.

Receptor Dist. Pathways Location (mi) Potable Water Fish Shoreline LGS Outfall O X X Citizen's Utility 2.5 X X X

~Phoenixville Watwr 9.0 X X X

'Phil. Sub. Water 13.6 X .._,y X

= Crew Course 37.8 X

. -. . . . .- . . . .- -_ . - - -. - - . ..-=. - -= - - .

l l ODCM Rsv.-18 l Page 71 l 4/97-i' 1.3.1-1 Potable Water Pathway R,y = ' 110 0 EOjD,jpy exp (-Al 483 ) (1-6)

MFi p

d 1.3.1-2 Fish (Aquatic Food) Pathway

, R,py = 1100b EOja ,Dupj exp (-Al (843 )

j (1-6)

MFi p

1.3.1-3 Shoreline Deposition Pathway R,j = 110,000b EOjTjDupj exp (-Al *p) [1-exp (-Al n.7sas.s)) ) (1 7)

M/ 2 where:

E, = equilibrium bioaccumulation factor for nuclide i in pathway p, expressed as the ratio of the concentration in biota, in pCi/kg, to the radionuclide concentration in water, in pC1/ liter (liters /kg)

l 1

l l ODCM Rev. 18 Page 72 l 4/97 BIQACCUMULATION FACTORS (pCi/kg/pci/ liter)

FRESHWATER SAL'DtATER ELEMENT FISH FISH H 9.0E-1 9.0E-1 C 4.6E 3 1.8E 3 Na 1.0E 2 6.7E-2

, P 3.0E 3 2.9E 4 Cr 2.0E 2 4.0F 2 Mb 4.0E 2 5.5E 2 l

' l Fe 1.0E 2 3.0E 3 Co 5.0E 1 1.0E 2 Ni 1.0E 2 1.0E 2 Cu 5.0E 1 6 72 2 Zn 2.0E 3 2.0E 3 Br 4.2E 2 1.5E-2 Rb 2.0E 3 8.3E O Sr 3.0E 1 2.0E O Y 2.5E 1 2.5E 1 Zr 3.3E O 2.0E 2 Nb 3.0E 4 3.0E 4 Mo 1.0E 1 1.0E 1 Tc 1.5E 1 1.0E'1 Ru 1.0E 1 3.0E O 4 Rh 1.0E 1 1.0E 1 ,

4 Te 4.0E 2 :.0E 1

. I 1.5E 1 1.0E 1 Cs 2.0E 3 4.0E 1 Ba 4.0E O 1.0E 1 LA 2.5E 1 2.5E 1 Ce 1.0E O 1.0E 1 Pr 2.5E 1 2.5E 1

Nd 2.5E 1 2.5E 1 W -1.2E 3 3.0E 1

! Np 1.0E 1 1.0E 1 Ref: 1) U.S.N.R.C Reg. Guide 1.109,-Rev. 1, Table A-1

2) Letter LTR 881209L001, from R.J. Clark, U.S.N.R.C., to

G.A. Hunger, Philadelphia-Electric Co., December 9, 1988, transmitting evaluativu of Limerick ODCM.

l ODCM rov. 18 Pcge 75 l 4/97 D, = dose factor specific to a given agt: group a, radionuclide i, pathway p, and organ j which car be used to calculate radiation dose (1) from an intake of a radionuclide, in mcem/pci, or (2) from exposure to a given concentration of a radionuclide in sediment, in mrem /hr per pC1/m*.

Values are listed by age group in Table 1-1.

F = waste dilution flow rate of liquid effluent dilution flow / number of batches (f t /sec) .

8 M, - dilution factor at point of exposure or at point of withdrawal of drinking water (dimensionless). Values are graphically listed by receptor location in Figures 1.3.1-1 to 1.3.1 5. Value will be based on average monthly river flow.

Q, = total release of nuclide 'i' for time period (Ci) .

Rg n total dose for calculation time period to organ j cf individuals of age group a from all nuclides i in pathway b (mrcm).

Ti = tadioactive half-life of nuclide 1 (days).

U,, = usage factor specifying exposure time or intake rats for an individual of age group a associated with pathway p (hr/yr, liters /yr, or kg/yr).

Pathway Infant Child Teen _

Adult Fish --

6. 9' 16* 21' Potable Water (1/yr) 3<.0* 510' 510' 730' Sr.oreline Recreation (hr/yr) --

14' 67' 12*

Shoreline Recreation (hr/yr) --

90 6 6006 6006 Ref:

Regulatorv Guide 1.109, Rev 1, Table E-5

EROL tam e 5.2.A-3 w = shoreline width factor (dimensionless) = 0.2.

Ref: Regulatory Guide 1.109, Rev.

1.

1.752E+5 = time period during which sediment is exposed to contaminated water (hrs) -(midpoint of plant life = 20 yrs)

A3 = udioactive decay cc,.c.stant of nuclide 'i' (hr-8 )

l ODCM Rev. 18 Page 74 l

4/97 12 = delay time for potable water pathway in hours to allow for nuclide decay during transport through the water purification plant and the water distribution system, Ref: Regulatory Guide 1.109, Rev. 1, App. A.

24 = delay time for potable fish pathway in hours to allow for nuclide decay during transport through the food chain, as well as during food preparation.

Ref: Regulatory Guide 1.109, Rev.

1, App. A.

1100 = factor +.o convert from Ci/yr per 8

f t /see to pCi/ liter.

110,000 = factor to convert from Ci/yr per 8

f t /see to pCi/ liter and to account for proportionately constant (100) used in sediment radioactivity model.

l ODCM Rev. 18 Page 75 >

l 4/97 1.4 Liouid Effluent Dose Proiections CDCM 13.2.4 requires that the liquid radwaste treatment syst un shall be operable and appropriate portions of the systems u- d to reduce the radioactive materials in liquid waste prior to their discharge when the projected doses due to the liquid ef fluent to UNRESTRIN AREAS would exces u

- 0.06 mrem /31 days to the total body or 0.2 mrem /31 days to any organ.

The applicable liquid radwaste treatment processing equipment f or maintainiL_i radioactive materials releases AIARA are delineated in Figure 1.4-6, Dose projections are made at least on, per 31-days by 1.he following equations:

Dg = (D./d)

31 days (1-8)

D, = (D_/d)

31 days (1-9) where:

D, g = the total body dose projection for the current 31-day period (mram).

D. -

the total body dose projection for the current calendar quarter as determined by equation 1-5, 1-6, and 1-7 (mrem).

D, = the maximum organ dose projection for the current 31-day period (mrem).

D. = the maximum organ dose to date for the current calendar quarter as determined by equations 1-5, 1-6, and 1-7 (mrem).

d -

the actual number of days in the currant calendar quarter at the end of the release (days). The minimum time elapsed is seven (7) days, i 31 days - the number of days of concern b

n

l l ODCM Rev. 18 Page 76 l 4/97 2.0 GASEOUS EFFLUENTS 2.1 Eadiation monitorina instrumentation and Controls The gaseous effluent monitoring instrumentation and controls at Limerick for co trolling monitoring radioactive material releases in accordance with the ODQ4 Part 1 are summarized as follows:

1) North Vent (Common): The plant gaseous discharges via this vent are monitored by two Particulate, Iodine and Gas (PIG) monitors (RY26-075A and RY26-075B) in parallel and by the Wide Range Accident Monitor (WRAM) (RIX26-076). The PIGS have separate Particulate, Iodine, and Gas sampling and monitoring channels but the Station ODCM Controls require only particulate and iodine sampling and noble gas monitoring. The WRAM has extended range (via three channels) noble gas monitoring and pa;rticulate and iodine sampling capability. In addition, the WRAM provides an isolation (Group A) of the large Drywell Purge and Vent valves.

2) South Vent (one per unit)- The plant gaseous discharges via each South Vent are monitored by two redundant PIG monitors (RY26-285A,B). As is the case of the North Vent, each PIG has separate particulate, iodine, and gas sampling and monitoring channels but the Station CF M Part I requires only particulate and iodine sampling with gas monitoring.

3) Hot Maintenance Shon (Commen)- Due to the composition of the radioactive materials in the effluent steam (i.e., very low potential for noble gas), this release point is sampled for particulate and iodine (P&I) monitors (RY26-025). The P&I monitor has a separate particulate and iodine sampling and monitoring channels but Station ODCM Part I requires only particulato and iodine sampling.

4) Auxiliary Boilers (Common) - Waste oil with some amount of )

radioactive particulate content may be burned in the site auxiliary boilers, as allowsd by 10CFR20.2004. In this case, the exhaust stack of the affected auxiliary boiler will be a release point for radioactive effluents. Doses calculated will be based on the radioactive content of the oil sampled prior to incineration. The radioactive l effluent will be summed with other effluents from the site and reported to the commission h the annual effluent report.

I,

l ODCM Rev. 18 Ptga 77 l 4/97 2.2 GASEOUS EFFLUENT MONITOR SETPOINT DETERM7 NATION ODCM I3.3.1 requires that an alarm setpoint be established for the noble gas effluent monitoring channels (RY26-075A,B,; RY26-185A.B,; RY26-285A,B,; and RIX26-076) to ensure that the release rate of radioactive materials does not exceed the limits of ODCd 13.3.2.a, which corresponds to a dose rate at the SITE BOUNDARY of 500 mrem /yr to the total body or 3000 mrem /yr to the skin. This specification hiso states that the dose rates from I-131, I-133, Tritium, and all radionuclides in particulate form with half-lives greater than eight days, shall be limited to a mavhmim of 1500 mrem /yr to any organ (inhalation pathway only).

ODCM Part I limits are expressed in terms of doce rate, while the instruments which monitor effluents produce data.in units of concentration or release rate. It is therefore necessary to identify the isotopes and calculate the corresponding release rate which will result in the dose rate limit being reachsd at the site boundary. Thib calculation is made more complex by the use of multf.ple release points at LGS.

Calculation Bases The alarm setpoint calculation is performed monthly and is based on analytical results of grab samples from the appropriate release pcint. The concentration of each identified radionu?lide in the grab samples is determined, and the data are used to perform a setpoint calculation for that nuclide mix and release point.

The highest calculated annual average concentration (X/0) for an area at or beyond the site boundary (:.1E-05sec/Nf, NE sector) is used in the setpoint calculation.

Mav4 ="m flow rates through the North and South vents are used in slarm setpoint calculations. This is necessary since flow can vary. By using maximum values, any flow less than the maximum will assure that the monitor will alarm before release rate lindts are nxceeded.

For each release point the noble gas release which would cause a SITE BOUNDAP.Y total body dose rate of 500 mrem /yr and a skin dose of 3000 mrem /yr is determined.

The fractional contribution of noble gas is cal ulated for each release point. The fractional contribution te ae whole body and skin dose rates due to noble gases is ca] .ated by taking

he product of this fraction and the limitin. .elease rate. A comparison of this release rate for whcle body and skin dose rates due to noble gas release is made to determine if the whole body or skin dose limit will be most restrictive. It is expected that the whole body limit will always be most restrictive, but the comparison is necessary to assure compliance with ODCM I. The sum of the contributions from each release point, independantly calculated for iodines and noble gases, will equal the maximum instantaneous release rate allowed from the site.

l l

ODCM Rev. 18 i

Page 78 l

l 4/97 1te purpose of calculating the release rate which corresponds to the site boundary dose limit is npa to determine an acceptab39 release rate, but to determine the maximum release rate which may be exceeded. It is D21 intended that releases will be maintained at or near this limit, and in fact, requirementt. to maintain offsite doses As Low As Reasonably Achievable (ALARA) are specified in ODCM 13.3.3 and ODCM I3.3.4.

2.2.1 North Vent Noble Gas Effluent Monitors - RY?6-075A-3.

EY26-075B-3. AND RIX2 6 - 076 - 2 The North Vent Noble Gas Effluent monitor high-high setpoint is calculated monthly based on the grab sample results performed in accordance with ODCM Table 13.3-3.

Due to the incorporation of the ALARA philosophy in the design and operation of the Limerick effluent t' stems, release point grab samples may not identify anl radionuclides. In this situation, chemistry may ase the results of the last grab sampie which identified radionuclides or use the default setnoint which is based on expected concentration ration as reported in the UFSAR. If any calculated alarm setpoint is less than the existing monitor setpoint, the setpoint will be reduced to the new value. If the cal:ulated setpoint value is greater than the existing value, the 3etpoint may remain at the lower value or increased to the new value.

2.2.1-1 Setooint Determinatign The High-High setpoint is calculated per equation (2-la) . The basis for the High-Righ setpoint is the Unusual Event Emergency Action Level Site Boundary Dose Rate of 0.114 mrem /hr. The High setpoint for the North Vent Noble gas Effluent Monitor is set at or below the lesser of the NVSPuown OR NVSPucsx value. (per equations 2-1 or 2-2) p" [VFa][500][ECm]

[ 3. 447 5E9] E [ ( Cm) (Kj) ]

2" NVSP(Hi-Hl)" s [3.4475E9]E((Cm) (K ) } [2] 3 (2-la)

. - - ~ . . - . .. - - . - .. .. -.- . - - ..

l ODCM Rsv. 18 P'aga 79 l 4/97

,p " [ VFal [3000] [E Cm) )

[3. 447 5ES) E [ ( Cm) (Lj +1.11N 3) )

where:

NVS P,,aw, = North Vent High Setpoint - Noble Gas Whole Body (pCi/cc)

NVSP m = Nc.th Vent High Setpoint - Noble Gas Skin (pCi/cc)

NVSP (Hi-Hi) ,eown = North Vent High-High Setpoint - Noble Gas

Whole Body (pCi/cc).

VF,meo = Fractional contribution to site boundary noble gas dose rate from the North Vent as calculated in equation 2-7. (unitiess).

500 - Total body dose rat.e limit (mrem /yr) ,

3000 - Skin Dose rate limit (mram/yr)

ECm = Total noble gas activity from North Vent grab sample (pCi/cc) 2 - Multiplication Factor to correspond to Unusual Event Emergency Action Level Site B9und!t.y Dose Rate Value

, of 0.114 mrem /hr. (Unitless) 3.4475E9 = Conversion factor (pCl) ( cc) '

m3 ) (pCl)

=(1.1E-5 sec/m8 ) (1E6 pCl/pCl) (664,000 cfm) (1/60 min /sec) (2.832E4 cc/ft 3)

(2-3) where:

i 1.1E-5 sec/m8 = highest annual average X/O (NE Sector) 1E6 pCi/pCi = units conversion 664,000 cfm = mavimnm North Vent flow rate for two unit operation 1/60 min /sec = units conversion 2.832E4 cc/ft 3

.= units conversion Cm = concentration of noble gas nuclide i as ;

determined by radioanalysis of North Vent grab sample (pCi/cc) !

J J

l

)

l ODCM Rev. 18 j Page 80 ;

l 4/97

& = Total body dose conversion factor for noble gas nuclide 1 (mrem /yr per pCi/d, from Table 2-1).

L, = Beta skin dose conversion factor noble gas nuclide 1 -(mrem /yr per pCim*, per Table 2-1) .

M. = Ganuna air dose conversion factor for noble gas nuclide 1 (mrad /yr per pCi/d, per Table 2 1).

2.2.2 South Vent Noble nam Effluent Monitors -RY26-185A-3, RY26185B-3, RY26-285A-3. AND RY26-285B-3 Each unit's South Vent Noble Gas Effluent monitor High setpoint is calculated monthly based on the grab sample results performed in acccrdance with ODCM I3.3-3. Due to the incorporation of the ALARA philosophy in the design and operation of the Limerick effluent systems, release point grab samplos may not identify any radionuclides. With this situation, chemistry may use the results of the grab sample which identified radionuclide or use the default setpoint which is based on expected concentration ratios as reported in the UFSAR. If any calculated alarm setpoint is less than the existing monitor setpoint, the setpoint will be reduced to the new value. If the calculated setpoint value is greater than the existing value, the setpoint may remain at the lower value, or increased to the new value.

4 2.2.2-1 Setyint determination The High setpoint for the South Vent Noble Gas Effluent Monitor is set at the lesser of the SVSP m and SVSP a ralue. SVSP m and SVSP a are calculated for each unit's South Vent.

The High-High setpoint is calculated per equation (2-4a).

The basis for the High-High setpoint is the Unusual Event Emergency Action Level Site Boundary Dose Rate of 0.114 mrem /hr.

gygp" g IVFm] [500] [IC 3,y)

[1. 2149ES) E [ ( C3 ,y) (Kj) ]

SVSP(Hi-Hl)" s [1.2149E9] E [ (C 3,y) (Kj)) (2)

(2-4a)

}~

l ODCM RT,v. 18 t

P2ga 81 l 4/97

,gygp" , (VFam) 13000) (ECin) zg_gy (1.2149E9) E ( (Cj ,y) (Lj+1.11M j) }

where SVSPwon = South Vent Setpoint - Noble Gas Whole Body (pCi/cc)

SVSPuosg - South Vent SJtpoint - Noble Gas Skin (pCi/cc)

VFavpo =

Fractional contribution to site boundary noble gas dose rate from the Unit's South Vent as calculated in equation 2-8 or 2-8a (unitless) 500 = Total body dose rate limit (mrem /yr) 3000 = Skin dose rate limit (mrem /yr)

IC, = Total noble gas activity from each unit South Vent grao sample (gCi/cc) 2 = Multiplication Factor to correspond to Unusual Event Emergency Action Level Site Boundary Lose Rate Value of 0.114 mrem /hr.

(Unitiess) 1.2149E9 = Conversion factor (pCl) (cc) 'l (m3 ) (pc/) .

=(1.1E-5 sec/m3) (1E6pCl/pCl) (234,000 cfm) (1/60 min /sec) (2.83F+4 cc/f t 3) (2 -6 )

where:

1.1E-5 soc /m 3

= highest annual average X/O (NE Sector) 1E6 pCi/pC3 = units conversion 234,000 c... = maximum South Vent flow rate 1/60 min /sec = units conversion 2.832E4 cc/ft 2

units conversion C,

concentration of noble gas nuclide i determined by radioanalysis cf South Vent grab sample !aCi/cc)

% = Total body dose conversion factor for noble gas nuclide 1 (mrem /yr per pCi/m',

from Table 2-1).

ODCM Rev. 18 Pays 82 l 4/97 4 = Beta skin dose conscrsion factor noble gas nuclide 1 (mrem /yr per pCi/m', per Table 2-1).

M. = Gamma air doJe conversion factor for noble gas nuclide 1 (mrad /yr per pCi/m',

per Table 2-1).

2.2.3 Noble Gas Effluent Practional Contribution The noble gas effluent fractional contribution is calculated monthly if activity in all 3 stacks is identified using results of the grX samples perfctmel in accordance with ODCM 11.3-3. The resul:.s of this calculation are used in equations 2-1, 2-2, 2-4, and 2-5. This methodology assumes that the total body dose is limiting for noble gas releases. If equations 2-1, 2-2, 2-4, and 2-5 show that the skin dose is limiting, fractional skin dose should be substituted for the whole body values used in equations 2-7, 2-8, and 2-Ba.

2.2.3-1 Calculation of VF m , VF m , and V'*sm VF** = E l (c ,) (K )) +E l (c32,) (K ) ) +E l (c,,y) (K ) ) ( 2 -7 )

s 3 3 3 i ' (2-C)

VF2 '" = E [ ( c,y) (K ) 3) -E [ ( c,',",) (K )3 ) +E [ ( c,,y) (K 3) )

VF '# (b " (2-8a) anw = g [ (c,p) (gi) ) .3 ( (c;,") (g,) ) 3 [ (c,,,, ) (gJ) )

i

l ODCM Rtv. 18 Ptga 83 l 4/97 where VFm,o = fracticaal cont'.fibutien to site boundary noble gas total body dose rate from the North Vent (unitless).

VFuywo = f ra .:t.ional contribution tG site boundary noble gas total Vent body) .dose (unitiess rate from the Unit 1 South VFavno = .' actional ccTtribution "a site boundary nuble gas total Vent S.>dy). dose rate Irom the Unit 2 South (unitless Cerv = concentration of noble gas nuclide i as determined by radioanalysis of North Vent grab sample (pCi/ce) ,

, K = total body dose conversion factor for noble gas radionuclide i (miem/yr per pC1/m')

Casy = concentration of noble gas nuclide i as

' determined by radioanalysis of Unit 1 South Vent grab sample (pci/cc)

Casy = concentration of noble gas nuclide i as

determined by radioanalysis of Unit 2 South Vent grab sample (pCi/cc) 2.2.4 Noble Gas Effluent Default SetDoint This met..todology may be used when grab sample results from either the North Vent or the South

, Vent do not identify any radionuclides, This r methodology is based on expected release l concentration ratios as outlined in s2ction 11.3 l of the Limerick UFSAR.

2.2.4-1 North Vent Noble Gas Monitors (RY26-075A-3 and RY26-075B-3). The default High setpoint for the North Vent noble gas effluent monitor is set at or below th.: NVSPyon value. (per equation 2-9).

gp" g [8. 9 0E-1] [500] [1.15E-6] (2-9)

[3 . 447 5E9] [4 . 3 0E-9 ]

NVSPN co s 3.45E-5 pCi/cc The Default High-High setpoint for the North Vent-Gas Effluent Monitor is calculated per equation (2-9a) .

Tire basis for the Defau2.t High-High setpoint is the Unusual Event Emergency Action Level Site Boundary Dose Rate of 0.114 mrem /hr.

I ODCM Rev. 18 Pace 84 l 4/97

~

"' [3. 4 47 5E9] [4. 3 0 -9)

NVSP (511-Hi)3ans 27.76 E-5 pCi/cc where:

NVSPge = Default North Vent High Setpoint - Noble Gas (pCi/cc)

NVSP(Hi-Hi)3op = Default North Vent High-High Setpoint - Noble Gas (pCi/cc) 8.90E-1 = Default fractional contribution to site boundary noble gas total body dose rate from the North (a Vent (unitiess)

, 4 . 3 0E-9 (4. 3 0E-9 ) + (5. 31E-10 )

I c

5 4.30E-9 - Summation 9t the North Vent concentration of

'W noble gao nuclide i avltiplied by the

N correspr nding whole body dose f actor, it .

P (pci) (mrem) (m 3)

(cc) (yr) (pCl) ,

5.31E-10 = Summation of the South Vent (Unit 1 & 2) concentration of noble gas nuclide i multiplied by the corresponding whole body dose factor.

(pc3) (mrem) (m8 )

(cc) (yr) (pCl)

Ref: a) Based on expected annual release from UFSAR Table 11.3 1.

b) Based on mmvirmur. North Vent flow of 664,000 cfm and South Vent flow of 234,000 cfm for Unit 1 and Unit 2 ven*.s.

c) ODCM II Table 2-1.

500 = Total body dose rate lh lt (mrem /yr)

M

l l ODCM R7,v. 18 l Pcgs 85 l 4/97 1.15E 6 = Total noble gas concentration from North Vent (pCi/cc)

Ref: a) Based UFSAR Table 11.3-1.

b) Based on maximum North Vent flow of 664,000 cfm 2 - Multiplication Factor to corruJpond to Unusual Event Emergency Action Level Site Boundary Dose Rate Value of 0.114 mrem /hr. (Unitiess) 3.4475E9 = Conversion factor (pCl) (cc) '

(m3) (pCl) ,

4.30E-9 = Summation of the North Vent concentration of noble gas nuclide i multiplied by the corres;>onding whole body dose factor.

(pCl) (mrem) (m 2)

( cc) (yr) (pC.f )

Ref: a) Based UFSAR Table 11.3-1.

b) Based on maximum North Vent flow of 664,000 cfm.

c) ODCM II Table 2-1.

I ! ODCM Rev. 18 Page 86 l 4/97 2.2.4-2 South Vent Noble Gas Monitors (RY26-185A 3, RY26-285A-3, RY26-185B-3, and RY26-285B 3).

The default High setpoint 1.or each Unit's South Vent noble gas effluent monitor is set at or below the SVSPuco value. (per equation 2-10) gygp" g [5.49E-2) [500) [7.14E-8) (2 - 10)

[1. 2149E9) [2. 65E-10)

SVSPuon s 6.09E-6 pCi/cc The default High-High setpoint for each units South Vent Noble Gas Effluent Monitor is calculated per equation (2-10a) .

The basis for the default High-High setpoint is the Unusual Event Emergency Action Level Site Boundary Dose Rate of 0.114 mrem /hr.

[500) [7.14E-8) (2-10 a) gygp* , [1.2149E9] [2.65E-10] [2]

SVSPNous .'.22E-4pCi/cc where:

SVSPsan = Default South Vent Setpoint - Noble Gas (pCI/cc)

SVSP(Hi-Hi)noo = Default South Vent Setpoint - Noble Gas (pCI/cc) 5.49E-2 - Default fractional contribution to site boundary noble gas total body dose rate from the South Vent (unitiess)

, 2.65E-10 (4. 3 0E-9 ) + (5. 315-10) where:

2.65E-10 = Summation of the Unit's South Vent concentration of noble 9as nuclide i multiplied by the corresponding whole body dose factor.

(pci) (rzem) (m 2)

(cc) (yr) (pci) 4.30E-9 =

Summation of the North Vent concentration of noble gas nuclide i multiplied by the corresponding whole body dose factor.

nii SO.

. <> g)

IMAG. EV ALU ATION

/////

gyt:Ah ,.., - ., -

,, ,M/,4

p 1.0 lf 2 Bla

((f Hai!

l-l E t:

m Me s=m

.4 l,h 4- 150mm >

< 6" >

+

d m#/-

%>, #4\ v D

O

('HOTOGRAPHIC SCIENCES CORPORATION 770 BASKET ROAD P.O. BOX 338 WEBSTER, NEW YORK 14580

+s%[f. A

'h4/ik' t

Ad g, l l

(716) 265-1600

d

'$l&@

'& IMAGE EVALUATION <' e

'[ qi!* TEST TARGET (MT-3)

/

fbje (p

// E 's y},?

2 V/ & gyp /Q %*

a b:bh hs

!" g22 l- a.c ==

l,l U"

kN M8 1.25 1.4 1.6 4 150mm >

6" *

+h#O Yt N ?'t>

ey S '

s,%

! ^

^

j e>Dc PHOTOGRAPHIC SCIENCES CORPORATION

.,D6e,4 4 ..

h 770 BASKET LOAD P.O. BOX 338 d(4hf'p, p d(O, WEBSTER, NF.W YORK 14580 4 (716;265 1600

pL*

4& o

%* IMAGE EVAL.UATION ///'p/

/@

TEST TARGET (MT-3) q)yle,h+

f g>+q,*' %gY*[6 0

l I.0 E2 M

! y @ E4 ii sm m EM 1.25 1.4 1.6 4 150mm *

< 6" >

+ft

%i /f4% A

% , hF __,==gg. e _ ++,++j,4 1 WEBSTER NE YORK 14580 (716) 265 1600

+$*

d) 'iO i

\' /.

O 't @, "* g,$g, IMAGE EVALUATION ////gf O,h

S

\///// i' %9 ;-

TEST TARGET (MT-3) NN/ f[)'@ ^*

+ v I.0 Fm" 2 L

L iM !!![=!

i= 2 2 l,j f hf L4

<;; i.25 i.4 i6 4 150mm >

4 6" >

/f4%#

') PHOTOGRAPHIC SCIENCES CORPORATION l h 770 BASKET ROAD 4(@4p+b 1,, 4 P.O. BOX 338 4g3 WEBSTER, NEW YORK 14580 L '

(716) 265 1600

l- ODCM rov. 18 Page 87 l 4/97 (s ci) (mram) (m*)

(cc) (yr) (pCl) ,

5.31E-10 =

Summation of the South Vent (Unit 1 & 2) concentration of noble gas nuclide i multiplied by the corresponding whole body cose factor.

(pci) (mram) (m 3)

(ce) (yr) (pCf) ,

Ref: a) Based on expected annual release from UFSAR Table 11.3-1.

b) Based on maximum North Vent flow of 664,000 cfm and South Vent flow of 234,000 cfm for Unit 1 and Unit 2 vents.

c) ODCM II Table 2-1.

500 = Total body dose rate limit (mram/yr) 7.14E-8 = Total noble gas concentration from North Vent (pCi/cc)

Ref: a) Based UFSAR Table 11.3-1.

b) Based on maximum North Vent flow of 664,000 cfm.

1.2149E9 = Conversion factor (pCl) (cc)

(m3 ) (pCl) ,

Reft a) ODCM II equation 2-3 2.65E-9 = Summation of the North Vent concentration of noble gas nuclide i multiplied by the corresponding whole body dose factor.

~

(pCl) (ce)

(m3 ) (pC3) ,

2 = Multiplication factor to correspond to Unusual Event Emergency Action Level Site Boundary Dose Rate. (Unitless)

_ - ~ . _ . _ _ _ _ _ . - . _ _ . . _ _ _ _ _ _ . . _ . _ .__ _. _ _ . _ . _ . _ _ . _ _ . _ _ . .

-j l ODCN Rev. 18 .

Page 88

, 4/97 ,

Reft a) Based UFSAR 7 dbl 6 11.3-1.

b) Based on maximum-North Vent flow of 664,000 cfm._ )

.c) ODCM II Table 2-1.

2.2.5 Mida ennae Accident hns tor Noble f1am Effitient Wnitor leTY-26-076-4)

The Wide Range Accident Monitor (WRAM) noble gas total effluent channel displays the North Vent noble gas release rate. This monitor has Main-Control Room Annunc4.ation as well as a group 6A-isolation function on the primary containment purge and vent valves. The isolation setpoint value of s2.1 gCi/cc-specified in Technical Specification 3.3.2-2 is based on the-accident dose limits for containment purge during an accident (Ref:- UFSAR Section 1.13). - For routine operations.the total effluent alert and high setpoints are based upon the methodology of

-Sections 2.2.5-1 and 2.2.5-2. The setpoint units are in microcuries per second using the two unit maxiu.am Ncrth Vent flow rate of-- 664,000 scfm. The total effluent channel High-High setpo'.nt is set at a value less than or equal to ten times the High setpoint (not to exceed the 2.1 pCi/cc equivalent using the two-unit =av4== North Vent flow rate).: These values are always.more

-conservative than the Technical Specification Table 3.3.2-2 required value of s 2.1pci/cc.

If the calculated.setpoint value is less than the existing monitor setpoint, the setpoint will be ,

reduced to the new value. If the calcula.ted-setpoint is greater than the existing value, the setpoint may remain at the lower value, or increased to the new value.

s U

1__i._'_.__.____t.____________'__.___

~ .~.s ,,,,--.-,a y s----, -,-w. -~----e

i l ODCM R;v. 18 !

P;ga 89 l 4/97 2.2.3-1 Epetine Doerations Hioh Setooint Determination For routine operations, the High setpoint for the WRAM Noble Gas total effluent channel is set at or below the lesser of the NVSPuov, OR NVSPuog value.

This setpoint is calculated to ensure compliance with Section 3.3.2.

yygg " g [VFmm) (500) [E Csni

[3. 447 5E9] E [ (Cgy) (Kj) ]

ggp" g [VFnwl [3000] [E Cfn] )

[3. 4475E9] E [ (C3y) (Lj + 1.11Mg) ]

where:

NVSPuaw, = North Vent Setpoint -

Noble Gas Whole Body (pCi/cc)

, NVSPuog = North Vent Setpoint -

Noble Gas Skin (pCi/cc)

VFuvua =

Fractional contribution to site boundary noble gas dose rate from the North Vent as calculated in equation 2-7.

(unitless).

500 = Total body dose rate limit (mrem /yr) 3000 - Skin Dose rate limit (mrem /yr)

ICm = Total noble gas activity from North Vent grab sample (pCi/cc) 3.4475E9 =

Conversion factor)

(pCl) (cc)

(m3 ) (pCl) ,

= (1.1E-5 sec/m ) (IE6pCl/pCl) (664,000 cfm) (1/60 min /sec) (2.832E4 cc/33) (2-3) 3 where:

1.1E-5 sec/m' = highest annual average X/Q (NE Sector) 1E6 pCi/pCi = units conversion 664,000 cfm =

maximum North Vent flow rate for two unit operation

. _ . - ... . . . = _ . . . . . . - - _

ODCM Rev. 18 l

Page 90 4 /9*7 l

1/60 min /sec = units conversion 2.832E4 cc/f t' = units conversion Cm = cancentration of noble gas nuclide i as determined by radioanalysis of North.

Vent grab sample (gCi/cc)

% = Total body dose conversion factor for j noble gas nuclide 1 (mrem /yr per pCi/m , 8 from Table 2-1).

4 - Beta skin dose conversion factor noble gas nuclide i (mram/yr per pCi/m', per Table 2-1).

M, = Gamma air dose conversion factor for noble gas nuclide 1 (mrad /yr per pCi/m , 8 I per Table 2-1).

I Thesetp=ointvaluesareconvertedfrom#Ci/cctopCi/secusing the - = two-unit North Vent flow rate:

NVSPnw = [NVSPmw] [3.134E8] (2-14)

NVSPum = [NVSPmal [3 .1*14E 8]. (2- 15 )

where:

NVSPnw = WRAM total etfluent channel North Vent !

High Setpoint - Noble Gas Whole Body (pCi/sec).

NVSPnm - WRAM total effluent channel North Vent High Setpoint - Noble Gas Skin (pCi/sec) .

NVSPmn = North Vent High Setpoint - Noble Gas Whole Body (pci/cc) . 4 NVSPma - North Vent High Setpoint - Noble Gas Skin (pci/ac) .

3.134E8 = Conversion factor (cc/sec).

= (664,000 scfm) (1/60 min /sec)

(2.832E4 cc/f t')

(2-16)

I l

l ODCM RT,v. 18 P;go 91 l 4/97 2.2.5 2 Routine Doerations Mich-Hiah Setnoint Determination For routine operations, the High-High setpoint for the WRAM Noble Gas total efflutnt channel is set at or below ten timo the lesser of the routine operations NVSP m or NVSP m value.

NVHPm = [NVSP m ) [10) (2-17)

NVHPm = [NVSP m) [101 (2-18) where:

NVHPnw, = WRAM total effluent channel North Vent j High-High Setpoint Noble Gas Whole Body '

(pci/sec).

NVHPug e WRAM total effluent channel North Vent i

. High-High Setpoint Noble Gas Skin (pCi/sec).

NVSP m = WRAM total effluent t/nnel North Vent Setpoint - Noble Gas Stole Body

(pCi/sec).

NVSP m = WRAM total effluent channel North Vent Setpoint - Noble Gas Skin (pCi/sec) .

10 = multiplication factor to calculate High value (unitless) 2.3 Gaseous Effluent Dose Evaluation The Annual gaseous effluent dose evaluations are per2crmed using the computer based RM 21A report processor.

Instantaneous Offsite Dose Calculations are performed with the MesoRem Jr Common Dose Model computer program. The following sections describe the computational models, assumptions and bases. Emergenc? dose. calculations are performed using the MesoRem Jr Ccumon Dose Model computer program.

Monthly dose calculations are performed based on limiting sector average annual meteorological dispersion parameters. For the noble gas monthly dose calculation, effluent release data are based on'the latest grab sample analysis for.radionuclide composition and the hourly average effluent monitor response for total release activity. For the iodine and particulate monthly dose calculations, the effluent release radionuclide composition and release activity are based on the continuous composite samples for the time period of the dose calculation.

The quarterly dose calculations are a summation of the applicable monthly ~ dose results.

T w --

l l ODCM Rev. 18 Page 92 t 4/97 The annual dose calculations are based on the actual meteorological conditions concurrent with the effluent ,

releases. Wind direction, temperature lapse rate, ambient temperature, ground level windspeed, ar' release elevation windspeed are provided for each hour of one year. The meteorological dispersion values (X/0, depleted X/0, and D/Q) are calculated for each hour and linked with the corresponding release data. The effluent release radionuclide composition and activity are based on the same parameters as the monthly dose analyses.

2.3.1 Site Boundary Dose Rate - Noble Gaseg ODCM I3.3.2.a limits the dose rate at the SITd BODNDARY due to noble gas releases to c500 mrem /yr total body and s3000 mrem /yr skin. Radiation monitor alarm setpoints are established to ensure that these release Ibnits are not exceeded.

Simultaneous releases from the North and South Vents are considered in avaluating compliance with the release rate limits of ODCM 13.3.2.a following any releases exceeding the alarm setpoints.

Monitor indications (readings) are averaged over time periods not to exceed 15 minutes when determining noble gas release rete based on correlation of the monitor reading and monitor sensitivity. The 15-min averaging allows for reasonable monitor response to potentially changing radioactive material concentrations and to exclude potential electronic spikes in monitor readings that may be unrelated to radioactive material releases. When identified, electronic spiking monitor responses are being excluded from the dose calculation.

NOTE: For administrative purposes, more conservative alarm setpoints than those required to meet 10 CFR 20 Dose Rate limits are iuposed. However, conditions exceeding these more limiting alarm setpoints do not necessarily indicate radioactive material release rates exceeding the dose limits of ODCM I3.3.2.a. Provided actual releases do not result in radiation monitor indications exceeding values based on the dose rate limits of ODCM I3.3.2.a, no further analysis are required for demonstrating compliance with the limits of ODCM I3.3.2.a.

_ - = = - -: - =

l' ODCM Rev. 18 P0g3-93

-l 4/97 In the event of a noble gas effluent release exceeding the setpoint value specified in ODQ4 II sections-2,2.1 or 2.2.2, the site boundary dose rate from the release is calculated using the methodology stated below. This methodology is based on worst sector (NE) annual average meteorological dispersion but, if further refinement is required to meet the requirements of ODCN I3.3.2.a actual meteorological data from the time period of-concern may be used to calculate-actual meteorological dispersion.

Dem= (53. 882 ) (X/0) '17(( (F,) (0,) 3 + (F 2,) (0 ,)32 + (F,RV) (Oj,y) ] KjJ (2-22

, J'8 ,

b [ [(F,) (0,)1 + (F SV)

'** 2 (0 42,) + (F SV)2 (Olm))Ls)

Dm= (53. 882) (X/0)

'(SF) b [(F,) (Oj,) + (F SV) 2 (Of2n) + (Fan) (Osm)lNJ Il 11)

Je3 ,

(2-23) where:

De = Total Body Plume Dose Rate (rem /hr) !

Da = Skin Plume Dose Rate (rem /hr) 53,882 = Units conversion-factor rem-m'-pCi-yr-min-cc '

, y C.i-br-mrem-m'-sec-f t' X/Q = 1.1E-05 highest annual average relative concentration (NE Sector) (sec/ng)

Fwy = North Vent Flow Rate-(cfm)

Om = concentration of noble gas nuclide i during period of release from North Vent (pCi/cc)

F isy =

Unit 1 South Vent Flow Rate (cfm)-

Qiisy - Concentration of noble gas nuclide i during period of-release from Unit 1 South Vent

( C1/cc).

Fay =

Unit 2 South Vent Flow Rate (cfm)

l- ODCM Rev. 1.

Page 94 l ' 4/97-Qany = Concentration of noble <ps nuclide-i during

$ period of release from cr.it 2 South Vent (pci/cc).

6 = Total body dose factor for noble gas nuclide

1. Values are listed in Table 2-1.

arem-m' pC1-yr, t

4 Li = Skin dose factor for the beta contribution for noble gas nuclide 1. Values are listed in Table 2-1.

arem-m 3 pCi-yr ,

1.11 = the average ratio of tissue to air energy absorption coefficients (mram/ mrad) (Ref:

Regulatory Guide 1.109 Section 2.2)

SF = 0.7 is the attenuation tactor that accounts for the dose reduction due to shielding-provided by resident!.a1 structure (dimensionless) (Ref: Regulatory Guide 1.109 Table E-15).

M, = Gansna air dose factor for noble gas nuclide

1. Values are listed in Table 2-1.

mrad-m3 pCi-yr ,

2.3.2 Site Botmdarv Dome Rate Radiciodine and Particulates e-ODCM I3.3.2.d limits the dose rate to s1500 mram/yr--to any organ (inhalation pathways only) for I-131, I-133, Tritium, and all radionuclides in particulate form with half-lives greater than 8 days in gaseous effluents.

Compliance with ODCM I3.3.2.d is determined monthly by performance of ODCM II Section 2.3.4.

Simultaneous releases from the Nort.h and South Vents

.are considered in evaluating camp.:.iance with the release rate-limits of ODCM I3.3.2.b. Release activity is based upon the-results of the continuous composite sampler analysis performed in accordance with ODCM

' Table I3.3-3.

l l

l

f l ODCM Rtv 18 Paga 95 l 4/97 This methodology is based on the worst sector (NE) I annual average meteorological dispersion but, if further refinement is required to meet the limits of '

ODCM I3.3.2.b, actual meteorological dhta from the time period of concern may be used to calculate actual meteorological dispersion.

2.3.3 Noble Gas Air Doses ODCM 13.3.3 limits the air dose due to noble gases released in gaseous effluents (from both reactor units) to areas at or beyond the SITE BOUNDARY to:

s 10 mrad gamma for any quarter s 20 mrad beta for any quarter s 20 mrad gamma during any calendar year s 40 mrad beta during any crlendar year As required by ODCM 13.3.3.1 Surveillance Requirement, these doses are calculated at least once per 31 days using the results of the most recent grab samples for isotopic composition performed in accordance with ODCM Table 13.3-3 when release point grab samples do not identify any radionuclides. Total release activity is based upon the hourly average effluent monitor response. As identified, electronic spiking monitor responses are excluded from the release activity analyses. The monthly dose calculation is performed using the most limiting average annual meteorological dispersion values. The quarterly doses are based on the surmation of the applicable monthly results. The annual dose calculations are based upon actual release meteorological conditions as dencribed in Section 2.3.5. The monthly dose calculations are performed in accordance with the methodology below.

DAIR= (0.114 ) (1,11E-5) (47 2) E [ (F,) (C3 ,) + (F2y)(C32y) + (Fay) (C3 ,y) ] M; (2-24 )

2 3 ,) + (F2y)(C42n)e(F2y)(C3 ,y))N3 (2-25)

Dp AIR = (0.114 ) (1.11E-5) (47 2) E [ (F,) (C 4

where:

D,rm - Gamma air dose fram noble gas releases (rad /hr)

Dua = Beta air dose from noble gas release (rad /hr) 0.114 - Units conversion rad-pCl-yr '

, p ci-hr-mrad 1.1E-5 = Highest average annual relative concentration (PE Sector) (sec/m?)

472 = Units conversion

l ODCM Rev. 18 Page 96 l 4/97 min-see sec-ft',

Fm = Average North Vent Flow rate f or period of release (cfm)

Cwy = Concentration of noble gas nuclide i from North Vent ef21uent (pci/cc)

F :v = Average Tinit 1 South Vent flow rate for period of release (cfm)

Cusv - Concentration of noble gas nuclide i from Unit 1 South Vent effluent (pCi/cc)

F2sv = Average Unit 2 South Vent flow rate for period of release (cfm)

Quv = Concentration of noble g_ nuclide i fran Unit 2 South Vent effluent (pCi/cc)

M, = Gamma air dose factor for noble gas nuclide i.

Values are listed in Table 2-1.

mrad-m3 pC.i-yr .

N, = Beta air dose factor for noble gas nuclide i, values are listed in Table 2-1.

mrad-m3 pC1-yr ,

2.3.4 Radiciodine and Particulate Dose Calculations ODCM I3.3.4 limits the dose (from both reactor units) to a .J A ER OF THE PUBLIC from I-131, I-133, Tritium, and all radionuclides in particulate form with half-lives greater than 8 days in gaseous effluents released to areas at or beyond the SITE BOUNDARY to:

s 15 mrem to any organ during any calendar quarter s 30 mrem to any organ auring any calendar year As required by ODCM I3.3.4.1 Surveillance Requirement, these doses are calculated at least once per 31 days using the results of the continuous composite s g le analysis performed in accordance with ODCM Table I3.3-3. Due to the incorporation of the ALARA philosophy in the design and operation of the Limerick effluent

= l- ODCM Rev. 18 POga 97

-l 4/97 systems, these composite samples may not identify

! any radionuclides. Total release activity is-based upon detectable concentration of the continuous composite samples and average appropriate vent flow during the sampling period.

The .nonthly dose calculation is performed using the most limiting average auntul meteorological dispersion values. The quarterly doses are based

on the sumnation of the applicable monthly results. The annual dose calculations are based upon actual release meteorology as described P Section 2.3.5. The monthly dose calculations . .

performed in accordance with the methodology below. Total organ dose is obtained by the summation of the organ dose from each pathway for each receptor.

2.3.4-1 Ground Pathway Do ,, = (3. 6 E-6 ) (47 2) (1. 82E-9 ) E, 35 -

E [ (Fyy) (0,y) 3 + (Fgy) (033,) + (F,,y) (03 ,,y) + (F ) (0 3 ) ) DF,,,,3,, (T g) (2-26) 2.3.4-2 y.ggetation. Maat. Cow Milk. and Goat Milk Pathway Dv,, = ( 3. 6 E-6 ) (47 2 ) I

,a <

( (F,y) (O,) + (F2,y) (Ojj,y) + ( F ,y) (Oj,,y) + (F ) (03 m) ) (1.1E-5) DF,,,,3,, +

'r as <

(Te)

, (F,y) (0.,y) + (F2 ,y) (Dj,,y) + (F as v) (OJ sv) + (Fm) (0 3 m)] (1. 82E-9 )DF,,,,3,,,

(2-27) e- ~~r sw

. .- --~ ~ . . - . - --- _ . . . - - - - ~ _ -

l ODCN Rev. 58 !

Page 98 l 4/97 2.3.4-3 Inhajatior2 Pathway Dun = (3.6E-6) (472)I '

E I (Fw) (0,..)

1 + (F2 y) (0 42 w) + (F an) (0 :n) 4 + (Fm) (Osm) ) (3 .1E-5) DFr,z,y +

.'

1

( T,)

' al g [ (Fw) (Oguy) + (Fgn,,a iG3,) + (Fasv) (0 4:sv) + (Fm) (Osm) ) (1. OE-5) DFg,3,,,

(2-28) where:

Daru = dose from ground pathway due to release of particulates and lodines (rem).

Dv,a = dose from vegetation, meat, cow .nilk, and goat milk, pathways due to releases of particulates, iodines, and tritium (rem)

D,a = dose from inhalation pathway due to release of particulates, iodines, and tritium (rem) 3.6E-6 = unit.s conversion factor rem-Cl-sec hr-mrem-p C1, 472 = units conversion factor

{ min-cc' t sec-fc.

1.82E-9 = highest average annual deposition (ESE Sector) l

. m8 I = summation for each release time period t (unitless).

Fw -

average North Vent-flow rate during' release (cfm).

Om = concentration of nuclide I from North Vent effluent (pC1/cc).

F isy = average Unit 1 South Vent flow rate during '

l ODCM rov. 18 P2g3 99 l 4/97 release (cfm) .

Onsv = concentration of nuclide i from Unit i South Vent effluent (pCi/cc).

Fay = average Unit 2 South Vent flow rate during release :fm).

Qmm = concentxtcion of nuclide i from Unit 2 South Vent effluent (pCi/cc).

Fma = average Hot Maintenance Shop flow rate during release (cfm).

Qems = concentration of nuclide i from Hot Maintenance effluent (pCi/cc).

DFus.LN = dose factor for organ type k, age group 1, pathway number n; dose factors are based on a compucer program which is similar to the NRC program GASPAR results from this program provide input data in the form of a lookup table - values of DFa are provided in Table 2-2.

i = isotope number (1 through 35) (3 through 17 are noble gasus).

K = organ type (1 through 8, where total body = 1, GI tract = 2, bone = 3, liver = 4, kidney = 5, thyroid = 6, lung = 7, skin = 8).

L = age group (1 through 4, where adult = 1, teen = 2, child = 3, infant = 4).

N = pathway number (1 through 7).

T, =

time duration of release (hrs).

1.1E-5 = highest average annual X/Q (NE Sector) (sec/d) .

1.0E-5 = highest average annual depleted X/Q (NE Sector) (sec/W) .

\

2.3.5 Annual Dose Evaluation ODCM I3.6 requi es an Annual Dose evaluation be performed and reported in accordance with Regulatory Guide 1.21 in the Annual Radioactive Effluent Release Report submitted 60 days after the first of each year. This dose evaluation is processed by the RM-21A. In the event that this computer model is unavailable, this anal be performed using the same methodology.ysis Thecan liquid portion of this annual dose calculation is described in Section 1.3 of ODCM II. The annual gaseous dose calculation uses the same methodology deLcribed in Section 2.3.1, 2.3.3, and 2.3.4 with tha exception of meteorology; which is based upon

l

-l- ODCM Rev. 18 Page-100 l; 4/97 actual sector average-atmospheric dispersion = I valuee using the guidance of Regulatory Guide--

l 1.111 (Section C ic) . Finalized hourly values of wind direction, ground level and release elevation !

wind speed, Asient temperature, and temperature: '

lapse rate (for P-G staDility class) are provided.

annually using the instrumentation specified-in -

ODC34 13.1- 1. These values are calculated for each hour =and linked to the corresponding hourly ,

averaged effluent releans rate.- Doses'are then calculated for each hour at the various receptors -

of interest (depending upon release direction).

Radioactive material release rate is calculated as ,

described in Sections 2.3.3 and 2.3.4. Dose at each receptor is accumulated for the year and the

-4="a dose for plume, inhalation, and ingestion-pathways-are reported. The gaseous affluent Cose:

receptors are listed in Table 2-4 and the dose is calculated using the methodology below.

2.3.5-1 Pluma Pathway Drumaa= (3.6E-6) (472) E (X/0) b ( (F,) (Om) + (Fm)(Osm)+(Faw)(Osm)3 e CJ o3

[e (*143 */ut)(DFja) Te) (2-29 )

2.3.5-2 Ground Pathway DeAAA"(3*Of*b)(472)Z(E/O)'

(OIfM) (T ) e

2'3, (Fm) (0 4m) + (Fas) (Dams) '

(2-30) 2.3.5-3 yeaetation. W- t . Cow Milk. Goat Milk Pathway Dm = "(3.6K-6) (472) Ee E ( (F,) (Om) + (Fm) (0 m) 4 + (Fm) (Osm) + (Fme) (03ms) ) [ (X/Oc) ) (DFJ,r,z,w) +

8'1 (Tc)

' 35

, 1 [ (Fw) (Oy) + (F n) 2 (D m) J (Faw) (O m) l + (Fms) (Olms)) [D/0) e(DF3 ,x,t,,)

(2-31)

.._ . .. . - . - . - . . . - - - - . _ - -...__.-- _~ ._. -- -. .- -- -

l ODCM rov. 18 P go 101 l l 4/97 3

2.3.5 4 Veoetation. Maat. cow Milk. Goat Milk Pathway l

Dnw = (3.6E-6) (472)E t .

,g

[ (Fw) (Om) + (Ft ,y) (Dj,,y) + (F ,) (Og,y) + (Fm) (Of m) ) [ (X/0,) ) (DF4 r.t,w)

L, (T e)

( (Fw) (Om) + (F is v) (044sv) + (Fan) (D i nv) + (Fm)(Dam))[D/pg) (DFj,g,3,y)

(2-32) where:

De - annual dose from plume pathway (rem)

Do,m = annual dose from ground pathway (rem) y,m - annual dose f rom vegetation, ; eat, cow milk, and goat milk pathways (rem)

D,m = annual dose from inhalation pathway (rem) 3.6E-6 = units conversion factor rem-Cl-sec'

. , hr-arem-pC1, 472 = units conversion factor

' min-ce'

,sec-ft, C = sumation for each release time period t (unitiess).

(r/Q), = relative concentration *or t.ime period "t" (sec/m') .

Fm = average Ncrth Vent flow rate during release (cfm).

Om = concentration of nuclide i from North Vent effluent (pCi/cc).

F isy - = average Unit 1 South Vent flow rate during release (cfm).

Qasy . = concentration of nuclide i from Unit 1 South Vent effluent (pCi/cc).

Fay = average Unit 2 South Vent flow rate during release (cfm).

p y ~ - -w -- .

w

l ODCM Rev. 18

Page 102 l 4/97 Qay = concentration of nuclide i from Unit 2 South vent effluent (pC1/cc). j hi - decay constant of nuclide 1 (sec 3) .

dr = distance to receptor "r'.

u, = average windspeed for tLne period atS (m/sec).

DF m = dose factor for organ type k, age group 1, pathway number n; dose factors are based on resulte of a computer program that is based on and is similar to the NRC program GASPAR; results from this program provide input data in the form of a lookup table - values of DFu are S ovided in Table 2-2.

i = isotope number (1 through 35) (3 through 17 are noble gases).

K = organ type (1 through 8, where total body = 1, GI tract = 2, bone = 3, liver = 4, kidney = 5, thyroid = 6, lung = 7, skin -

8).

L = age group (1 through 4, where adult = 1, teen = 2, child = 3, infant = 4).

N = pathway number (1 through 7).

T, = time durat.;7 of release (hrs).

Fma = average Hot Maintenance Shop flow rate during release (cfm).

Omus = concentration of nuclide i from Hot Maintenance Shop effluent (pCi/cc).

(D/Q), = de osition concentration fcr tLne period 't" (1 af) .

(X/Q.g) = relative depleted concentration for time i period "t" (sec/n?) .

l 2.4 Gaseous Effluent Dose Proiection ODCM I3.3.5 requires the ' VENTILATION EXHAUST TP.EA' DENT SYSTEM be used to reduce radioactive material levels prior to discharge when projected doses from both units to areas at and beyond the SITE BOUNDARY would exceed 0.6 mrem to any organ in a 31 day period.

l I

E

l ODCM R v. 18 P;ga 103 l 4/97 i The applicable gaseous processing systems for maintaining radioactive material releases ALARA are the Gaseous Radwaste Treatment System and Exhaust Treatment System in )

Figures 2 1 and 2-2.

A dose projection is performed at least once per 31-days by the following equation: )

Dma.cp = (Dmax/d) = 31d (2-33) where: I Dmaxp = maximum organ dose projection for current 31-day period (mrem)

Dmax = maximum organ dose to date for current calendar quarter as determined by equation (2-26) (2-27) or (2-26) (mrem).

d = number of days remaining f.n current calendar quarter. The minimum time elapsed is seven (7) days.

31d = the number of days of concera.

3.0 Special Dose Analysis 3.1 Total Dose to MEMBERS OF THE PUBLIC ODCM I3.3.7 requires that the annual dose or dose commitment to any MEMBER OF TEE PUBLIC, due to releases of radioactivity and radiation, from the uranium fuel cycle shall be limited to:

s 25 mrem whole body or any organ except thyroid s 75 mrem thyroid ODCE I3.3.7.2 Surveillance Requirement requires that cumulative dose contributions from direct radiation from operations be evaluated when the calculated dose from the release of radioactive materials in liquid or gaseous effluents exceed twice the limits of ODCM 13.2.3.a, 3.2.3.b, 3.3.3.a, 3.3.3.b, 3.3.4.a, or 3.3.4.b. The direct radiation contribution shall ba determined by the methodology described below. This methodology calculates the direct radiation contribution which then must be added to the dose or dose commitment determined in accordance with sections ODCM III.3.1, 2.3.3, and 2.3.4 to determine total dose from all pathways. This evaluation of direct radiation contribution is in accordance with ANSI /ANS 6.6.1-1979 Section 7. The error using this method is estimated to be approximately 8%. The following evaluation is performed for each receptor of concern.

Dani = D77to: - D x ,xo - D itm, (3-1)

_-_ _ _ _ _ - _ _ _ . _ . . _ . . . _ . . . . _ . ~ - _ . _ _ _ _ _ _ _ _ , . _ _

l ODCM Rev.-10 Page 104 l __ 4/97 where:

Doan = cumulative dose contribution from direct radiation at receptor 1 (mram).

NOTE: Due-to the statistics ofLradiation measurements and to the conservation of effluent calculations it is-In this plausible situationthe the D,lue va for Dansmay yield be shall a negativa reportedvalue. as zero (0) . .

Dmm = total dose at receptor _of interest (as eve.luated by TLD measurement) (mram) .

NOTE: If there is not a TLD location at the actual receptor '

location, a more conservative location will be used to evaluate Total Dose.

Dx,so = mean of the background dose as evaluated by TLDs at background sites (mram).

D i am,= effluent contribution to dose (as evaluated-in sc etions 2.3.3 and 2.3.4.1) .

3.2 Dosas Due to Activities Inside the SITE BOUNDARY In accordance with ODCM I3.6, the Annual Radioactive affluent Release Roport submitted within 60 days after January 1 of each year shall include an assessment of radiation dose from radioactive liquid and gaseous effluents to MEMBERS OF THE PUBLIC due to their activities inside the SITE BOUNDARY.

There are three locations within the SITE BOUNDARY that~are accessible to MEMBERS OF THE FUBLIC for activities unrelated to the operation of Limerick Station. These locations are:- 1) the railroad tracks which run along the river within the SITE BOUNDARY;

2) the Limerick Atomic Information Center, on Longview Road next to the 500kv substation; and 3) Pricks Lock environmental-laboratory,-operated by RMC Environmental Services, Inc. Of these three locations, the railroad tracks are the closest to-the plant-confines. The highest annual dose for the.three locations should be determined by calculating dose at che railroad track location.

_a 1' . - . - - - . ___ - __.

i

'l .ODCM RCv. 18 Pag 3 105

-l. 4/97 '

The following methodology is-used to evaluate-dose at-the railroad tracks, Infonnation Center, and Pricks Lock locations. This dose assessment is: based on the results of the annual. dose evaluation outlined in 03CM Section 2.3.5. The maximum dose calculated will be

-reported.

/

D,,,, = D *- = 0.25 - (3 -2 )

7

'where D, sx -=

Dese to MEMBERS OF TNB PUBLIC within the SITE BOUNDARY in Sector'X' (mrem).

Danx = Dose at SITE BOUNDARY in Sector "X" (mrem).

X/Qex = Relative' average annual atmospheric dispersion for year of interest at SITE BOUNDARY in-Sector "X' (sec/m') .

X/Qay -

Relative average annual atmospheric dispersi6n for year of- interect at railroad, Infonnation Center or Fricks Lock for distances listed below in Sector "X" (sec/nf)

Sector Distance to Location (m)

Railroad Tracka:

S 300 SSW 225 '

SW 225 WSW 225 W 225 WNW 345

, NW 450 Tnfomation Canter ESE 884 Fricka-Lock WSW 450-0.25 = ' mav4== occupancy factor for raalroad tracks, Limerick Atomic Information Center or Pricks Lock Environmental Laboratory (unitiess) .

h-

_ _,____-----------a- 'm--

l ODCM Rev. 18 !

' l Page 106 l l

4/97 1 4.0 Radiolooiemi Envirnn==ntal Monitorina Proaram

_4.1 s==nlina Program The operational phase of the Radiological Environmental Monitoring Program (REMP) is conducted

' in accordance with the requirements of ODCM I3.4-3.

The objectives of the program are:

- To provide data on msasurable levels of radiation and radioactive materials in the site environs.

- To evaluate the relationship between quantities of radioactive materials released from LGS and resultant radiation doses to individuals from principal pathways of exposure.

i The sampling requirements (type of samples, collection frequency, and analysis) and sample locations are presented in Appendix B.

4.2 Interlaboratory Cn=narison Proaram Technical Specification 6.8.4.e.3 requires analyses be performed on radioactive material supplied as part of an Interlaboratory Comparison.

Participation in an approved Interlaboratory Comparison Progs 1nn provides a check on the preciseness of '

measurements of radicactive material in environmental samples. A sunstary of the Interlaboratory Comparison Program results is provided in the Annual Radiological Environmental Operating Repart pursuant to ODCM I3.5.

,A. .b--A h - -'A '

TABLES

. _ _ ._ . .-... . . ._. _ . . _ . - _ _ . _ . _ _ _ _ . _ _ . _ - _ . . . . . . . ._~.,- . . . ~ . . . . - . . - . . . . - _ . _ . . -

l ODCM R0v 18' Psga 107 l 4/97 TABLE 1-1 INGESTION INDIVIDUAL DOS 3 FACTORS (Dm)

For liquid' effluents Units For All Ingestion' Pathways are:

mram/pci i

i i

k-h-

J 1

d

1. -

s i

i l

l 1

i w- 4 y g- *,t - -

-- r* - - -

e~

l ODCM Rev. 18 l Page 108 '

l 4/97 Table 1-1 Licuid Dose Factors From Table B-11 or Reg. Guide 1.109 Ingestion Dose Factors For Adult:

BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H3 0.000E+00 1.050E-07 1.050E-07 1.050E-07 1.050E-07 1.050E-07 1.050E 07 C14 2.840E-06 5.680E-07 5.680E-07 5.680E-07 5.680E-07 5.680E-07 5.680E 07 N224 1.700E-06 1.700E-06 1.700E-06 1.700R-06 1.700E-06 1.700E-06 1.700E-06 P32 1.930E-04 1.200E-05 7.460E-06 0.000E+00 0.000E+00 0.000E+00 2.170E 05 Cr51 0.000E+00 0.000E+00 2.660E-09 1.590E-09 5.860E-10 3.530E-09 6.690E-07 Mn54 0.000E+00 4.570E-06 8.720E-07 0.000E+00 1.360E-06 0.000E+00 1.400E 05 Mn56 0.000E+00 1.150E-07 2.040E-08 0.000E+00 1.460E-07 0.000E+00 3.670E 06 F055 2.750E-06 1.900E-06 4.430E-07 0.000E+00 0.000E+00 1.060E-06 1.090E-06 F059 4.340E-06 1.020E-05 3.910E-06 0.000E+00 0.000E+00 2.850E-06 3.400E-05 CoS8 0.000E+00 7.450E-07 1.670E-06 0.000E+00 0.000E+00 0.000E+00 1.510E-05 Co60 0.000E+00 2.140E-06 4.720E-06 0.000E+00 0.000E+00 0.000E+00 4.020E 05 Ni63 1.300E-04 9.010E-06 4.360E-06 0.000E+00 0.000E+00 0.000E+00 1.880E-06 Ni65 5.280E-07 6.860E-08 3.130E-08 0.000Be00 0.000E+00 0.000E+00 1.740E-06 Cu64 0.000E+00 8.330E-08 3.910E-08 0.000E+00 2.100E-07 0.000E+00 7.100E-06 Zn65 4.840E-06 1.540E-05 6.960E-06 0.000E+00 1.030E-05 0.000E+00 9.700E-06 Zn69 1.030E-08 1.970E-08 1.370E-09 0.000E+00 1.280E-08 0.000E+00 2.960E-09 Br83 0.000E+00 0.000E+00 4.020E-08 0.000B+00 0.000E+00 0.000E+00 5.790E-08 Br84 0.000E+00 0.000E+00 5.210E-08 0.000E+00 0.000E+00 0.000E+00 4.090E-13 Br85 0.000E+00 0.000E+00 2.140E-09 0.000E+00 0.000B+00 0.000E+00 0.000E+00 Rb86 0.00^E+00 2.110E-05 9.830E-06 0.000E+00 0.000E+00 0.000E+00 4.160E-06 Rb88 0.000E+00 6.050E-08 3.210E-08 0.000E+00 0.000E+00 0.000E+00 8.360E-19 Rb89 0.000E+00 4.010E-08 2.820E-08 0.000B+00 0.000E+00 0.000E+00 2.330E-21 Sr89 3.000E-04 0.000E+00 8.840E-06 0.000E+00 0.000E+00 0.000E+00 4.940E-05 Sr90 7.580E-03 0.000E+00 1.860E-03 0.000E+00 0.000E+00 0.000E+00 2.1905 04 Sr91 5.6V0E-06 0.000E+00 2.290E-07 0.000E+00 0.000E+00 0.000E+00 2.700E-05 Sr92 2.150E-06 0.000E+00 9.300E-08 0.000E+00 0.000E+00 0.000E+00 4.260E-05 Y90 9.620E-09 0.000E+00 2.580E-10 0.000E+00 0.000E+00 0.000E+00 1.020E-04 Y91m 9.090E-11 0.000E+00 3.520E-12 0.000E+00 0.000E+00 0.000E+00 2.670E>10 Y91 1.410E-07 0.000E+00 3.770E-09 0.000E+00 0.000B+00 0.000E+00 7.670E-05 Ys2 8.450E-10 0.000E+00 2.470E-11 0.000E+00 0.000E+00 0.000E+00 1.480E-05 Y93 2.680E-09 0.000E+00 7.400E-11 0.000E+00 0.000E+00 0.000E+00 8.500E-05 Zr95 3.040E-08 9.750E-09 6.600E-09 0.000E+00 1.530E-08 0.000E+00 3.090E-05 Zr97 1.680E-09 3.390E-10 1.550E-10 0.000E+00 5.120E-10 0.000E+00 1.050E-04 Nb95 6.220E-09 3.460E-09 1.860E-09 0.000E+00 3.420E-09 0.000E+00 2.100E-05 Mo99 0.000E-00 4.310E-06 8.200E-07 0.000E+00 9.760E-06 0.000E+00 9.990E-06 Tc99m 2.470E-10 6.980E-10 8.890E-09 0.000E+00 1.060E-08 3.420E-10 4.130E-07 Tc101 2.540E-10 3.660E-10 3.590E-09 0.000E+00 6.590E-06 1.870E-10 1.100E-21 Rul03 1.850E-07 0.000E+00 7.970E-08 0.000E+00 7.060E-07 0.000E+00 2.160E-05 Ro105 1.540E-08 0.000E+00 6.080E-09 0.000E+00 1.990E-07 0.000E+00 9.420E-06 Rul06 2.750E-06 0.000E+00 3.480E 07 0.000E+00 5.310E-06 0.000E+00 1.780E-04 Ag110m 1.600E-07 1.480E-07 8.790E-08 0.000E+00 2.910E-07 0.000E+00 6.040E-05 TO125m 2.860E-06 9.170E-07 3.590E-07 8.060E-07 1.090E-05 0.000E+00 1.070E-OS T3127m 6.770E-06 2.420E-06 8.250E-07 1.730E-06 2.750E-05 0.000E+00 2.270E-05 TG127 1.100E-07 3.950E-08 2.380E-08 8.150E-08 4.480E-07 0.000E+00 8.680E-06 T0:29m 1.150E-05 4.290E-06 1.820E-06 3.950E-06 4.800E-05 0.000E+00 5.790E-05 TQ129 3.140E-08 . 180E-08 7.650E-09 2.410E-08 1.320E-07 0.000E+00 2.370E-08 l

l l

l 1 ODCM ROV. 18 POge 109 l 4/97 l Table 1 1 (Continued)

Licuid Dose Factors From Table E 11 or Reg. Guide 1.109 Ingestion Dose Factors For Adult:

BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI Tc131m 1.730E-06 8.460E-07 7.050E-07 1.340E 06 8.570E-06 0.000E+00 8.400E-05 T0131 1.970E-08 8.230E-09 6.220E-09 1.620E-08 8.630E-08 0.000E+00 2.790E-09 To132 2.520E-06 1.630E 06 1.530E-06 1.800E-06 1.570E-05 0.000E+00 7.710E-05 1130 7.560E 07 2.230E 06 8.800E-07 1.890E-04 3.480E-06 0.000E+00 1.920E 06 I131 4.160E-06 5.950E 06 3.410E-06 1.950E-03 1.020E-05 0.000E+00 1.570E-06 I132 2.030E-07 5.430E-07 1.900E 07 1.900E-05 8.650E-07 0.000E+00 1.020E-07 1133 1.420E-06 2.470E 06 7.530E-07 3.630E 04 4.310E-06 0.000E+00 2.220E-06 I134 1.060E-07 2.880E-07 1.030E-07 4.990E-06 4.5803-07 0.000E+00 2.510E-10 I135 4.430E-07 1.160E-06 4.280E-07 7.650E-05 1.860E-06 0.000E+00 1.310E-06 CJ134 6.220E-05 1.480E 04 1.210E-04 0.000B+00 4.790E-05 1.590E-05 2.590E-06 C0136 6.510E-06 2.570E-05 1.850E-05 0.000E+00 1.430E-05 1.960E-06 2.920E-06 C0137 7.970E-05 1.090E-04 7.140E-05 0.000E+00 3.700E 05 1.230E-05 2.110E-06 CJ139 5.520E-08 1.090E-07 5.400E-08 0.000E+00 8.010E-08 7.910E-08 4.650E-13 Ba139 9.700E-08 6.910E-11 2.840E-09 0.000E*00 6.460E-11 3.910E-11 1.720E-07 Ba140 2.030E-05 2.550E 08 1.330E-06 0.000E+00 8.670E-09 1.460E-08 4.180E-05 Ba141 4.710E-08 3.560E-11 ". 590E-09 0.000E+00 3.310E-11 2.020E-11 2.220E-17 Ba142 2.130E-08 2.190E-11 1.340E-09 0.000E+00 1.850E-11 1.240E-11 3.000E-26 La140 2.500E-09 1.260E-09 3.330E-10 0.000E+00 0.000E+00 0.000E+00 9.250E-05 La142 1.28FE-10 5.820E-11 1.450E-11 0.000E+00 0.000E+00 0.000E+00 4.250E-07 C0141 9.360E-09 6.330E 09 7.180E-10 0.000E+00 2.940E-09 0.000E+00 2.420E-05 C3143 1.650E-09 1.220E-06 1.350E-10 0.000E+00 5.370E-10 0.000E+00 4.560E-05 Ca144 4.880E-07 2.040E-07 2.620E-08 0.000E+00 1.210E-07 0.000E+00 1.650E-04 Pr143 9.200E-09 3.690E-09 4.560E-10 0.000E+00 2.130E-09 0.000E+00 4.030E-05 Pr144 3.010E-11 1.250E-11 1.530E-12 0.000E+00 7.050E-12 0.000E+00 4.330E-18 Nd147 6.290E-09 7.270E-09 4.350E-10 0.000E+00 4.250E-09 0.000E+00 3.490E-05 W187 1.030E-07 8.610E-08 3.010E-08 0.030E+00 0.000E+00 0.000E+00 2.820E-05 Np239 1.190E 09 1.170E-10 6.450E-11 0.000E+00 3.650E-10 0.000E+00 2.400E-05

1 l ODCM Rev. 18 Page 110 ,

l 4/97 Table 1 1 (Continued)

Liouid Dose Factors From Table E-12 or Reg. Guide 1.109 Ingestion Dose Factors For Teen:

BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H3 0.000E+00 1.060E-07 1.060E-07 1.060E 07 1.060E-07 1.060E-07 1.060E-07 I C14 -4.0608-06 8.120E-07 8.120E-07 8.120E-07 8.120E-07 8.120E-07 8.120E-07 Na24 2.300E-06 2.300E-06 2.300E-06 2.300E-06 2.300E 06 2.300E-06 2.300E-06 P32 2.760E-04 1.710E-05 1.070E-05 0.000E+00 0.000E+00 0.000E+00 2.320E-05 Cr51 0.000E+00 0.000E+00 3.600E-09 2.000E-09 7.890E-10 5.140E-09 6.050E-07 Mn54 0.000E+00 5.900E-06 1.170E-06 0.000E+00 1.760E-06 0.000E+00 1.210E-05 Mn56 0.000E+00 1.580E 07 2.810E-08 0.000E+00 2.000E-07 0.000E+00 1.040E-05 FG55 3.780E-06 2.680E-06 6.250E-07 0.000E+00 0.030E+00 1.700E-06 1.160E-06 F039 5.870E-06 1.370E 05 5.290E-06 0.000E+00 0.000E+n0 4.320E-06 3.240E-05 CoS8 0.000E+00 9.720E 07 2.240E-06 0.000E+00 0.000E+00 0.030E+00 1.340E-05 Co60 0.000E+00 2.810E-06 6.330E-06 0.000E+00 0.000E+00 0.000E+00 3.660E-05 Ni63 1.770E-04 1.250E-05 6.000E-06 0.000E+00 0.000E+00 3.000E+00 1.990E-06 Ni65 7.490E-07 9.570E-08 4.3603-08 0.000E+00 0.000E+00 0.000E+00 U.190E-06 0064 0.000E+00 1.150E-07 5.410E-08 0.000E+00 2.910E-07 0.000E+00 8.920E-06 Zn65 5.760E-06 2.000E-05 9.330E-06 0.000E+00 1.280E-05 0.000E+00 8.470E-06 Zn69 1.470E-08 2.800E-08 1.960E-09 0.000E+00 1.830E-08 0.000E+00 5.160E-08 Br83 0.000E+00 0.000E+00 5.740E-08 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Or04 0.000E+00 0.000E+00 7.220E-08 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Br85 0.000E+00 0.000E+00 3.050E-09 0.000E+00 0.000S+00 0.000E+00 0.000E+00 Rb86 0.000E+00 2.980E 05 1.400E-05 0.000E+00 0.000E+00 0.000E+00 4.410E-06 Rb88 0.000E+00 8.520E 08 4.540E-08 0.000E+00 0.000E+00 0.000E+00 7.300E-15 Rb89 0.000E+00 5.500E-08 3.890E-08 0.000E+00 0.000E+00 0.000E+00 8.430E-17 Sr89 4.400E-04 0.000E+00 1.260E-05 0.000E+00 0.000E+00 0.000E+00 5.240E-05 Sr90 8.300E-03 0.000E+00 2.050E-03 0.000E+00 0.000E+00 0.000E+00 2.330E-04 Sr91 8.070E-06 0.000E+00 3.210E-07 0.000E+00 0.000E+00 0.000E+00 3.660E-05 Sr92 3.050E-06 0.000E+00 1.300E-07 0.000E+00 0.000E+00 0.000E+00 7.770E-05 Y90 1.370E-08 0.000E+00 3.690E-10 0.000E+00 0.000E+00 0.000E+00 1.130E-04 Y91m 1.290E-10 0.000E+00 4.930E-12 0.000E+00 0.000E+00 0.000E+00 6.090E-09 Y91 2.010E 07 0.000E+00 5.390E-09 0.000E+00 0.000E+00 0.0COE+00 8.240E-05 Y92 1.210E-09 0.000E+00 3.500E-11 0.000E+00 0.000E+00 0.000E+00 3.320E-05 Y93 3.830E-09 0.000E+00 1.050E-10 0.000E+00 0.000E+00 0.000E+00 1.170E-04 Zr95 4.120E-08 1.300E-08 8.940E-09 0.000E+00 1.910E-08 0.000E+00 3.000E-05 Zr97 2.370E-09 4.690E-10 2.160E-10 0.000E+00 7.110E-10 0.000E+00 1.270E-04 Nb95 8.220E-09 4.560E-09 2.510E-09 0.000E+00 4.420E-09 0.000E+00 1.950E-05 Mo99 0.000E+00 6.030E-06 1.150E-06 0.000E+00 1.380E-05 0.000E+00 1.080E-05 Tc99m 3.320E-10 9.260E-10 1.200E-OS 0.000E+00 1.380E-08 5.140E-10 6.080E-07 Tc101 3.600E-10 5.120E-10 5.030E-09 0.000E+00 9.260E-09 3.120E-10 8.750E-17 Rul03 2.550E-07.0.000E+00 1.090E-07 0.000E+00 8.990E-07 0.000E+00 2.130E-05 Rul05 2.180E-08 0.000E+00 8.460E-09 0.000E+00 2.750E-07 0.000E+00 1.760E-05 Rul06 3.920E-06 0.000E+00 4.940E-07 0.000E+00 7.560E-06 0.000E+00 1.880E-04 Ag110m 2.050E-07 1.940E-07 1.180E-07 0.000E+00 3.700E-07 0.000E+00 5.450E-05 T0125m 3.830E-06 1.380E-06 5.120E-07 1.070E-06 0.000E+00 0.000E+00 1.130E-05

.T0127m- 9.670E-06 3.430E-06 1.150E-06 2.300E-06 3.920E-05 0.000E+00 2.410E-05

_TG127 1.580E-07 5.600E-08 3.400E-08 1.090E-07 6.400E-07 0.000E+00 1.220E-05 Te12Sm 1.630E-05-6.050E-06 2.580E-06 5.260E-06 6.820E-05 0.000E+00 6.120E-05 Te129 4.480E-08 1.670E-08 1.090E-08 3.200E-08 1.880E-07 0.000E+00 2.450E-07 TG131m 2.440E-06 1.170E-06 9.760E-07 1.760E-06 1.220E-05 0.000E+00 9.390E-05 T3131 2.790E-09 1.150E-08 8.720E-09 2.150E-08 1.220E-07 0.000E+00 2.290E-09 TG132 3.400E-06-2.210E-06 2.080E-06 2.330E-06 2.120E-05 0.000E+00 7.000E-05

i ODCM Rev. 18 l

l Paga 111 l 4/97 Table 1-1 (Continued)

Licuid Dose Factors From Table E 12 or Reg. Guide 1.109 Ingestion Dose Factors For Teen:

BONE LIVER T. BODY THYROID KIDNEY LUNG G1-LLI I130 1.030E 06 2.980E-06 1.190E 06 2.430E-04 4.590E-06 0.000E+00 2.290E 06 1131 5.850E 06 8.190E-06 4.400E 06 2.390E-03 1.410E-05 0.000F^00 1.620E-06 1134 2.790E 07 7.300E-07 2.620E-07 2.460E-05 1.150E-06 0.000E+00 3.180E-07 1133 2.010E 06 3.410E 06 1.040E 06 4.750E-04 5.980E-06 0.000E+00 2.580E-06 1134 1.460E 07 3.870E-07 1 390E-07 6.450E-06 6.100E-07 0.000E+00 5.100E-09 1135 6.300E-07 1.570E-06 5.820E-07 1.010E-04 2.480E-06 0.000E+00 1.740E-06 C3134 8.370E 05 1.970E-04 9.140E 05 0.000E+00 6.260E-05 2.390E-05 2.450E 06 C3136 8.590E 06 3.380E-05 2.270E-05 0.000E+00 1.840E-05 2.900E-06 2.720E-06 CJ137 1.120E-04 1.490E-04 5.190E-05 0.000E+00 5.070E-05 1.970E-05 2.120E-06 C3138 7.760E 08 1.490E-07 7.450E-08 0.000E+00 1.100E-07 1.280E-08 6.760E-11 Ba139 1.390E 07 E.780E-11 4.050E 09 0.000E+00 9.220E-11 6.740E-11 1.240E-06 Ba140 2.840E 05 3.480E-0E 1.830E-0C 0.000E+00 1.180E-08 2.340E-08 4.380E-05 Ba141 6.710E-08 5.010E-11 2.240E-09 0.000E+00 4.650E-11 3.430E-11 1.430E-13 Ba142 2.99us 08 2.990E-11 1.840E-09 0.000E+0C 2.530E-11 1.990E-11 9.180E-20 La140 3.460E 09 1.710E-09 4.550E-10 0.000E+00 0.000E+00 0.000E+00 9.820P-05 La142 1.790E-10 7.950E-11 1.980E-11 0.000E+00 0.000E+00 0.000E+00 2.420E-06 C3141 1.330E-08 8.880E-09 1.020E-09 0.000E400 4.180E-09 0.000E+00 2.540E-05 C3143 2.350E-09 1.710E-06 1.910E-10 n.000E+00 7.6703-10 0.000E+00 5.140E-05 C;144 6.960E-07 2.880E-07,3.740E-08 0.000E+00 1.720E-07 0.000R400 1.750E-04 Pr143 1.310E-08 5.230E-09 6.520E-10 0.000E+00 3.040E-09 0.000h+00 4.310E-05 Pr144 4.300E-11 1.760E-11 2.180E-12 0.000E+00 1.010E-11 0.000E+00 4.740E-14 Nd147 9.380E-09 1.020E-08 6.110E-10 0.000E+00 5.990E-09 0.000E+00 3.680E-05 W187 1.460E-07 1.190E-07 4.170E-08 0.000E+00 0.000E+00 0.000E+00 3.220E-05 Np239 1.760E-09 1.660E-10 9.220E 11 0.000E+00 5.210.E-10 0.000E+00 2.670E-05

i l

ODCM Rev. 18 l l Page 112 l

4/97 Table 1-1 (Continued)

Licuid D3se Factors From Table H 13 or Reg. Guide 1.309 Ingestion Doce Factors For Child 1 BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI l

)

H3 0.000E+00 2.030E-07 2.030E-07 2.030E-07 2.030E-07 2.030E-07 2.030E-07 I C14 1.210E-05 2.420E-06 2.420E-06 2.420E-06 2.420E-06 2.420E-06 2.420E-06 Na24 5.800E-06 5.800E-06 5.800E-06 5.800E-06 $.800E-06 5.800E-06 5.800E-06 P32 8.250E-04 3.860E-05 3.180E-05 0.000E+00 0.000R+00 0.000E+00 2.280E-05 Cr51 0.000E+00 0.000E+00 8.900E-09 4.940E-09 1.350E-09 9.020E-09 4.720E-07 Mn54 0.000E+00 1.070E-05 2.850E-06 0.000E+00 3.000E-06 0.000E+00 8.980E-06 Mn56 0.000E+00 3.340E-07 7.540E-08 0.000E+00 4.040E-07 0.000E+00 4.840R-05 F055 1.150E-05 6.100E-06 1.890E-06 0.000E+00 0.000B+00 3.450E-06 1.130E-06 F059 1.650E-05 2.670E-05 1.330E-05 0.000E+00 0.000E+00 7.740E-06 2.780E-05 CoS8 0.000E+00 1.800E-06 5.510E 06 0.000E+00 0.000E+00 0.000E+00 1.050E-05 Co60 0.000E+00 5.290E-06 1.560E-05 0.000E+00 0.000E+00 0.000B+00 2.930E-05 Ni63 5.380E-04 2.880E-05 1.830E-05 0.000E+00 0.000E+00 0.000E+00 1.940E-06 Ni65 2.220E-06 2.090E-07 1.220E-07 0.000E+00 0.000E+00 0.10E+00 2.560E-05 CuG4 0.000E+00 2.450E-07 1.480E-07 0.000E+00 5.920E-07 6.000B+00 1.153E-05 Zn65 1.370E05 3.650E-05 2.270E-05 0.000B+00 2.300E-05 0.000E+00 6.410E-06 Zn69 4.380E-08 6.330E-08 5.850E-09 0.000E+00 3.840E-08 0.000E+00 3.990E-06 Er83 0.000E+00 0.000E+00 1.710E-07 0.000B+00 0.000E+00 0.000E+00 0.000E+00 Br84 0.000E+00 0.000E+00 1.980E-07 0.000E+00 0.000B+00 0.000E+00 0.000E+00 Br85 0.000E+00 0.000E+00 9.120E-09 0.000E+'9 0.000E+00 0.000B+00 0.000E+00 Rb86 0.000E+00 6.700E-05 4.120E-05 0.000E+0c 0.000E+00 0.000E+00 4.310E-06 Rb88 0.000E+00 1.900E-07 1.320E-07 0.000E+0c 1.000E+00 0.000E+00 9.320E-09 Rb89 0.000E+00 1.170E-07 1.040E-07 0.000E+00 0.000E+00 0.000E+00 1.020E-09 Sr89 1.320E-03 0.000E+00 3.770E-05 0.000E+00 0.000E+00 0.000E+00 5.110E-05 Sr90 1.700E-02 0.000E+00 6.310E-03 0.000E+00 0.000E+00 0.000E+00 2.290E-04 Sr91 2.400E-05 0.000E+00 9.060E-07 0.000E+00 0.000E+00 0.000E+00 5.300E-05 Sr92 9.030E-06 0.000E+00 3.620E-07 0.000E+00 0.000E+00 0.000E+00 1.710E-04 Y90 4.110E-08 0.000E+00 1.100E-09 0.000E+00 0.000E+00 0.000E+00 1.170E-04 Y91m 3.820E-10 0.000E+00 1.390E-11 0.000E+00 0.000E+00 0.000E+00 7.480E-07 Y91 6.020E-07 0.000E+00 1.610E-08 0.000E+00 0.000E+00 0.000E+00 8.020E-05 Y92 3.600E-09 0.000E,00 1.030E-10 0.000E+00 0.000E+00 0.000E+00 1.040E-04 Y93 1.140E-08 0.000B+00 3.130E-10 0.000E+00 0.000E+00 0.000E+00 1.700E-04 Zr95 1.160E-07 2.550E 08 2.270E-08 0.000E+00 3.650E-08 0.000E+00 2.660E-05 Zr97 6.990E-09 1.010E-09 5.960E-30 0.000E+00 1.450E-09 0.000E+00 1.530E-04 Nb95 2.250E-UB 8.760E-09 6.260E-09 0.000E+00 8.230E-09 0.000E+00 1.620E-05 Mo99 0.000E+G'. 1.330E-05 3.290E-06 0.000E+00 2.840E-05 0.000E+00 1.100E-05 Tc99m 9.230E-10 1.810E-09 3.000E-08 0.000E+00 2.630E-08 9.190E-10 1.030E-06 Tc101 1.070E 09 1.120E-09 1.420E-08 0.000E+00 1.910E-08 5.920E-10 3.560E-09 Rul03 7.310E-07 0.000E+00 2.810E-07 0.000E+00 1.840E-06 0.000E+00 1.890E-05 Rul05 6.450E-08 0.000E+00 2.340E-08 0.000B+00 5.670E-07 0.000E+00 4.210E-05 Rul06 1.170E-05 0.000E+00 1.460E-06 0.000E+00 1.580E-05 0.000E+00 1.820E-04 Ag110m 5.390E 07 3.640E-07 2.910E-07 0.000E+00 6.780E-07 0.000E+00 4.330E-05 Ta125m 1.140E-05 3.090E-06 1.520E-06 3.200E-06 0.000E+00 0.000E+00 1.100E-05 Ta127m 2.890E-05 7.780E-06 3.430E-06 6.910E-06 8.240E-05 0.000E+00 2.340E-05 TG127 4.710E-07 1.270E-07 1.010E-07 3.230E-07 1.340E-06 0.000E+00 1.840E-05 TQ129m 4.870E-05 1.360E-05 7.560E-06 1.570E-05 1.430E-04 0.000E+00 5.940E-05 70129 1.340E-07 3.740E-08 3.180E-08 9.560E-08 3.920E-07 0.000E+00 8.340E-06 Ta131m 7.200E-06 2.490E-06 2.650E-06 5.120E-06 2.410E-05 0.000E+00 1.010E-04 Tal.~ 1 8.300E-08 2.530E-08 2.470E-08 6.350E-08 2.510E-C7 0.000E+00 4.360E 07 Ta132 1.010E-05 4.470E-06 5.400E-06 6.510E-06 4.150E-05 0.000E+00 4.500E-05

l ODCM R;v. 18 P go 113 l (/97 1

Table 1-1 (Continued)

Licuid Dose Factors From Table E-13 or Reg. Guide 1.109 l Ingestion Dose Factors For Child: '

BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI I130 2.920E-06 5.900E-06 3.040E-06 6.500E-04 8.820E-06 0.000E+00 2.760E 06 1131 1.720E-05 1.730E-05 9.830E-06 5.720E-03 2.840E-05 0.000E+00 1.540E-06 1132 8.000E-07 1.470E-06 6.7603-07 6.820E-05 2.250E 06 0.000E+00 1.730E 06 I133 5.920E-06 7.320E 06 2.7?OE-06 1.360E-03 1.220E-05 0.000E+00 2.950E-06 I134 4.190E-07 7.780E 07 3.580E-07 1.790E-05 1.190E-06 0.000E+00 5.160E-07 I135 1.750E 06 3.150E-06 1.490E-06 2.790E-04 4.830E-06 0.000E+00 2.400E-06 C0134 2.340E 04 3.840E 04 8.100E-05 0.000E+00 1.190E-04 4.270E-05 2.070E-06 Cs136 2.350E-05 6.460E-05 4.180E-05 0.000E+00 3.440E-05 5.130E-06 2.270E-06 Cs137 3.270E-04 3.130E-04 4.620E-05 0.000E+00 1.020E-04 3.670E-05 1.960E-06 C3138 2.280E-07 3.170E 07 2.010E-07 0.000E+00 2.230E-07 2.400E-08 1.460E-07 Ba139 4.140E-07 2.210E 10 1.200E-08 0.000E+00 1.930F-10 1.300E-10 2.390E-05 Ba140 8.310E-05 7.280E 08 4.850E-06 0.000E+00 2.370E-08 4.340E-08 4.210E 05 Ba141 2,000E-07 1.120E-10 6.510E-09 0.000E+00 9.690E-11 6.580E-10 1.140E-07 Ba142 8.740E-08 6.290E-11 4.880E-09 0.000E+00 5.093E '.1 3.700E-11 1.14CE 09 La140 1.010E-08 3.530E-09 1.190E-09 0.000E+00 0.000E+00 0.000E+00 9.840E-05 La142 5.240E-10 1.670E-10 5.230E-11 0.000E+00 0.000E+00 0.000B+00 3.310E-05 C3141 3.970E-08 1.980E 08 2.940E-09 0.000E+00 8.630E-09 0.000B+00 2.470E-05 C0143 6.990E-09 3.790E 06 5.490E-10 0.000E+00 1.590E-09 0.000E+00 5.550E-05 C3144 2. 0 ROE-06 6.520E-07 1.110E-07 0. 000E+00 3. 610E-07 0.000E+00 1. 700E-04 Pr143 3.930E-08 1.180E-08 1.950E-09 0.000B+00 6.390E-09 0.000E+00 4.240E-05 Pr144 1.290E-10 3.9905-11 6.490E-12 0.000E+00 2.110E-11 0.000E+00 8.590E-08 Nd147 2.790E-08 2.260E-08 1.750E-09 0.000E+00 1.240E-08 0.000E+00 3.580E-05 W187 4.290E-07 2.540E-07 1.140E-07 0.000B+00 0.000E+00 0.000E+00 3.57CE-05 Np239 5.250E 09 3.770E-10 2.650E-10 0.000E+00 1.090E-09 0.000F+00 2.790E-05

a i j l ODCM Rev. 18 Page 114 l 4/97 Table 1-1 (Continued)

Liquid Dome Factora From Table E 14 or Reg. Guide 1.109 Ingestion Dose Factors For Infant BONE LIVER T. BODY THYROID KIDNEY LUNG GI LLI H3 0.000E+00 3.080E 07 3.080E-07 3.080E-07 3.080E-07 3.080E 07 3.080E 07 C14 2.370E 05 5.060E 06 5.060E 06 5.060E 06 5.060E 06 5.060E-06 5.0GOE 06 ,

Na24 1.010E 05 1.010E 05 1.010E 05 1.010E 05 1.010E-05 1.010E 05 1.010E 05 P32 2 ?00E 03 1.000E 04 6.590E 05 0.000E+00 0.000E+00 0.000E+00 2.300E 05 Cr51 0.000E+00 0.000E+00 1.410E 08 9.200E-09 2.010E-09 1.790E 08 4.1108 07 Mn54 0.000E+00 1.990E 05 4.510E 06 0.000E+00 4.410E 06 0.000E+00 7.310E 06 Mn56 0.000E+00 8.180E-07 1.410E 07 0.000E+00 7.030E-07 0.000E+00 7.430E 05 Fe55 1.390E 05 8.980E 06 2.400E-06 0.000h+00 0.000B+00 4.390E 06 1.140E 06 F059 3.080E 05 5.380E 05 2.120E 05 0.000E+00 0.000E+00 1.590E-05 2.570E 05 CoS8 0.000E+00 3.600E 06 8.980E 06 0.000B+00 0.000E+00 0.000E+00 8.970E 06 ,

Co60 0.000E+00 1.080E 05 2.550E 05 0.000B+00 0.000E+00 0.0008400 2.570E 05 Ni63 6.340E 04 3.920E 05 2.200E-05 0.000E+00 0.000D+00 0.000E+00 1.950E 06 NiG5 4.700E 06 5.320E 07 2.420E 07 0.000E+00 0.000E+00 0.000E+00 4.050E 05 Cu64 0.000E+00 6.090E 07 2.820E 07 0.000E+00 1.030E-06 0.000E+00 1.250E 05 En65 1.840E 05 6.310E 05 2.910E-05 0.000E+00 3.060E-05 0.000E+00 5.330E-On Zn69 9.330E 08 1.6805 07 1.250E 08 0.000E+00 6.980E-08 0.000E+00 1.370E 05 Br83 0.000E+00 0.000E+00 3.630E 07 0.000E+00 0.000E+00 0.000B+00 0.000E+00 Br84 0.000E+00 0.000E+00 3.820E 07 0.000B+00 0.000E+00 0.000E+00 0.000E+00 Br85 0.000S+00 0.000E+00'1.940E 08 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Rb86 0.000E+00 1.700E 04 8.400E 05 0.000E+00 0.000B+00 0.000E+00 4.350E 06 Rb88 0.000E+00 4.980E 07 2.730E 07 0.000E+00 0.000E+00 0.J00E+00 4.850E 07 Rb89 0.000E+00 2.860E 07 1.970E 07 0.000E+00 0.000E+00 0.000E+00 9.740E 08 Sr89 2.510E 03 0.000E+00 7.200E-05 0.000E,00 0.000E+00 0.000E+00 5.160E 05 Sr90 1.850E 02 0.000E+00 4.710E-03 0.000E+00 0.000E+00 0.000E+00 2.310E 04 Sr91 5.000E 05 0.000E+00 1.810E 06 0.000E+00 0.000E+00 0.000E+00 5.920E 05 Sr92 1.920E 05 0.000E+00 7.130E-07 0.000E+00 0.000E+00 0.000E+00 2.070E 04 Y90 8.690E 08 0.000E+00 2.330E 09 0.000E+00 0.000E+00 0.000E+00 1.200E-04 Y91m 8.100E-10 0.000E+00 2.760E-11 0.000E+00 0.000E+00 0.000E+00 2.700E 06 Y91 1.130E 06 0.000E+00 3 010E 08 0.000B+00 0.000E+00 0.000E+00 8.100E 05 Y92 7.650E 09 0.000E+00 2.150E-10 0.000E+00 0.000E+00 0.000E+00 1.460E 04 Y93 2.430E-08 0.000E+00 6.620E-10 0.000E+00 0.000E+00 0.000E+00 1.920E 04 Zr95 2.060E 07 5.020E 08 3.560E-08 0.000E+00 5.41.0E 08 0.000E+00 2.500E 05 Zr97 1.480E 08 2.540E 09 1.160E-09 0.000E+00 2.560E-09 0.000E+00 1.620E 04 Nb95 4.200E 08 1.730E 06 1.000E-08 0.000E+00 1.240E 08 0.000E+00 1.460E-05 Mo99 0.000E+00 3.400E 05 6.630E-06 0.000E+00 5.080E-05 0.000E+00 1.120E 05 Tc99m 1.920E-09 3.960E-09 5.100E-08 0.000E+00 4.260E-08 2.070E 09 1.150E 06 Tc101 2.270E 09 2.860E 09 2.830E 08 0.000E+00 3.400E-08 1.560E-09 4.860E 07 Rus03 1.480E 06 0.000E+00 4.950E-07 0.000E+00 3.080E-06 0.000E+00 1.800E 05 Rul05 1.360E-07 0.0000+00 4.580E-08 0.000E+00 1.000E-06 0.000E+00 5.410E 05 Rul06 2.410P. 05 0.000B+00 3.010E-06 0.000E+00 2.850E-05 0.000B+00 1.830E 04 Agi10m 9.9wCE 07 7.27CE 07 4.810E-07 0.000E+00 1.040E-06 0.000E+00 3.770E 05 Te125m 2.330E-05 7.790E-06 3.150E-06 7.840E-06 0.000E+00 0.000E+00 1.110E 05 To127m 5.850E-05 1.940E-05 7.080E 06 1.6903-05 1.440E-04 0.000E+00 2.360E-05 To127 1.000E 06 3.350E 07 2.150E-07 8.140E-07 2.440E 06 0.000E+00 2.100E 05 To129m 1.000E 04 3.430E 05 1.540E 05 3.840E-05 2.500E-04 0.000E400 5.970E 05 TG129 2.840E 07 9.790E 08 6.630E 08 2.380E 07 7.070E-07 0.000E+00 2.270E-05 Ta131m 1.520E 05 6,120E 06 5.050E-06 1.240E-05 4.210E-05 0.000E+00 1.030D 04 TG131 1.760E-07 6.500E-08 4,940E-08 1.570E-07 4.500E-07 0.000E+00 7.110E 06 TG132 2.000E 05 1.0303 05 9.610E-06 1.520E.05 6.440E-05 0.000E+00 3.810E 05

l ODCM R0v. 18 Pogn 115 l 4/97 Table 1 1 (Continued)

Licuid Dose Factors From Table E 14 or Reg. Guide 1.109 Ingestion Dose Factors For Infant s BONE LIVER T. BODY THYROID KIDNEY LUNG GI LLI 1130 6.000E-06 1.320E-05 5.300E 06 1.480E 03 1.450E 05 0.000E+00 2.830E 06 I131 3.590E 05 4.230E-05 1.860E 05 1.390E 02 4.940E 05 0.000E+00 1.510E 06 1132 1.660E 06 3.370E 061.200E 061.580E 04 3.760E 06 0.000E+00 2.730E 06 1133 1.250E 05 1.820E-05 5.330E 06 3.310E 03 2.140E 05 0.000E+00 3.080E 06 I134 8.690E 07 1.780E 06 6.330E 07 4.150E-05 1.990E 06 0.000E+00 1.840E 06 1135 3.640E-06 7.240E 06 2.640E-06 6.490E 04 8.070E 06 0.000E+00 2.620E 06 Cs134 3.7708 04 7.030E-04 7.100E 05 0.000E+00 1.810E 04 7.420E 05 1.910E 06 Cs136 4.590E-05 1.350E 04 5.0iOE 05 0.000E+00 5.380E 05 1.100E-05 2.050E 06 Cs137 5.220E-04 6.110E-04 4.230E 05 0.000E+00 1.640E 04 6.640E 05 1.910E-06 Cs138 4.810E 07 7.820E 07 3.790E 07 0.000E+00 3.900E 07 6.090E-08 1.250E-06 Ba139 8.810E-O'/ 5.840E-10 2.550E 08 0.000E+00 3.510E-10 3.540E 10 5.580E 05 Ba140 1.710E 04 1.710E-07 8.810E-06 0.000E+00 4.060E 08 1.050E 07 4.200E 05 Ba141 4.250E-07 2.910E 10 1.340E 08 0.000E+00 1.750E 10 1.770E 10 5.190F 06 Ba142 1.840E 07 1.530E-10 9.060E-09 0.000E+00 8.810E-11 9.260E 11 7.590E 07 La140 2.110E 08 8.320E 09 2.140E-09 0.000E+00 0.000E+00 0.000E+00 9.770E 05 La142 1.100E-09 4.040E 10 9.C70E-11 0.000E+00 0.000E+00 0.000E+00 6.860E-05 Cc141 7.870E 08 4.800E-08 5.650E-09 0.000E+00 1.480E 00 0.000E+00 2.480E 05 Co143 1.480E 08 9.820E-06 1.120E-09 0.000E+00 2.860E 09 0.000E+00 5.730E-05 C0144 2.980E-06 1.220E-06 1.670E-07 0.000E+00 4.930E 07 0.000E+00 1.710E-04 P1143 8.130E 08 3.040E 08 4.030E-09 0.000E+00 1.130E-08 0.000E+00 4.290E 05 Pr144 2.740E 10 1. 060E-10 1.380E-11 0.000E+00 3.840E 11 0. 000E+00 4.930E-06 Nd147 5.530E 08 5.680E 08 3.480E-09 0.000E+00 2.190E-08 0.000E+00 3.600E-05 W187 9.030E-07 6.280E-07 2.170E-07 0.000E+00 0.000E+00 0.000E+00 3.690E 05 Np239 1.110E 08 9.930E-10 5.610E 10 0.000E+00 1.980E-09 0.000E+00 2.870E 05

ODCM R;v. 18 !

l Page 116 l

4/97 Table 1 2 Assumptions used in Limerick Liquid Effluent Dose Evaluation 1Dd2% Descrintion Value 1 Fraction of produce from local garden 7.600E 01 3 Fraction of leafy veg from local garden 1.000E+00 3 So;t density in plow layer (kg/m**2) 2.400E+02 4 Praction of activity retained on sprayed vegetation 2.500E 03 5 Shielding factor for residential structures 7.000E 01 6 Period of buildup of activity in soil (hr) 1.752E+05 7 Period of pasture grass exposure to activity (hr) 7.200E+02 8 Period of crop exposure to activity (hr) 1.440E+03 9 Holding time in animal drinking water pond (hr) 0.000E+00 10 Delay time for ingestion of grass by animals (hr) 0.000E+00 11 Delay time for ingestion of stored fee by animals (hr) 2.160B+03 12 Delay time for ingestion of leaf vec by man (hr) 2.400E+01 13 Delay time for ingestion of other veg by man (hr) 1.440E+03 14 Transport time udlk man (hr) 4.800E+01 15 Time between slaughter and consumption of meat animal (hr) 4.800E+02 16 Grass yield, wet wt (kg/m**2) 7.000E 01 17 Other vegetation yield, wet wt (kg/m**2) 2.000E+00 18 Weathering rate constant for activity on vegetation (1/hr) 2.100E 03 l

19 Milk cow feed consumption rate (kg/ day wet) 5.000B+01 20 Goat feed consumption rate (kg/ day wet) 6.000F+00 21 Beef Cattle feed consumption rate (kg/ day wet) 5.000E+01 22 Milk cow water consumption rate (1/ day) 6.000E+01 23 Goat water consumption rate (1/ day) 0.000E+00 24 Beef cattle water consumption rate (1/ day) 5.000E+01 25 Envcl transit time for water ingestion (hr) 1.200E+01 26 Envcl transit time for fish ingestion (hr) 2.400E+01 27 Enytl transit time for invertebrate ingestion (hr) 2.400E+01 28 Enytl transit time for shore exposure (hr) 0.000E+00 29 Water ingestion (1/yr) adult 7.300E+02 30 Water ingestion (1/yr) teen 5.100E+02 31 Water ingestion (1/yr) child 5.100E+02 32 Water ingestion (1/yr) infant 3.300E402 33 Shore exposure (hr/yr) adult 1.200E+01 34 Shore exposure (hr/yr) teen 6.700E+01 35 Shore exposure (hr/yr) child 1.400E+01 l 36 Shore exposure (hr/yr) infant 0.000E+00 37 Fresh water sport fish ingestion (kg/yr) adult 2.100E+01 38 Fresh water sport fish ingestion (kg/yr) teen 1.600E+01 39 Fresh water sport fish ingestion (kg/yr) child 6.900B+00 40 Fresh water sport fish ingestion (kg/yr) infant 0.000E+00 l 41 Fresh water commercial fish ingestion (kg/yr) adult 2.100E+01 42 Fresh water commercial fish ingestion (kg/yr) teen 1.600E+01 43 Fresh water commercial fish ingestion (kg/yr) child 6.900E+00 44 Fresh water commercial fish ingestion (kg/yr) infant 0.000E+00 45 Fresh water invertebrate ingestion (kg/yr) adult 5.000E+00 l 46 Fresh water invertebrate ingestion (kg/yr) teen 3.800E+00 47 Fresh water invertebrate ingestion (kg/yr) child 1.700E+00 48 Frcsh water invertebrate ingestion (kg/yr) infant 0.000E+00 l

l ODCM rov. 88 Page 117 4/97 Table 1 2 Assumptions used in Limerick Liquid Effluent Dose Evaluation Index Description Value 49 Salt Water Sport Fish Ingestion (kg/yr) Adult 2.100E+01 50 Salt Water Sport Fish Ingestion (kg/yr) Teen 1.600E+01 51 Salt Water Sport Fish Ingestion (kg/ Child 6.900Ev00 52 Salt Water Sport Fish Ingestion (kg/yr) yr) Infant 0.000E.00 53 Salt Water Commercial Fish Ingestion (kg/yr) Adult 2.100E+01

, 54 Salt Water Commercial Fish Ingestion (kg yr) Teen 1.600E+01 i

55 Salt Water Commercial Fish Ingestion (kg yr) Child 6.900E+00 56 Salt Water Commercial Fish Ingestion (kg yr) Infant 0.000E+00 57 Salt Water Invertebrate Ingestion (kg/yr) Adult 5.000E+00 58 Salt Water Invertebrate Ingestion (kg/ Teen 3.800E+00 69 Salt Water Invertabrate Ingestion (kg/yr) yr) Child 1.700E+00 60 Salt Water Invertebrate Ingestion (kg/yr) Infant 0.000E+00 61 Irrigated Leafy Vegetable Ingestion (kg yr) Adult 6.400E,ul 62 Irrigated Leafy Vegetable Ingestion (kg yr) Teen 4.200E+01 63 Irrigated Leafy Vegetable Ingestion (kg yr) Child 2.600E+01 64 Irrigated Leafy Vegetable Ingestion (kg yr) Infant 0.000E+00 2 65 Irrigated Other Vegetable Ingestion (kg yr) Adult 5.200E+02 66 Irrigated Other Vegetable Ingestion (kg/yr) Teen 6.300E+02 67 Irrigated Other Vegetable Ingestion (kg/yr) Child 5.200E+02 68 Irrigated Other Vegetable Ingestion (kg/yr) Infant 0.000E+00 69 Irrigated Root Vegetable Ingestion (kg/yr) Adult 5.200E+02 70 Irrigated Root Vegetable Ingestion (kg/yr) Teen 6.300E+02 71 Irrigated Root Vegetable Ingestion (kg/yr) Child 5.200E+02 72 Irrigated Root Vegetable Ingestion (kg/yr) Infant 0.000E+00 3

73 Irrigated Cow Milk Ingestion (1/yr) Adult 3.100B+02 74 Irrigated Cow Milk Ingestion (1/yr) Teen 4.000E+02 75 Irrigated Cow Milk Ingestion (1/yr) Child 3.300E(02 76 Irrigated Cow Milk Ingestion (1/yr) Infant 3.300E+02 77 Irrigated Goat Milk Ingestion (1/yr) Adult 3.100E+02 78 Irrigated Goat Milk Ingestion (1/yr) Teen 4.000E+02 79 Irrigated Goat Milk Ingestion (1/yr) Child 3.300E+02 80 Irrigated Goat Milk Ingestion (1/yr) Infant 3.300E+02 81 Irrigated Beef Ingestion (1/yr) Adult 1.100E+02 82 Irrigated Beef Ingestion (1/yr) Teen 6.500E+01 83 Irrigated Baef Ingestion (1/yr) Child 4,100E+01 84 Irrigated B6.f Ingestion (1/yr) Infant 0.000E+00 i

3 g , -- .e.w r - -_--,s.- - - - -

-<,e- . . - , . . - , , , . - - . , , , .,,,,,--.--,----r,---

l ODCN Rev. 18 Page 118 l 4/97 i

l Table 2.1 l Dose Factors for F c:e %

Total Body Beta Skb " " IJL Q, 6fl Beta Air Dose Factor Dose Fat.u r e: tere N+/> Dore Factor F Ki (mram/yr Li (mrec/p* !N 55 2.0. b Ni (mrad /yr per per per per Index Radionuclide pCi/m') pCi/m') pCi/m') pCi/m')

3 Ar 41 8.84E 03 2.692 03 9.30E 03 Po28E 03 4 Kr 83m 7.56E 08 -- - - 1.93E 05 2.88E 04 5 Kr 85m 1.175 03 1.465 03 1.238 03 1.97E 03 [

6 Kr 85 1.61E 05 1.34E-03 1.72E 05 1.95E 03 -

3 7 Kr 87 5.92E 03 9.73E 03 6.17E-03 1.03E 02 4 8 Kr 88 1. 4 /E-02 2.37E 03 1.52E 02 2.938 03 9 Kr 89 1.66E 02 1.013-02 1.73E-02 1.065-02 10 Kr 90 1.56E 02 7.29E 03 1.63E 02 7.83E 03 11 Xe-131m 9.15E-05 4.768 04 1.56E 04 1.11E 03 12 -Xe 133m 2.51E-04 9.94E 04 3.27E 04 1.48E 03 13 Xe 133 2.94E 04 3.06E 04 3.53E-04 1.05E 03 14 Xe 135m 3.12E 03 7.118 04 3.36E-03 7.39E 04 15 Xe-135 1.81E-03 1.868 03 1.92E 03 2.465-03 16 Xe 137 1.42E-03 1.22E 02 1.51E-03 1.27E 02 17 Xe 138 8.83E 03 4.13E-03 9.21E 03 4.75E 03

l ODN R v. 18 P g3 119

l. 4/97 :

1 TABLE 2 2 l r

INGESTION INDTVIDUAL DOSE FAC'M)RS (DFu,w) :

For Gaseous Iffluents i i

i a

j UNITS FOR AIRBORNE PATHMAYS (Pathway Numbers 1 and 7) ares

mram m'/Ci-sec

4 i

UNITS FOR DEPOSITION PATHWATS (Pathway Numbers 2 6) are; mrem m /Ci 8 1

Pathway No. Pathway

) 1 Plume -

l 2 Ground

3 Vegetable 4 Meat 5 Cow Milk 6 Goat Milk ,

j 7 Inhalation I

i a

4 ,

e d

I 4

L i

. . _ _ . . _ _~._._ _. ,_ _ .. _ . _ . _ _ . - _ . _ _. _ . . . _ .

-- _- .- -- - _ - . _ - . ---- .. .. .- . . ~ . - - - - .

! l ODCM Rev. 18 Page 120 l 4/97 1

Table 2 2 INDIVIDffif. DOSE FACTORS FOR nacEOUS EFFLUENTS -- FOR ISOTOPEt M3 For Pathways Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN .

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i TOCn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 9.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E400 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B,00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 TOCn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 1 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathways Vegetable T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.53E+01 6.53E+01 0.00E+00 6.53E+01 6.53E+01 G.53E+01 6.53E+01 0.00E+00 TOOn 7.75E+01 7.75E+01 0.00E+00 7.75E+01 7.75E+01 7.75E+01 7.75E+01 0.00E+00 Child: 1.21E+02 1.21E+02 0.00E+00 1.21E402 1.21E+02 1.21E+02 1.21E+02 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.98E+00 7.98E+00 0.00E+00 7.98E+00 7.98E+00 7.98E+00 7.98E+00 0.00E+00 ;

Torn 4.75E+00 4.76E+00 0.00E+00 4.76E+00 4.76E+00 4.76E+00 4.76E+00 0.00E+00 child: 5.75E+00 5.75E+00 0.00E+00 5.75E+00 5.75E+00 5.75E+00 5.75E+00 0.00E+00 infants 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pa:hway: Cow Milk T. BODY GI TRACT BONE LIVER KIDNEY THn OID LUNG SCN Adult: 1.88E+01 1.88E+01 0.00E+00 1.88E+01 1.88E+01 1.36E+01 1.88h+01 0.00E+00 TOOns 2.45E+01 2.45E+01 0.00E+00 2.46E+01 2.45E+01 2.45E+01 2.45E+01 0.00E+00 Childs 3.878+01 3.87E+01 0.00E+00 3.87E+01 3.87E+01 3.87E+01 3.87E+01 0.00E+00 Infant: 5.87E401 5.87E+01 0.00E+00 5.37E+01 5.87E+01 5.87E+01 5.87E+01 0.00E+00 For Pathway: Goat Milk ,

T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.83E+01 3.88E+01 0.00E+00 3.83E+01 3.83E+01 3.83E+01 3.83E+01 0.00E+00 TOOns 4.99E+01 4.99E+01 0.00E+00 4.99E+01 4.99E+01 4.99E+01 4.99E+01 0.00E+00 Childs 7.89E+01 7.89E+01 0.00E+00 7.89E+01 7.89E+01 7.89E+01 7.89E+01 0.00E+00 Infant: 1.20E402 1.20E+02 0.00E+00 1.20E+02 1.20E+02 1.20E+02 1.20R+02 0.00E+00 For Pathways Inhalation T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.01E+01 4.01E+01 0.00E+00 4.01E+01 4.01E+01 4.01E+01 4.01E+01 0.00E+00 TOOns 4.03E+01 4.03E+01 0.00E+00 4.03E+01 4.03E+01 4.03E+01 4.03E+01 0.00E+00 Childs 3.57E+01-3.57E+01 0.00E+00 3.57E+01 3.57E+01 3.57E+01 3.57E+01 0.00E+00

-Infant: 2.05E+01 2.05E+01 0.00E+00 2.05E+01 2.05E+01 2.05E+01 2.05E+01 0.00E+00

l ODCM Rcv. 18 Pag 3 121 l 4/97 i

i

, Table 2 2 (Continued)

TNDIVIDttit. DOSE FAEPORS FOR M10EOUS EFFLUENTS - - POR ISOTOPEt Cid For Pathways Plume j T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l' Tc n: 0.00E+00 0.00F+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

Intents 0.00E+00 0.00E+00 0.00E+00 0.00E~00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathways Ground j T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

Adult - 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

TCOns 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

?

Infcnts 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00R+00 0.00E+00 0.00E+00 For Pathway Vegetable T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 5.22E+03 5.22E+03 2.61E+04 5.22E+03 5.22E+03 5.22E+03 5.22E+03 0.00E+00 TCOn 8.798+03 8.79E+03 4.39E+04 8.795+03 8.79E+03 8.793+03 8.79E+03 0.00E+00 Child: 2.14E+04 2.14E+04 1.075+05 2.14E+04 2.14E+04 2.14E+04 2.14E+04 0.00B+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i

For Pathway: Meat 3

T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

Adults 1.64E+03 1.64E+03 8.22B+03 1.64E+03 1.64E+03 1.64E+03 1.64E+03 0.00E+00 To n: 1.39E+03 1.398+03 6.94E+03 1.39E+03 1.39E+03 1.39E+03 1.39E+03 0.00E+00 Child: 2. 61E+03 2. 611+ 03 1.31E+04 2. 61E+03 2. 61E+03 2. 61R+03 2. 61E+03 0. 00E+00 Infcnt 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 For Pathways Cow Milk T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 1 Adults 1.79E+03 1.79E+03 8.97E+03 1.79E+03 1.79E+03 1.79E+03 1.795+03 0.00E+00 Tecn: 3.31E+03 3.31E-03 1.65E+04 3.31E+03 3.31E+03 3.31E+03 3.31E+03 0.00E+00 Child 8.13E+03 8.13E 03 4.07E+04 8.13E+03 3.13E+03 8.13E+03 8.13E+03 0.00E+00 Infcut: 1.70E+04 1.70E+04 7.97E+04 1.70E+04 1.70E+04 1.70E+04 1.70E+04 0.00E+00

For Pathway: Goat Milk T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.79E+03 1.79E+03 8.97E+03 1.79E+03 1.79E+03 1.79E+03 1.79E+03 0.00E+00 TO:n 3.31E+03 3.31E+03 1.65E+04 3.31E+03 3.31R+03 3.31E+03 3.'J1E+03 0.00E+00 Child: 8.13E+05 8.13E+03 4.07E+04 8.13E+03 8.13E+03 8.13E+03 8.13E+03 0.00E+00 Infant 1.70E+04 1.70E+04 7.97E+04 1.70E+04 1.70E+04 1.70E+04 1.70E+04 0.00E+00 For Pathway: Inhalation i

T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.08E+02 1.08E+02 5.76E+02 1.08E+02 1.08E+02 1.08E+02 1.08E+02 0.00E+00 .

TGcn 1. 54E+02 1. 54E+02 8.24E+02 1.54E+02 1.54E+02 1.54E+02 1.54E+02 0. 00E+00 Child: 2.13E+02 2.13E+02 1.14E+03 2.13E+02 2,13E+02 2.13E+02 2.13E+02 0.00E+00 Infant: 1.68E+02 1.68E+02 8.39E+02 1.68E+02 1.69E+02 1.68E+02 1.68E+02 0.00E+00 4

,. .s-,--...n-,.,c.-. ., . , - , , . , . omr.- ,,- ,- e.. ,, ,, ..,,,_,,,,,w,.--w..+ ,m, e-- , n- -,.we., -v..-,..w-.~.va-.,

l ODCM Rev. 18 Page 122 l

4/97 I

Table 2 2 (Continued)

INDIVIDUAL DOSE FA N RS 1UR GAEROUS EFFLUENTS -- FOP TSOTOPEt Artl For Pathway: Plume T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN !

Adults 1.P6E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.968+02 l Tonn: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 Child 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 Infant 1.96E+02 1.968+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 j For Pathway: Ground T. BODY GI TRACT BONE LIVER KIDNEY THfROID LUNG SKIN Adult 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 To n: 0.003+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 Infants 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathways Yegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN j Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 l

Tcen 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

Infants 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Torn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For rathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SCN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+0C 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway Goat Milk T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tc:n 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infants 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 To n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

l ODCM R0v. 18 Pago 123 l 4/97 Table 2 2 (Continued)

INDIVIDUAL DOSE FArPORS FOR GASE0US EFFLUENTS -- FOR ISOTOPEt Cr51 For Pathway: Plure T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4

To:n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E400 0.00E+00 0.00E+00 0.00E+00

! Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l'

For Pathway Ground T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.69E405 Tccn 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.69E+05 Child 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.69E+05 Infant: 1. 4 3 E+ 05 1. 4 3E+ 05 1. 43E+05 1. 43E+ 05 1. 43E4 05 1. 4 3 E+ 05 1. 43E+05 1. 69E+05 h

For Pathways Vegetable T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adults 1.06E+03 2.66E+05 0.00B+00 0.00E+00 2.33E+02 6.31E+02 1.40E+03 0.00E+00 TCOn 1.55E+03 2.61E+05 0.00E+00 0.00E+00 3.40E+02 8.61E+02 2.21E+03 0.00E+00 Child 3.05E+03 1.62E+05 0.00E+00 0.00E+00 4.63B+02 1.70E+03 3.10E+03 0.00E+00 Infants 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 For Pathway: Meat .

T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adults 1.29E+02 3.23E+04 0.00E+00 0.00E+00 2.83E+01 7.68E+01 1.71E+02 0.00E+00 To:n 1.03E+02 1.73E+04 0.00B+00 0.00E+00 2.25E+01 5.71E+01 1.47E+02 0.00E+00 i Child: 1.60E+02 8.50E+03 0.00E+00 0.00E+00 2.43E+01 8.90E+01 1.62E+02 0.00E+00 Infants 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

Adult: 5.20E+02 1.31E+05 0.00E+00 0.00E+00 1.15E+02 3.11E+02 6.91E+02 0.00E+00 T cn 9.09E+02 1.53E+05 0.00E+00 0.00E+00 1.99E+02 5.05E+02 1.30E+03 0.00E+00 Child: 1.85E+03 9.83E+04 0.00E+00 0.00E+00 2.81E+02 1.03E+03 1.88B+03 0.00E+00 Inftnt: 2.94E+03 8.56E+04 0.00E+00 0.00E+00 4.19E+02 1.92E+03 3.73E+03 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult 6.24E+01 1. 57E+04 0.00E+00 0.00E+00 1. 3 8E+01 3. 73E+01 8.29E+01 0. 00E+00 Togn 1.09E+02 1.83E+04 0.00E+00 0.00E+00 2.39E+01 6.06E+01 1.56E+02 0.00E+00 Child 2.22E+02 1.18E+04 0.00E+00 0.00E+00 3.37R+01 1.23E+02 2.25E+02 0.00E+00 Infant: 3.52E+02 1.03E+04 0.00E+00 0.00E+00 5.02E+01 2.30E+02 4.47E+02 0.00E+00 For Pathway: Inhalation T.DODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.17E+00 1.05E+02 0.00E+00 0.00E+00 7.23E 01 1.89E+00 4.56E+02 0.00E+00 TO:n: 4.29E+00 9.51E+01 0.00E+00 0.00E+00 9.74E-01 2.38E+00 6.64E+02 0.00E+00 Child 4.89E+00 3.44E+01 0.00E+00 0.00E+00 7.71E 01 2.71E+00 5.38E+02 0.00E+00 Inf ant s 2.84E+00 1.13E+01 0.00E+00 0.00E+00 4.19E 01 1. 82E+00 4.07E+02 0.00E+00

1 l

l ODCM Rev. 18 Page 124 ,

4/97 l

Table 2 2 (Continued)

INDIVIDUAL DOSE FACTORS FOR CASEOUS EFFLUENTS - FOR ISOTOPEt Mn54 For Pathways Plume T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 TC:n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 0.00E+00 0.00E+00 0.00B+00 0.003+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 For Pathways Ground T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.%3E+07 4.23E+07 4.96E+07 Tccn 4.23E+07 4.23E+07 4.23E+07 4.23B+07 4.23B+07 4.23E+07 4.23E+07 4.96E+07 Child 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23B+07 4.23B+07 4.23B+07 4.96E+07 Infant: 4.23B+07 4.23B+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23B+07 4.96E+07 For Pathways Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adults 1.61B+06 2.58E+07 0.00E+00 8.43E+06 2.51E+06 0.00E+0A 0.00E+00 0.00E+00 TCOns 2.53E+06 2.61E+07 0.00E+00 1.27E+07 3.80E+06 0.00E+0s 0.00E+00 0.00E+00 Child 5.03E+06 1.59E+07 0.00E+00 1.89E+07 5.30E+06 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.21E+04 5.16E+05 0.00E+00 1.68E+05 5.01E+04 0.00E+00 0.00E+00 0.00E+00 TC:n 2.55E+04 2.63E+05 0.00E+00 1.28E+05 3.83E+04 0.00E+00 0.00B+00 0.00E+00 Child 3.91E+04 1.23E+05 0.00E+00 1.47E+05 4.12E+04 0.00E+00 0.00E+00 0.00E+00 Infants 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN-Adult: 2.94E+04 4.73E+05 0.00E+00 1.54E+05 4.59E+04 0.00Ev00 0.00E+00 0.00E+00 TC:n: 5.10E+04 5.27E+05 0.00E+00 2.57E+05 7.67E+04 0.003+00 0.00E+00 0.00E+0C Child: 1.02E+05 3.23E+05 0.00E+00 3.85E+05 1.00E+05 0.30E+00 0.00E+00 0.00E+00 Infant: 1.62E+05 2.63E+05 0.00E+00 7.15E+05 1.59E+05 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.53E+03 5.67E+04 0.00E+00 1.85E+04 5.51E+03 0.00E+00 0.00E+00 0.00E+00 TO n 6.12E+03 6.33E+04 0.00E+00 3.09E+04 9.20E+03 0.00E+00 0.00E+00 0.00E+00 Child: 1.23E+04 3.87E+04 0.00E+00 4.62E+04 1.29E+04 0.00E+00 0.00E+00 0.00E+00 Infant: 1.95E+04 3.15E+04 0.00E+00 8.58E+04 1.90E+04 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.00E+02 2.45E+03 0.00E+00 1.26E+03 3.12E+02 0.00E+00 4.44E+04 0.00E+00 TCOn: 2.66E+02 2.12E+03 0.00E+00 1.62E+03 4.03E+02 0.00E+00 6.29E+04 0.00E+00 Child 3.01E+02 7.26E+02 0.00E+00 1.36E+03 3.18E+02 0.00E+00 5.00E+04 0.00E+00 Infant: 1.58E+02 2.24E+02 0.00E+00 8.03E+02 1.58E+02 0.00E+00 3.17E+04 0.00E+00

l l ODCM Rev. 18 i Pago 125 l l 4/97 l t i

)

Table 2 2 (Continued)

, TNDIVID11AL DOBE FACTORE FOR M cEOUS EFFLUENTS -- FOR ISJTOPEt CoEB I

For Pathway Plume T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 To0n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i

Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.60E+00 0.00E+00 Infants 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

! For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 1 4 Adults 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.168+07 1.16E+07 To n 1.168+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.1(?.+0' 1.168+07 Child: 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.163+07 1.16',Li A.16E+07 '

Infcut 1.16E+07 1.16E+07 1.16E+07 1.168+07 1.165+07 1.165+07 1.16t+07 1.16E+07 J t

i For Pathways Vegetable T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.76E+06 1.59F+07 0.00E+00 7.85E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i T0cn: 2.72E+06 1. 63E+07 0.00E+00 1.185+06 0. 00E+00 0. 00E+b0 0.00E+00 0.00E+00 Childs 5.43E+06 1.04E+07 0.00E+00 1.775+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

For Pathway Meat i

T. BODY GI TRAW BONE LIVER KIDNEY THYROID LUNG SKIN

- Adult 7.30E+05 6.60E+06 0.00E+00 3.265+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tc0n: 5.79E+05 3.46E+06 0.00E+00 2.51E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 j Child: 8.98E+05 1.71E+06 0.00E+00 2.93E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Inicnt 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00*s+00 0.00E+00 0.00E+00

! For Pathway: Cow Milk ,

T. BODY GI TRAW BONE LIVER KIDNEY THYROID LUNG SKIN Adult:

' 1.89E+05 1.71E+06 0.00E+00 8.42E+04 0.00E+00 0.00E+00 0.00E+00 0.00B+00 Tc0n: 3.27E+05 1.95E+06 0.00E+00 1.42E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Cnilds 6.63E+05 1.26E+06 0.00E+00 2.17E+05 0.00E+00 0.00E+00 0.00E+00 0.00B+00 Infant: 1.08E+05 1.08E+06 0.00E+00 4.33E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 j '

For Pathways Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.26E+04 2.05E+05 0.00E+00 1.01E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00

.Toen 3.92E+04 2.35E+05 0.00E+00 1.70E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 7.96E+04 1.52E+05 0.00E+00 2.60E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00

) Infant: 1.30E+05 1.30E+05 0.00E+00 5.20E+04 0.00E+00 0.00E+00 0.00E400 0.00E+00 -

For Pathway: Inhalation l T. BODY GI-TRACT BONE LIVER KIDNEY THfROID LUNG SKIN i Adult: 6.575+01 3.375+03 0.00E+00 5.02E+01 0.00E+00 0.00E+00 2.94E+04 0.00E+00 TOOn: 8.80E+01 3.02E+03 0.00E+00 6.57E+01 0.00E+00 0.00E+00 4.26E+04 0.00E+00 Child: 1.00E+02 1.09E+03 0.00E+00 5.62E+01 0.00E+00 0.00E+00 3.51E+04 0.00E+00 Infant: 5.778+01 3.53E+02 0.00E+00 3.87E+01 0.00E+00 0.00E+00 2.46E+04 0.00E+00 i

5

,-----.,m-w w aAmn-m,.-,---,-,-n-- - - = - .e> mm----n--r-n -m--- --

-me-m- ---n --

n -e v ~-.-v ~ ~ ~ - = +,---~v -~---

l ODCM R0v. 18 Page 126 l

4/97 Table 2 2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS FOR ISOTOPEt Fe59 For Pathways Plume T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TCOn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI TRACT BONE LIVER K!DNEY THYROID LUNG SKIN Adult: 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 9.80E+06 TOCn: 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 9.80E+06 Child: 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 9.80E+06 Inftnt: 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 9.80E+06 For Pathway Vegetable T. BODY GI-TRAC"r BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.80E+06 2.43E+07 3.11E+06 7.30E+06 0.00E+00 0.UOE+00 2.04E+06 0.00E+00 TOtn 4.2CE+06 2.62E+07 4.75E+06 1.11B+07 0.00E+00 0.00E+00 3.50E+06 0.00E+00 Child: 8.69E+06 1.32E+07 1.08E+07 1.75E+0 / 0.00E+00 0.00E+00 5.06E+06 0.00E+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Heat T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.29E+06 : 73E+07 4.76E+06 1.12E+07 0.00E+00 0.00E+00 3.12E+06 0.00B+00 TO:nt 3.43E+06 2.10E+07 8.87E+06 8.87E+06 0.00E+00 0.00E+00 2.80E+06 0.00E+00 Child: 5.43E+06 1.14E+07 6.74E+06 1.09E+07 0.00E+00 0.00B+00 3.16E+06 0.00E+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 For Pathways Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIH Adult: 4.79E+05 4.17E+06 5.32E+05 1.25E+06 0.00E+00 0.00E+00 3.49E+05 0.00E+00 TC n: 8.37E+05 5.12E+06 9.288+05 2.17E+06 0.00E+00 0.00E+00 6.83B+05 0.00E+00 Child: 1.74E+06 3.63E+06 2.15E+06 3.48E+06 0.00E+00 0.00E+00 1.01E+06 0.00E+00 Infant 2.71E+06 3.35E+06 4.02E+06 7.02E+06 0.00E+00 0.00E+00 2.07E+06 0.00B+00 For Pathways Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.23E+03 5.42E+04 6.91E+03 1.63E+04 0.00E+00 0.00E+00 4.54E+03 0.00E+00 TOOn 1.09E+04 6.66E+04 1.21E+04 2.82E+04 0.00E+00 0.00E+00 8.86E+03 0.00E+00 Child: 2.26E+04 4.71E+04 2.80E+04 4.53E+04 0.00E+00 0.00E+00 1.31E+04 0.00E+00 Infant: 3.60E+04 4.36E+04 5.22E+04 9.12E+04 0.00E+00 0.00E+00 2.70E+04 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.35E+02 5.96E+03 3.73E+02 8.80E+02 0.00E+00 0.00E+00 3.22E+04 0.00E+00 TccL: 4.54E+02 5.66E+03 5.05E+02 1.17E+03 0.00E+00 0.00E+00 4.84E+04 0.00E+00 Childs 5.29E+02 2.24E+03 6.56E+02 1.06E+03 0.00E+00 0.00E+00 4.02E+04 0.00E+00 Infant: 3.00E+02 7.86E+02 4.30E+02 7.46E+02 0.00E+00 0.00E+00 1 22E+04 0.00E+00

___..__._______ _ _.__ -____ _ _ _____.___ _ _ __.~ _ ___

l ODCM Rev. 18 P go 127 l 4/97

. Table 2 2 (Continued) l TNDIVIDUAL DOSE FACTORS POR McEOUS EFFLUENTS POR 190'"OPEt coSO For Pathway Plume T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E400 TO:n 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infants 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathways Ground T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 8.34E+08 TC:n 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 8.34E+08

Child 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.098+08 7.09E+08 7.09E+08 8.34E+08 Infant: 7.09E+08 7.098+08 7.09E+00 7.09E+08 7.09E+08 7.09E408 7.09E+08 8.34E408 1

For Pathways Vegetable T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adults 1.02E+07 8.688+07 0.00E+00 4.62E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tc n 1.61E+07 9.29E+07 0.00E+00 7.13E+06 0.00E+00 0.00E+00 0.00E+00 0.00E400 Childs 3.24E+07 6.08E+07 0.00E+00 1.10E+07 0.00B+00 0.00E+00 0.00E+00 0.00E+00 Inftnt 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0,00E+00 0.00B+00 Os00E+00 0.00E+00 For Pathways Meat T. BODY GI TRACT BONE LIVER KIDNBY THYROID LUNG SKIN Adult: 3.11E+06 2.65E+07 0.00E+00 1.41E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TO:n 2.46E+06 1.42B+07 0.00E+00 1.09E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Childs 3.83E+06 7.19E+06 0.00L+00 1.30E+06 0.00E+00 0.00E+00 0.00E+00 0.00E400 Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.78E+05 5.77E+06 0.00E+00 3.07E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 To:n: 1.17E+06 6.78E+06 0.00E+00 5.21E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 2.385+06 4.488+06 0.00E+00 8.09E+05 0.00E+00 0.00E+00 0.00E+00 0.00E400 Infant: 3.90E+06 3.93E+06 0.00E+00 1.65E+06 0.00E+00 0.00B+00 0.00E+00 0.00E+00 '

For Pathways Goat Milk T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 8.13E+04 6.93E+05 0.00E+00 3.69E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcent 1.41E+05 8.14E+05 0.00E+00 6.25E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 2.86E+05 5.37E+05 0.00E+00 9.70E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt: 4.68E+05 4.71E+05 0.00E+00 1.98E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pithway: Inhalation T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.69E+02 9.03E+03 0.00E+00 3.65E+02 0.00E+00 0.COE+00 1.89E+05 0.00E+00 TO:n 6.29E+02 8.22E+03 0.00E+00 4.79E+02 0.00E+00 0.00E+00 2.76E+05 0.00E+00

. Child 7.18E+02 3.05E+03 0.00E+00 4.16E+02 0.00E+00 0.00E+00 2.24E+05 0.00E+00' 7nfcnt: 3.73E+02 1.01E+03 0.00E+00 2.54E+02 0.00E+00 0.00E+00 1.43E+05 0.00E+00 d

e nn..en n - - - - - -- - ~~ 4 . , n ~ as. m ,.n,. w ~m a- w ~~ .-_=-n ^--

ODCM R;v. 18 l

Page 128 l 4/97 Table 2-2 (Continued)

INDIVIDUAL DOSE FAC"I' ORS FOR GASEOUS EFFLUENTS - - FOR ISO'IOPE t Zn6B For Pathways Plume T. BODY GI TPJCT BO!E LIVER KID!EY THYROID LUNG SKIN Adult: 0.00E+00 0.00F+00 0.00R+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 To:n 0.00E400 0.00L+00 0.00E+00 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathways Ground T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07 Tc n 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07 Child 2.29E407 2.298+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07 InfOnt: 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07 For Pathways Vegetable T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.58S+07 2.20E+07 1.10E+07 3.508407 2.34E+07 0.00E+00 0.00E+00 0.00E+00 T0cn: 2.43E+07 2.25E407 1.53E+07 5.32E+07 3.40E+07 0.00E+00 0.00E+00 0.00E+00 Childs 4.93E+07 1.39E+07 2.98E+07 7.93E+07 5.00E+07 0.00E+00 0.00B+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E400 For Pathway: Meat T E9? GI-TRACT BONE LIVER KID!EY THfROID LUNG SKIN Adults 1.00E+07 1.50E+07 7.50E+06 2.39E407 1.60E+07 0.00E+00 0.00E+00 0.00E+00

[ To:n: 8.54E+06 7.75E+06 5.27E+06 1.33E+07 1,17E+07 0.00E+00 0.00E+00 0.00E+00 Child: 1.31E+07 3.70E+06 7.91E+06 2.11E+07 1.33E+07 0.00E+00 0.00E+00 0.00E400 Infant 0.00B+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.15E+07 5.79E+07 2.89E+07 9.20E+07 6.15E+07 0.00E+00 0.00E+00 0.00E+00 Tc n: 7.19E+07 6.63E+07 4.44E+07 1.54E+08 9.86E+07 0.00E+00 0.00E+00 0.00E+00 Child: 1.44E408 4.07E+07 8.71E+07 2.32E+08 1.46E+08 0.00E+00 0.00E+00 0.00E+00 Infant: 1.85E+08 3.39E+08 1.17E+08 4.01E+08 1.95E+08 0.00E+00 0.00E+00 0.00E+00 For Pathways Goat Milk

, T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 4.99E+06 6.95E+06 3.47E+06 1.10E+07 7.30E+06 0.00E+00 0.00E+00 0.00E+00 Adult:

Tcen: 8.63E+06 7.83E+06 5.33E+06 1.85E+07 1.18E+07 0.00E+00 0.00E+00 0.00E+00 Child: 1.73E+07 4.89E+06 1.05E+07 2.78E+07 1.75E+07 0.00E+00 0.00E+00 0.00E+00 II.fant 2.22E+07 4.07E+07 1.40E+07 4.81E+07 2.33E+07 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.43E+08 1.69E+03 1.03E+03 3.27E+03 2.19E+03 0.00E+00 0.00E+00 0.00E+00 T;en: 1.93E+08 1.4bE+03 1.22E+03 4.24E+03 2.74E+03 0.00E+00 0.00E+00 0.00E+00 Child: 2.23E+03 5.17B+02 1.35E+03 3.59E+03 2.26E+03 0.00E+00 0.00E+00 0.00E+00 Infant: 9.85E+02 1.63E+03 6.12E+02 1.98E+03 1.03E+03 0.00E+00 0.00E+00 0.00E+00

l ODCM R3v. 18 P ga 129 l 4/97 Table 2 2 (continued) l UDIVIDUAL DOSE PACTORS POR GASEOUS EPPLUENTS - POR ISOTOPEt Kr83m For Psthway Plume l T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adults 1.68E 03 1.68E 03 1.68E 03 1.68E 03 1.68E-03 1.68E 03 9.39E 02 4.75E 01 TOcn 1.68E 03 1.68E 03 1.688-03 1.68E 03 1.68E 03 1.68E 03 9.39E 02 4.75E 01 Child: 1.68E-03 1.68E 03 1.68E 03 1.68E 03 1.68E-03 1.68E 03 9.39E 02 4.75E 01 l Infant: 1.68E 03 1.68E 03 1.68E 03 1.68E 03 1.68E 03 1.68E 03 9.39E-02 4.75E 01 l For Pathway Ground T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tc:n: 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 Infants 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l For Pathway Vegetable T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 :

TO:n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult. 0.00E+00 0.00E+00 0.00E+00 0.00h+00 0.00E+00 0.00E+00 0.00B+00 0.10E+00 TOCn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E400 0.CCE+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.0'0E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E400 0.00E+00 0.00E+00 TC:n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inf0nt 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tocn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt 0.00E+00 0.0CE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0,00E+00 0.00E+00 0.00E+00 0.00E+00 Tccn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

ODCM Rev. 18 Page 130 4

Table 2 2 (Continued)

INDIVIDUAL _ DOSE FANRS . FOR GASEOUS . EFFLUENTS - POR ISOTOPEr Kr95 For Pathways Plure T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.57E 01 3.578-01 3.b 78 01 3.575 01 3.57E 01 3.57E- 01 9.50E 01 4.29E+01 TCcn 3.57E 01 3.57E-01 3.57E 01 3.57E 01 3.575 01 3.57E-01 9.50E 01 4.I9E+01 Child 3.57E 0* 3.57E 01 3.57E 01 3.57E 01 3.57E 01 3.57E-01 9.50E 01 4.29E+01 Infant: 3.57E 01 3.57E 01 3.57E 01 3.57E 01 3.575 01 3.578 01 9.50E 01 4.295+01 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TOOns 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+0C 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathways Vegetabl's T. BODY GI T RCT BONE LIVER KIDNEY THfROID LUNG SKIN.

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 T0rn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway Meat T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 T20n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E400 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 T0cn 0.00E+00.0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infants 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG S.NIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.q0E+00 0.00E+00 0.00E+00 Tccn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tccn t - 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

l ODCH RGv. 18 Pags 131 l 4/97 Table 2 2 (Continued)

INDIVIDUAL DOSE FACTORE FOR GAREOUS EFFLUENTS - FOR ISOTOPEt KrB5m i

For Pathways Plume T. BODY GI TRAC"T LIVER KIDNEY THYROID SKIN BONE LUNG Adult: 2.60E+01 2.60E+01 2.60B+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.66E+01 Toen 2.60E+01 2.60B+01 2.60E+01 2.60E+01 2.60E+01 2. ICE +01 2.66E+01 7.66E+01 Child: 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.66E+01 Infant 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.66E+01

?

For Pathway: Ground T. BODY GI TRAC *T BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

, TO:n 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 Child 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 For Pathway Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.0011+00 0.00E+00 T0cn 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infants 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRAC"r BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i

TOGn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0,00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt 0.00E+00 d 90E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Fo'c Pathway Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TO:n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 For Pathway Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

- Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 T3:n 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00'O.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tosnt 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Childt 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infants 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.'0E+00

l ODCM Rev. 18 Page 132 l 4/97 Table 2 2 (Continued) l INDIVIDitat. DOSE PACTORE FOR nacEOUS EPPLUENTS - POR IS3TOPEi KrB7 ;

Por Pathways Plume T. BODY GI TRA W BONE LIVER KIDNEY WYAND LUNG SKIN Adult: 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31t+02 1.35E+02 4.60W+02 TOOn 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31R+02 1.35E+02 4.60E+02 i Child: 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31B+02 1.31L+02 1.35E+02 4.60E+02 l Infant 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E&O2 1.35E+02 4.60B+02 For Pathways Ground T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0,00E+00 0.00E+00 0.00E+00 0.0)E+00 TOcn 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00Ecb0 0.00D+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 )

Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+0C 9.00E+00 0.00E+00 ,

For Pathways Vegetable T. BODY GI TRAW BONE LIVER KIDNEY THYRGID LUO Wl?i Adult: 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00B+00 0.00E+0C 0.001e00 TCOn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00' e+00 Child: 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI TRACT BouE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TCOn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.005+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.005,C*

For Pathways Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYRCID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TG:n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0. DOE +00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYP.0ID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+v0 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TO n 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00L+00 For Pathway: Inhalation T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00B+00 0.00E+00 0.00E+00 0.00B+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00

'T00n 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0 90E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

l ODCH R:v. 18 POg3 132 l 4/97 Table 2 2 (Continued)

INDIVIDUAL DOSE fat *INI POR GASEOUS EFFLUENTS POR ISOTOPEt Kr8B

?or Pathway Plume T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02 4.50E+02 Turn 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02 4.50E+02 Childs 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.16E+02 3.27E+02 4.50E+02 Infants 3.26B+02 3.26E402 3.26E+02 3.26E+02 3.26E+02 3.J6E+02 3.27B+02 4.50E+02 For Pathway Ground T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TC:n: 0.00E400 0.00E+00 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 Infants 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.03B+00 For Pathways Vegetable T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00B+00 0.00E400 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TcCn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00k+00 0.00E+00 0. GOB +00 0.00E+00 Child: 0-00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 Infantt 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00B+00 0.00E400 For Pathway Heat T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Torn 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Childt 0.00B+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.0C]+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0. SOB +00 For Pathway Cow Milk T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Torn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway Goat Milk T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TO:n 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.000+00 0.00E400 0.00E+00 0.00E+00 Tctna 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child Infant 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

- - - _ _ . . . _ . - - _ _ - -. . _ . . - - - _ _ . _ . ~ _ - . _ _ _ _

i l ODCM Rev. 18 Page 134

, 4/97 Table 2 2 (Continued)

INDIVIDUAL . DOSE FACTORE FOR MSEOUB RFFLUENTS -- POR ISOTOPEr Kr89 For Pathways Plume T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.68E+02 3.68E+02 3.685+02 3.68E+02 3.68E+02 3.68E+02 3.72E+02 7.468+02 TO:n: 3.68E+02 3.68E+02 3.685+02 3.68E+02 3.68E+02 3.685+02 3.72E+02 7.46E+02 Child: 3.685+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.685+02 3.72E+02 7.46E+02 Infants 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.685+02 3.72E+02 7.46B+02 For Pathways Ground .

T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN t Adult 0.00Ee00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4 Teen 0.008400 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.002+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infants 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Fcr Pathways Vegetable T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00R+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TO:n 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.10E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infants 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

TC n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 For Pathway: Cow Milk T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TC n 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 Infant 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TO:n: 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E400 0.3CE+00 0.00E+00 0.0CE+00 Infants 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcen: 0.00E+00-0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+03 0.00E+00 Child: 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00

'i l ODCM R v. 18 P g3 135 i

l 4/97 Table 2 2 (Continued)

INDIVIDUAL DOSE PA CORS FOR GASEOUS EFFLUENTS -- POR ISOTOPEr srb 9

! For Fathway: Plume T. BODY GI TRAC BONE LIVER KIDNEY THYROID LUNG SKIN Adults C.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

TO:n 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 Infants 0.00E+00 0.00E+00 0.00R+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.62B+02 6.62B+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02 TO:n 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02 ,

Childs 6.62E+02 6.62E+02 6.62B+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02 Infant: 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02

For Pathway Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult 7.42E+06 4.14E+07 2.588+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TOOn 1.20E+07 5.00E+07 4.20R+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 2.91E+07 3.95E+07 1.02E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+0D 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult 1.68E+05 9.41E+05 5.86E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 To n 1.42E+05 5.90E+05 4.95E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

', Child: 2.68E+05 3.63E+05 9.37E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Infants 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG S4!N Adult: 8.09E+05 4.52E+06 2.82E+07 0.00E+00 0.00E+00 0.iOE+00 0.00E+00 0.00E+00 TO:n: 1.49E+06 6.19E+06 5.20E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 3.67E+06 4.98E+06 1.29E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infknt: 7.02E+06 5.03E+06 2.45E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk ;

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SK1W Adults 1.70E+06 9.50E+06 5.92E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TC n 3.13E+06 1.30E+07 1.09E+0B 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Childs 7.72E+06 1.05E+07 2.70E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 InfCnt: 1.47E+07 1.06E+07 5.14E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l

For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.76E+02 1.11E+04 9.64E+03 0.00E+00 0.00E+00 0.00E+00 4.44E+04 0.00E+00 TC n: 3.96E+02 1.18E+04 1.38E+04 0.00E+00 0.00E+00 0.00E+00 7.66E+04 0.00E+00 l Child 5.47E+02 5.30E+03 1.90E+04 0.00E+00 0.00E+00 0.00E+00 6.84E+04 0.00E+00 '

Infcnt: 3.62E+02 2.03E+03 1.26E+04 0.00E+00 0.00E+00 0.00E+00 6.44E+04 0.00E+00

_ . ~ . - - - . - . . - - - - _ _ . _ - - - . - _ - _ - - - . - - - - _ . _ _ _

l l

ODCM Rev. 18 Page 136 i

l 4/97 Table 2 2 (Continued)

INDIVIDUAL DOSE _ FACTORS FOR MAROUS EFFLUENTS

-- FOR ISDTOPEt Kr90 For Pathways Plum & ,

T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult 3.46E+02 3.46E+02 3.46B+02 3.46E+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02 )

Tocn: 3.46E+02 3.46E+02 3.465+02 3.46E+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02 l Childs 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49'E+02 6.33E+02 l Infant: 3.46E+02 3.46E+02 3.46E+02 3.465+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02 For Pathway Ground T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen: 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathways Vegetable T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infants 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.v0E+00 For Pathways Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 TO n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '.

Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tocu s - 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+90 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 F04 Pathways Goat Milk T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TOOn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00B+00 For Pathway Inhalation T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TOOn: -0.00E+00.0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-0.00E+00 0.00E+00 Childs. 0.00E+00 0.00E<d0 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00E+s0 0.00E< 00 0.00E+00 0.00E&OO 0.00E+00 0.00E+00 0.00E+00

l ODCM ROV. 18 ,

P0go 137 l l 4/97 1

Table 2 2 (Continued)

INDIVIDif1L DOSE FACTORS FOR dicEOUS EFFLUENTE - FOR ISOTOPEr Er90 l

l For Pathways Plume T. BODY GI TRACT LIVER XI9NEY THYROID SKIN DONE LUNG :

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TOOns 0.00E+00 0.00E400 0.00E+00 0.00E+00 0.00R+00 0.00E+00 0.00E+00 0.00F+00 .

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 !

Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway Ground T. BODY GI TRAW BONE LIVER KIDNEY TH'00ID LUNG SUN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TOOns 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult 1.38E+10 1.63E+09 5.64E+10 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 TCOn 1.79E+10 2.04E+09 7.27E+10 0.00E+00 0.00E+00 0.00E+00 0.00R+00 0.00E+00 Childs 3.09E+10 1.54E+09 1.22E+10 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

) Adult: 4.45E+08 5.24E+07 1.81B+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 TCOns 2.90E+08 3.29E+07 1.17E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 3.84E+08 2.04E+07 1.52E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infants.0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4 For Pathways Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adults 1.67E+09 1.97E+08 6.32E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TCOn 2.388+09 2.70E+08 9.64E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 4.13E+09 2.19E+08 1.63E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 4.51E+09 2.21E+08 1.77E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 4

Adult: 3.51E+09 4.14E+08 1.43B+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 To0n: 5.00E+09 5.68E+08 2.02B+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 8.67E+09 4.61E+08 3.42E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Infcnt: 9.47E+09 4.65E.08 3.72E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.0CE+00 For Pathway -Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult 1.93E+05 2.28E+04 3.14E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 >

T33nt 2.12E+05 2.42E+04 3.42E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 2.04E+05 1.09E+04 3.20E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 8.21E+04 4.15E+03 1.30E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 J

s -n..w,a- - ,- s .,.e ,,-,,.g. y . . , . , _ . -.,,,.,,w--m,.y,,,,,-7 . , _ . , ,-m 4 , 7 r, , - - , - .r,- - ,

. . , , , . - ,vn. , ,.

l ODCM Rev. 18 Page 138 l 4/97 Table 2 2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS - POR ISOTOPEt Zr95 For Pathway: Plume T. BODY G! TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 n.00E+00 0.00E+00 0.00E+00 l TC:n 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00B+00 0.00E+00 0.00B+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.n0E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 For Pathway: Ground T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.48E+06 7.4 8E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67E+06 T0:n 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67B+06 Child: 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67E+06 Infant: 7.48E+06 7.48E+06 7.48E+06 7.48E406 7.48E+06 7.48E+06 7.48E+06 8.67E+06 For Pathways Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.46E+03 3.03E+07 2.98E+04 9.55E+03 1.50E+04 0.00E+00 0.00E+00 0.00E+00 TOCn: 1.01E+04 3.37E+07 4.63E+04 1.46E+04 2.15E+04 0.00B+00 0.00E+00 0.00E+00 Child- 2.07E+04 2.43E+07 1.06E+05 2.33E+04 3.33E+04 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.26E+03 3.40E+07 3.34E+04 1.07E+04 1.68E+04 0.00E+00 0.00E+00 0.00E+00 TO:n 5.81E+03 1.95E+07 2.68E+04 8.45E+03 1.24E+04 0.00E+00 0.00E+00 0.00E+00 Child: 9.30E+03 1.09E+07 4.75E+04 1.05E+04 1.50E+04 0.00E+00 0.00B+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00Et00 For Pathway Cow Milk T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3. 65E+00 1. 71E +04 1. 68E+01 5.4 0E+00 8.47E+00 0. 00E+00 0. 00E+00 0. 00E+00 TOCn: 6.39E+00 2.14E+04 2.94E+01 9.29E+00 1.36E+01 0.00E+00 0.00E+00 0.00E+00 Child: 1.34E+ 01 1. 57E+04 6. 84E+01 1. 50E+01 2.15E+01 0. 00E+00 0. 00E+00 0. 00E+00 Infant 2.10E+01 1.47E+04 1.21B+02 2.96E+01 3.19E+01 0.00E+00 0.00E+00 0.00E+00 For Pathway Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4. 39E 01 2. 05E+03 2.02E+00 6.48E-01 1. 02E+00 0. 00E+00 0. 00E+00 0. 00E+00 TO:n 7.66E 01 2.57E+03 3.53E+00 1.11E+00 1.64S+00 0.00E+00 0.00E+00 0.00E+00 Child: 1.61E+00 1.88E+03 8.20E+00 1.80E+00 2.58E+00 0.003+00 0.00E+00 0.00E+00 Infant 2.52E+00 1.77E+03 1.46E+01 3.55E+00 3.83E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.38E+02 4.77E+03 3.40E+03 1.09E+03 1.72E+03 0.00E+00 5.60E+04 0.00E+00 TOCn: 9.99E+02 4.72E+03 4.62E+03 1.45E+03 2.14E+03 0.00E+00 8.52E+04 0.00E+00 Child: 1.17E+03 1. 94 E+03 6. 02E+03 1. 33E+03 1. 89E+03 0. 00E+00 7. 07E+04 0. 00E+00 Infant: 6.44E+02 6.88E+02 3.66E+03 8.83E+02 9.85E+03 0.00E+00 5.55E+04 0.00E+0v

-~ _.-. _- . . - - - - - - - _ _ - - - - - - - - - -

l ODCM R0". 10 P:go 139 l 4/97 Table 2 2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPEt Sb124 For Pathways Plume i T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00R+00 0.00E+00 1 TcOn: 0.00E+00 0.00E+00 0.00E+00 0.00E900 0.00E+00 0.00E+00 0.00E+00 0.00E+00

, Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ;

Infants 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathways Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SCN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathways Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tc n 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E400 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0,00E+C 3 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 For Pathways Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0,00E+00 Torn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnts 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway Goat Milk T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.*0E+0C 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TcOns 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI TRAC *r BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 To n 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 r v rn,- .,v-~r --,w -

w-tv ~ c v vei w - - - w- a v w -

ODCM Rev. 18 l

Page 140 l

4/97 Table 2 2 (Centinued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPEt 1131 For Patnways Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcon: 0.00E+00 0.00E+00 0.00E+00 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infants 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathways Ground T. BODY GI TRACT BONE LIVER KIDN8Y THYROID LUNG SKIN Adult 2.63E+05 2.63E405 2.63B+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 3.19E+05 TCOns 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63B+05 2.63E+05 3.19E+05 Child 2.63E+05 2.63E+05 2.638+05 2.63B+05 2.63E+05 2.63B+05 2.63E+05 3.19E+05 Infant 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63B+05 2.63E+05 2.63E+05 3.19E+05 I

For Pathways Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.43B+05 2.04E+05 5.41E+05 7.74E+05 1.33E+06 2.54E+08 0.00E+00 0.00E+00 TOCn: 4.02E+05 1.488+05 5.35E+05 7.48E+05 1.29E+06 2.18E+08 0.00E+00 0.00E+00 Child 5.83E+05 9.13E+04 1.02B+06 1.03E+06 1.68E+05 3.39E+08 0.00E+00 0.00E+00 Infanrt 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI TRAC"T BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 8.70E+04 4.01E+04 1.06E+05 1.52E+05 2.60E+05 4.98B+07 0.00E+00 0.00E+00 TO n 6.64E+04 2.44E+04 8.82E+04 1.24E+05 2.13E+05 3.60E+07 0.00E+00 0.00E+00 Childs 9.35E+04 1.46E+04 1.64E+05 1.65E+05 2.70E+05 5.44E+07 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathways Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.39E+06 1.10E+06 2.92B+06 4.17E+06 7.16E+06 1.37E+09 0.00B+00 0.00E+00 TC:n: 3.90E+06 1.47E+06 5.30E+06 7.42E+06 1.28E+07 2.16E+09 0.00E+00 0.00E+00 Child 7.34B+06 1.15E+06 1.28E+07 1.29E+07 2.12E+07 4.27E+09 0.00E+00 0.00E+00 Infant 1.39E+07 1.13E+06 2.68E+07 3.16E+07 3.69E+07 1.04E+10 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.87E406 1.32E+06 3.50E+06 5.01E+06 8.59E+06 1.64E+09 0.00E+00 0.00E+00 TOcn 4.78E+06 1.76E+06 6.36E+06 8.90E+06 1.53E+07 2.60E+09 0.00E+00 0.00E+00 Child 8.81E+06 1.38E+06 1.54E+07 1.55E+07 2.55E+07 5.13E+09 0.00E+00 0.00E+00 infant: 1.67E+07 1.35E+06 3.22E+07 3.79E+07 4.43E+07 1.25E+10 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.49E+02 1.99E+02 7.99E+02 1.13E+03 1.94E+03 3.78E+05 0.00E+00 0.00B+00 TCOn: 8. 37E+02 2. 06E+02 1.12E+03 1. 56E+03 2. 66E+03 4. ( i M+05 0. 00E+00 0. 00E+00 Child 8.64E+02 9.01E+01 1.52E+03 1.52E+03 2.50E+03 5.158+0S 0.00E+00 0.00E+00 Infant: 6.21E+02 3.36E+01 1.20E+03 1.41E+03 1.64E+03 4.70E+04 0.00E+00 0.00E+00

l ODCM rov. 18 l Pago 141 J

l 4/97 Table 2 2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS - - FOR ISOTOPE r Xe131m For Pathways Plume ,

i T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.388*00 1.d9E+01 Tcen: 2.0* 3+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.38E+00 1. 89E+01 l Child 2. 03E+0C 2. 03E+00 2.03E+00 2.03E+00 2. 038+00 2. 03E+00 2.38E+00 1. 89E+01

Inf ant s 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.3BE+00 1.89E+01 1

For Pathways Ground T. BODY GI-TRACT BONE LIVER KDNEY THYROID LUNG SKIN Adult; 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TO ns 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0. 00E+00 0.00B+00 0.00E+00 0.00E+00 0.00B+00 0..'0E+00 0.00E+00 0.00E+00 Inf ant s 0.00E+00 0.00E+00 0.00E+0C 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathways Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Torn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E 70 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00A+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tocn: 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00Ev00 e Child: 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathways Cow Milk

-T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TOOn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 For Pathway: Goat Milk T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 Tccn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adulti- 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tocn: 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: .0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

l ODCM Rev. 18 Page 142 l l 4/97 l l

Table 2 2 (Continued)

INDIVIDUAL DOSE PAC 70RS FOR GASI'OUS EFFLUENTS -- POR ISOTOPEt I133 i

For Pathway: Plume 1 T. BODY GI-TRACT BONE LIVER KIDNEY TH(RsID LUNG SKIN l Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 1 Teen 0.00E,00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Grourd T. BODY GI-TRACT . TONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.75E+04 3.75E+04 3."iE+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 TOcn: 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 Child: 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 Infant: 3.75E+04 3.75E+04 3.75B+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 For Pathway: Vegetable T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN.

Adult: 7.07E+03 2.08E+04 1.33E+04 2.32E+04 4.05E+04 3.41E+06 0.00E+00 0.00E+00 T0cn: 6.41E+03 1.59E+04 1.24E+04 2.10E+04 3.69E+04 2.93E+06 0.00F+00 0,00B+00 Child: 1. 06E+04 1.13E+04 2.26B+04 2.79E+04 4. 65E+04 5.19E+06 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pa".hway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SIIN Adult: 2. 01E-03 5.93E-03 3.79E-03 6.60E-03 1.15E-02 9. 70E-01 0.00E+00 0.00E+00 TOCn: 1.64E-03 4.07E-03 3.17E-03 5.38E-03 9.44E-03 7.52E-01 0.00E+00 0.00E+00 Child: 2.76E-03 2.94E-03 5.90E-03 7.29E-03 1.22E-02 1.35E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.07E+04 6.12E+04 3.91B+04 6.81E+04 1.19E+05 1.s0E+07 0.00E+00 0.00E+00 Tc n: 3.70E+04 9.17E+04 7.15E+04 1.21E+05 2.13E+05 1. 69E+07 0. 00E+00 0. 00E+00 Child: 8.12E+04 8.65E+04 1.74E+05 2.15E+05 3.58E+05 3.99E+07 0.00E+00 0.00E+00 Infant: 1.56E+05 9.03E+04 3.67E+05 5.34E+05 6.28E+05 9.71E+07 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.49E+04 7.34E+04 4.69E+04 8.17E+04 1.42E+05 1.20E+07 0.00E+00 0.00E+00 TOCn: 4.44E+04 1.10E+05 8.57E+04 1.45E+05 2.55E+05 2.03E+07 0.00E+00 0.00E+00 Child: 9.75E+04 1.04E+05 2.08E+05 2.58E+05 4.29E+05 4.79E+07 0.00E+00 0.00E+00 Inftnt: 1. 88E+05 1. 08E -05 4.40E+05 6.41E+05 7.53E+05 1.16E+08 0. 00E+00 0. 00Ev00 For Pathway: Inhalation T. BODY' GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.43E+02 2.81E+02 2.74E+02 4.69E+02 8.19E+02 6.82E+04 0.00E+00 0.00E+00 Ts;n: 1. 97E+02 3.27E+02 3. 85E+02 6.49E+02 1.14E+03 9. 26E+04 0. 00E+00 0. 00E+00 Child: 2.44E+02 1.74E+02 5.25E+02 6.44E+02 1.07E+03 1.22E+05 0.00E+00 0.00E+00 Infant: 1.78E+02 6.83E+01 4.20E+02 6.08E+02 7.10E+02 1.13E+05 0.00E+00 0.00E+00

I l ODCM R v. 18 P gs 143 l 4/97 Table 2-2 (Continued) l INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe133 !

For Pathway Plume l T. BODY GI TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.52E+00 6.52E+00 6.52E+00 6.52E+00 S.52E+00 6.52E+00 6.86E+00 1.84E+01 TG n: 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86B+00 1.84E+01 l Child: 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 Infant: 6.52E+00 6.52R+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 For Pathway: Ground T. BODY GI-TRAC? BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tccn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

. Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT PONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

, Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tosn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 T02n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 7- For Pathway: Goat Milk T. BODE GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 T2cn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Ad' ult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TsGn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

l ODCM Rev. 18 Page 144 l 4/97 Table 2 2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPEr Xe133m For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00 5.57E+00 6.03E+00 3.96E+01 Tc;n: 5.57E+00 5.57B+00 5.57E+00 5.57E+005.57E+00 5.57E+00 6.03E+00 3.96E+01 Child: 5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00 5.57E+00 6.03E+00 3.96E+01 Infant: 5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00 5.57E+00 6.03E+00 3.96E+01 For Pathways Ground ,

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TOCn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tccn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+v0 0.00E+00 0.00B+00 Child: 0.00E+00 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TGcn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT DONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 Tsen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E400 0.00E+00 Child: 0.00E+00 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 T;en: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 w

l ODCM R;v. 18 I

Paga 145 l 4/97 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Cs134 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TOCn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00S+00 0.00E+00 0.00B+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infnnt: 0.00E+00 0.00E+00 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.46E+08 Tctn 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.,6E+08 Child: 2.11E+08 2.11B+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.46E+08 Infant: 2.11E+08 2.11E+08 2.11E+08 2.11B+08 2.11E+08 2.11E+08 2.11E+08 2.46E+08 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.50E+08 5.34E+06 1.28E+08 3.05E+08 9.88E+07 0.00E+00 3.28E+07 0.00E+00 Tccn: 2.21E+08 5.93E+06 2.03E+08 4.77E+08 1.52E+08 0.00E+00 5.79E+07 0.00E+00 Child: 1.60E+08 4.10E+06 4.63E+08 7.60E+08 2.36E+08 0.00E+00 8.46E+07 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNRY THYROID LUNG SKIN Adult: 2.38E+07 5.10E+05 1.22E+07 2.91E+07 9.43E+06 0.00E+00 3.13E+06 0.00E+00 TOOn: 1.06E+07 2.35E+05 9.74E+06 2.29E+07 7.28E+06 0.00E+00 2.78E+06 0.00E+00 Child: 5.94E+06 1.52E+05 1.72E+07 2.82E+07 8.73E+06 0.00E400 3.13E+06 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.05E+08 4.38E+06 1.05E+08 2.50E+08 8.11E+07 0.00E+00 2.69E+07 0.00E+00 TO:n: 2.00E+08 5.35E+06 1.83E+08 4.30E+08 1.37E+08 0.00E+00 5.22E+07 0.00E+00 Child. 1.46E+08 3.73E+06 4.22E+08 6.92E+08 2.14E+08 0.00E+00 7.69E+07 0.00E+00 Infant: 1.28E+08 3.44E+06 6.79E+08 1.27E+09 3.26E+08 0.00E+00 1.34E+08 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.14E+08 1.32E+07 3.16E+08 7.51E+08 2.43E+08 0.00E+00 8.07E+07 0.00E+00 Tscn: 5.99E+08 1.61E+07 5.48E+08 1.29E+09 4.10E+08 0.00E+00 1.57E+08 0.00E+00 Child: 4.38E+08 1.12E+07 1.26E+09 2.08E+09 6.43E+08 0.00E+00 2.31E+08 0.00E+00 Infant: 3.84E+08 1.03E+07 2.04E+09 3.80E+09 9.78E+08 0.00E+00 4.01E+08 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.31E+04 3.30E+02 1.18E+04 2.69E+04 9.10E+03 0.00E+00 3.09E+03 0.00E+00 TOOn: 1.74E+04 3.09E+02 1.59E+04 3.58E404 1.19E+04 0.00E+00 4.64E+03 0.00E+00 Child: 7.12E+03 1.22E+02 2.06E+04 3.21E+04 1.05E+04 0.00E+00 3.84E+03 0.00E+00 Infant: 2.36E+03 4.23E+01 1.26E+04 2.23E+04 6.04E+03 0 SOE+00 2.53E+03 0.00E+00

'l ODCM Rev. 18 Page 146 l 4/97 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GLSEOUS EFFLUENTS -- FOR ISOTOPEr Xe135m For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.95E+01 1.05E+02 Tecn: 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.95E+01 1.05E+02 Child 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.95E+01 1.05E+02 Infant: 6.92E+01 6.92E+01 6.92E+01 6.92E+01 G.92E+01 6.92E+01 6.95E+01 1.05E+02 For Pathway: Ground T. BODY GI-TRAC"r BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 To n 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.0GE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 J For Pathway: Meat T.30DY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.0^E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

Tsen: 0.00E+00 0. ' E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Adult:

Tsen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E,00 0.00E+00 0.00E+00 0.00E+00 Tsen: 0.00E+00 0.00E+00 0.00E4 0 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TGen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I

.- . . . .. . - - . . - - . - - - _ - . . --~ . -

l ODCM Rsv. 18 Pago 147 l 4/97 Table 2 2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR IGOTOPEr Xe135 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4. 02E+ 01 4. 02E+ 01 4. 02E+01 4. 02E+01 4. 02E+ 01 4. 02E+01 4. 09E+01 1. 06E+02 Tocn: 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 Child: 4. 02E+ 01 4. 02E+01 4. 02E+01 4. 02E+01 4. 02E+01 4. 02E* 01 4. 09E+01 1. 06E+ 02 Infant: 4. 02E+01 4. 92E+01 4. 02E+01 4. 02E+ 01 4. 02E+01 4. 02E+01 4. 09E+01 1. 06E+02 For Pathways Ground ,

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 T03nt 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E400 0.00E+00 0.00E+00 Infanc.: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 T3:n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00

Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcsn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

' Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 ).00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY TH!ROID LUNG SKT.N Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

. Infant:-0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Plathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-0.00E+00 0.00E+00 TsOn: 0.00E+00.0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4

l

ODCM Rcv. 18 l Page 148 4/97 l

Table 2-2 (Continued)

Cs136 INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:

i For Pathway: Plume LUNG SKIN T. BODY GI-TRAC'T BONE LIVER KIDNEY THYROID Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 To n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.C0E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt 0.00E+00 0.00E+00 0.00E+00 9.00E+00 0.00E+00 C.00E+00 0.00E+00 0.00E+00 For Pathway: Ground LUNG SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID Adult: 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06 Toon: 4.60E+06 4.60E+06 4.60B+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06 i

Child: 4.60E+06 4.60E+06 4.608+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06 Infant: 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06 i

For Pathway: Vegetable LUNG SKIN

- T. BODY GI-TRACT BONE LIVER KIDNEY THYROID Adult: 1.99E+05 3.15E+05 7.01E+05 2.77E+06 1.54E+06 0.00E+00 2.11E+05 0.00E+00 Tcsn: 2.14E+06 2.57E+05 8.10E+05 3.19E+06 1.74E+06 0.00E+00 2.74E+05 0.00E+00 Child: 2.88E+06 1.57E+05 1.62E+06 4.46E+06 2.37E+06 0.00E+00 3.54E+05 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4 For Pathway: Meat SKIN BONE LIVER KIDNEY THYROID LUNG T. BODY GI-TRACT Adult: 6.53E+05 1.03E+05 2.30E+05 9.08E+05 5.05E+05 0.00E+00 6.92E+04 0.00E+00 TcGn: 4.74E+05 5.68E+04 1.79E+05 7.05E+05 3.84E+05 0.00E+00 6.05E+04 0.00E+00 Child: 5.50E+05 2.99E+04 3.09E+05 8.50E+05 4.53E+05 0.00E+00 6.75E+04 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG Adult: 1.43E+07 2.26E+06 5.03E+06 1.99E+07 1.10E+07 0.00E+00 1.51E+06 0.00E+00 Tcan: 2.26E+07 2.71E+06 8.56E+06 3.37E+07 1.83E+07 0.00E+00 2.89E+06 0.00E+00 Child: 3.44E+07 1.8?E+06 1.93E+07 5.31E+07 2.83E+07 0.00E+00 4.22E+06 0.00E+00 Infant: 4.14E+07 1.69E+06 3.77E+07 1.11E+08 4.42E+07 0.00E+00 9.05E+06 0.00E+00 For Pathway: Goat Milk SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG Adult: 4.29E+07 6.77E+06 1.51E+07 5.96E+07 3.31E+07 0.00E+00 4.54E+06 0.00E+00 TGsn: 6.79E+07 8.13E+06 2.57E+07 1.01E+08 5.50E+07 0.00E+00 8.67E+06 0.00E+00 Child: 1.03E+08 5.60E+06 5.80E+07 1.59E+08 8.49E+07 0.00E+00 1.27E+07 0.00E+00 Infant: 1.24E+08 5.06E+06 1.13E+08 3.33E+08 1.33E+08 0.00E+00 2.71E+07 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.50E+03 3.70Ev02 1.24E+03 4.64E+03 2.71E+03 0.00E+00 3.80E+02 0.00E+00 Tctn: 4.34E+03 3.45E+02 1.63E+03 6.14E+03 3.50E+03 0.00E+00 5.63E+02 0.00E+00 Child: 3.68E+03 1.33E+02 2.06E+03 5.42E+03 3.03E+03 0.00E+00 4.61E+02 0.00E+00 Infant: 1.68E+03 4.53E+01 1.53E+06 4.26E+03 1.79E+03 0.00E+00 3.73E+02 0.00E+00

ODCM R7 . 18 Pega 149 l 4/97 Table 2-2 (Continued)

PDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Cs137 For Pathways Plume T. BODY GI TRACT 3ONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TCOn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.S8E+08 3.98E+08 4.64E+08 TO:n: 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 4.64E+08 Child: 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 4.64E+08 Infant: 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 4.64E+08 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY Ttr/ROID LUNG SKIN Adult: 1.88E+08 5.56E+06 2.10E+08 2.87E+08 9.75E+07 0.00E+00 3.24E+07 0.00E+00 Totna 1.61E+08 6.57E+06 3.47E+08 4.62E+08 1.57E+08 0.00E+00 6.11E+07 0.00E+00 Child: 1.17E+08 4.97E+06 8.29E+08 7.94E+08 2.59E+08 0.00E+00 9.31E+07 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat .

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.63E+07 4.80E+05 1.81E+07 2.48E+07 8.42E+06 0.00E+00 2.80E+06 0.00E+00 TC2n 6.98E+06 2.85E+05 1.51E+07 2.00E+07 6.82E+06 0.00E+00 2.65E+06 0.00E+00 Child: 3.92E+06 1.66E+05 2.77E+07 2.66E+07 8.65E+06 0.00E+00 3.11E+06 0.00E+00 Inftnt 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.38E+08 4.07E+06 1.54E+08 2.10E+08 7.13E+07 0.00E+00 2.37E+07 0.00E+00 TG:n: 1.29E+08 5.27E+06 2.78E+08 3.70E+08 1.26E+08 0.00E+00 4.90E+07 0.00E+00 Child 9.48E+07 4.02E+06 6.71E+08 6.42E+08 2.09E+08 0.00E+00 7.53E+07 0.00E+00 Infant: 8.88E+07 3.92E+06 1.07E+09 1.25E+09 3.36E+08 0.00E+00 1.36E+08 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.13E+08 1.22E+07 4.61E+08 6.30E+08 2.14E+08 0.00E+00 7.11E+07 0.00E+00 Tacn: 3.87E+08 1.58E+07 8.35E+08 1.11E+09 3.78E+08 0.00E+00 1.47E+08 0.00E+00 Child: 2.84E+08 1.21E+07 2.01E+09 1.93E+09 6.28E+08 0.00E+00 2.26E+08 0.00E+00 infant: 2. 66E+08 1.18E+07 3.21E+09 3.76E+09 1.01E+09 0.00E+00 4.09E+08 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.36E+04 2.66E+02 1.52E+04 1.97E+04 7.05E+03 0.00E+00 2.38E+03 0.00E+00 Tc;nt 9.87E+03 2.69E+02 2.13E+04 2.69E+04 9.64E+03 0.00E+00 3.83E+03 0.00E+00 Child: 4.07E+03 1.15E+02 2.87E+04 2.62E+04 8.95E+03 0.00E+00 3.30E+03 0.00E+00 Infant: 1.44E+03 4.23E+01 1.74E+04 1.94E+04 5.46E+03 0.00E+00 2.26E+03 0.00E+00

l l ODCM Rev. 18 Page 150 l l 4/97 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe137 For Pathway Plune T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.15E+ 01 3 .15E+ 01 3.15E+ 01 3.15E+ 01 3.15E+ 01 3. '.5E+01 3 . 54E+ 01 4. 2 4 E+ 02 TCOn 3.15E+ 01 3.15E+ 01 3.15E+ 01 3.15E+ 01 3.15E+ 01 3 .15E+01 3 . 54E+01 4 . 2 4 E+ 02 Child: 3.15E+ 01 3.15E+ 01 3.15E+ 01 3.15E+ 01 3 .15E+ 01 3.15E+ 01 3 . 54E+01 4. 2 4E+ 02 Infant: 3.15E+ 01 3.15E+ 01 3.15E+ 01 3.15E+ 01 3.15E+01 3.15E+ 01 3 . 54E+01 4. 2 4E+ 02 For Pathway Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TOCn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E*00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathways Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TOcn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

, For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TOOn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00Es00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 T0rn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathwty: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TG0n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY -GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 T3cn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l

A

l ODCM R0v. 18 Paga 151 l 4/97 Table 2-2 (Continued)

JJQIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPEr Xe138 For Pathway Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02 To n: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02 Child: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02 Infant: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tern: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRAC"r BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tocn: 0.00E+00.0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TCOn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+c0 0.00E+00 TGcn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For-Pathway: Inhalation

-T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tscn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.03E+00 0.00E+00 Child: .0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

ODCM rov. 18 l Page 152 4/97 l

Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS POR GASEOUS EFFLUENTS -- FOR ISOTOPE: Ba140 For Pathway: Plume SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TO n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.0CE+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground LIVER KIDNEY THYROID LUNG SKIN T. BODY GI-TRACT BONE Adult: 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 7.16E+05 TOCn: 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27t+05 7.16E+05 Child: 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 7.16E+05 Infant: 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 7.16E+05 For Pathway: Vegetable SKIN BONE LIVER KIDNEY THYROID LUNG T. BODY GI-TRACT Adult: 1.36E+05 4.29E+06 2.08E+06 2.62E+03 8.89E+02 0.00E+00 1.50E+03 0.00E+00 T;cn: 1.62E+05 3.88E+06 2.52E+06 3.09E+03 1.05E+03 0.00E+00 2.07B+03 0.00E+00 Child: 3.13E+05 2.72E+06 5.36E+06 4.69E+03 1.53E+03 0.00E+00 2.80E+03 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Heat GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN T. BODY Adult: 3.61E+04 1.13E+06 5.50E+05 6.91E+02 2.35E+02 0.00E+00 3.96E+02 0.00E+00 TCOn: 2.93E+04 7.02E+05 4.55E+05 5.58E+02 1.89E+02 0.00E+00 3.75B+02 0.00E+00 Child: 4.90E+04 4.25E+05 8.40E+05 7.36E+02 2.40E+02 0.00E+00 4.39E+03 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG Adult: 3.37E+04 1.06E+06 5.15B+05 6.47E+02 2.20E+02 0.00E+00 3.70E+02 0.00E+00 TOOn: 5.99E+04 1.43E+06 9.29E+05 1.14E+03 3.86E+02 0.00B+00 7.66E+02 0.00E+00 Child: 1.31E+05 1.14E+06 2.24E+06 1.97E+03 6.40E+02 0.00E+00 1.17E+03 0.00E+00 Infant: 2.38E+05 1.13E+06 4.62E+06 4.62E+03 1.10E+03 0.00E+00 2.83E+03 0.00E+00 For Pathway: Goat Milk SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG Adult: 4.05E+03 1.27E+05 6.18E404 7.76B+01 2.64E+01 0.00E+00 4.44E+01 0.00E+00 T;en: 7.18E+03 1.72E+05 1.12E+05 1.37E+02 4.63E+01 0.00E+00 9.19E+01 0.00E+00 Child: 1.57E+04 1.36E+05 2.69E+02 2.36E+02 7.68E+01 0.00E+00 1.41E+02 0.00E+00 Infant: 2.85E+04 1.36E+05 5.54E+05 5.54E+02 1.32E+02 0.00E+00 3.40E+02 0.00E+00 For Pathway: Inhalation T.LODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 8.14E+01 6.92E+03 1.24E+03 1.55E+00 5.30E-01 0.00E+00 4.03E+04 0.00E+00 TGen: 1.12E+02 7.25E+03 1.73E+03 2.13E+00 7.23E-01 0.00E+00 6.44E+04 0.00E+00 Child: 1.37E+02 3.23E+03 2.35E+03 2.05E+00 6.70E-01 0.00E+00 5.52E+04 0.00E+00 Infant: 9.19E+01 1.22E+03 1.78E+03 1.78E+00 4.26E-01 0.00E+00 5.06E+04 0.'OE+00

-l ODCM rov 18 Page 153 I

l 4/97 Table 2 2 (Continued)

INDIVIDUAL DOSE FACTORS FOR CAEROUS EFFLUENTS -- POR ISOTOPEr Caldi For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i Adult: 4.17E+05 4.17E+05 4.17E+05 4.178+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 TGcn: 4.17E+05 4.17E+05 4.175+05 4.178+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 Child: _4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17B+05 4.70E+05 i Infant: 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 For Pathways Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.55E+02 1.20E+07 4.63E+03 3.13E+03 1.45E+03 0.10E+00 0.00E+00 0.00E+00 T0cn 5.57E+02 1.39C+07 7.26E+03 4.85E+03 2.28E+03 0.00E+00 0.00E+00 0.00E+00 Child: 1.29E+02 1.08E+07 1.74E+04 8.67E+03 3.80E+03 0.00B+00 0.00E+00 0.00E+00 i Infant 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i Adult: 1.95E+01 6.56E+05 2.54E+02 1,72E+02 7.97E+01 0.00E+00 0.00E+00 0.00E+00 To:n: 1. 63E+01 4. 07E+05 2.13E+02 1.42E+02 6.70E+01 0. 00E+00 0. 00E+00 0.00E+00 Child: 2.97E+01 2.50E+05 4.01E+02 2.00E+02 8.778+01 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY CI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adulti- 6.71E+00 2.26E+05 8.75E+01 5.92E+01 2.75B+01 0.00E+00 0.00E+00 0.00E+00 T20n: 1.23E+01 3.06E+05 1.60E+02 1.07E+02 5.04E+01 0.00E+00 0.00E+00 0.00E+00 Chi]d: 2.93E+01 2.46E+05 3.95E+02 1.97E+02 8.64E+01 0.00E+00 0.00E+00 0.00E+00 Inftnt: 5.62E+01 2.473+05 7.83E+02 4.78E+02 1.47E+01 0.00E+00 0.00E+00 0.00E+00 4

For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 8.06E-01 2.72E+04 1.0i +01 7.10E+00 3.30E+00 0.00E400 0.00E+00 0.00E+00 Tasn: 1.48E+00 3.68E+04 1.933+01- 1.29E+01 - 6.05E+00 0. JCE+00 0.00E+00 0.00E+00 -

, Child: 3.51E+00 2.95E+04 4.74E+01 2.37E+01 1.04E+01 0.00E+00 0.00E+00 0.00E+00 Inftnt: 6.75E+00 2.96E+05 9.40E+01-5.73E+01 1.77E+01 0.00E+00 0.00E+00 0.00E+00 For-Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.84E+01 3.80E+03 6.31E+02 4.29E+02 1.99E+02 0.00E+00 2.46E+05 0.00E+00 Torn: 6.87E+01 4.01E+03 9.00E+02 6.01E+02 2.81E+02 0.00E+00 4.24E+05 0.00E+00 Child: 9.13E+01 1.79E+03 1.24E+03 6.19E+02 2.71E+02 0.00E+00 3.79E+05 0.00E+00

-Infant: 6.30E+01 6. 83E+02 8.79E+02 5.28E+02 1 G6E+02 0.00E+00 3.12E+05 0.00E+00 l

l ODCM Rev. 18 l- Page 154 l

4/97 ,

i Table 2 2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- POR ISOTOPE: Ce144 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tc0n 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.COE+00 For Pathway Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.45E+06 TC2n: 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.45E+06 Child: 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.45E+06 Infant: 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.45E+06 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN, Adult: 4.63E+04 2.91E+08 8.62E+05 3.60E+05 2.14E+05 0.00E+00 0.00E+00 0.00E+00 Tccn 7.73E+04 3.62E+08 1.44E+06 5.95E+05 3.56E+05 0.00E+00 0.00E+00 0.00E+00 Child: 1.87E+05 2.87E+08 3.51E+06 1.10E+06 6.10E+05 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult 1.41E+03 8.90E+06 2.63E+04 1.10E+04 6.53E+03 0.00E+00 0.00E+00 0.00E+00 T02n: 1.19E+03 5.58E+06 2.22E+04 9.18E+03 5.43E+03 0.00E+00 0.00E+00 0.00E+00 Child: 2.23E+03 3.42E+06 4.18E+04 1.31E+04 7.26E+03 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY TEfROID LUNG SKIN Adult: 3.47E+02 2.18E+06 6.46E+03 2.70E+03 1.60E+03 0.00E+00 0.00E+00 0.00E+00 T3:n: 6.39E+02 2.99E+06 1.19E+04 4.92E+03 2.94E+03 0.00E+00 0.00E+00 0.00E+00 Child: 1.56E+03 2.40E+06 2.93E+04 9.19E+03 5.09E+03 0.00E+00 0.00E+00 0.00E+00 Infant 2.35E+03 2.41E+06 4.20E+04 1.72E+04 6.95E+03 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.16E+01 2.62E+05 7.75E+02 3.24E+02 1.92E+02 0.00E+00 0.00E+00 0.00E+00 Tcen: 7.67E+01 3.59E+05 1.43E+03 5.90E+02 3.53E+02 0.00E+00 0.00E+00 0.00E+00 Child: 1.88E+02 2.88E+05 3.52E+03 1.10E+03 6.11E+02 0.00E+00 0.00E+00 0.00E+00 Infant: 2.82E+02 2.89E+05 5.04E+03 2.06E+03 8.34E+02 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 5.83E+03 2.59E+04 1.09E+05 4.54E+04 2.69E+04 0.00E+00 2.46E+05 0.00E+00 Tctn: 8.32E+03 2.74E+04 1.55E+05 6.42E+04 3.83E+04 0.00E+00 4.24E+05 0.00E+00 Child: 1.15E+04 1.23E+04 2.15E+05 6.71E+04 3.72E+04 0.00E+00 3.79E+05 0.00E+00 Infant: 5.59E+03 4.70E+03 1.01E+05 3.84E+04 1.70E+04 0.00E+00 3.12E+05 0.00E+00

l l

l l ODCM RGv. 18 l

POg3 155

. 4/97 i TABLE 2-3 Assumptions Used in Limerick Gaseous Effluent Dose Evaluation Index Description Value 1 Fraction of produce from local garden 0.76 2 Fraction of leafy vegetable from local garden 1.00 6 3 Soil density in plow layer (kg/m**2) 240.0 4 Fraction of deposited particulates retained on vegetation 0.20 5 Fraction of deposited iodines retained on vegetation 1.0 6 Shielding factor of residential structures 0.7 7 Period of buildup of activity in soil (hr) 175200.0 8 Period of pasture grass exposure to activity (hr) 720.0 9 Period of crop exposure to activity (hr) 1440.0 10 Transport time milkman (hr) 48.0 11 Dalay time for ingestion of grass by anLmals (hr) 0.0 12 Delay time for ingestion of stored feed by animalt. (hr) 2160.0 13 Delay time for ingestion of leafy vegetable by ma- (hr) 24.0 14 Delay time for ingestion of other vegetable by man (hr) 1440.0 15 Time between slaughter and consumption of meat animal (hr) 480.0 16 Grass yield, wet wt (kg/m**2) 0.7 17 Other vegetation yield, wet wt (kg/m**2) 2.0 18 Weathering rate constant for activity on veg (1./hr) 0.0021 19 Milk cow feed consumption rate (kg/ day wet) 50.0 20 Beef cattle consumption rate (kg/ day wet) 50.0 21 Goat feed consumption rate (kg/ day wet) 6.0 22 Plume exposure adult (hr/yr) 8760.0 23 Plume exposure teen (hr/yr) 8760.0 24 Plume exposure child (hr/yr) 8760.0 25 Plume exposure infant (hr/yr) 8760.0 26 Ground exposure adult (hr/yr) 8760.0 27 Ground exposure teen (hr/yr) 8760.0 28 Ground exposure child (br/yr) 8760.0 29 Ground exposure infant (hr/yr) 8760.0 30 Inhalation exposure adult (m**3/yr) 8000.0 31 Inhalation exposure teen (m**3/yr) 8000.0 32 Inhalation exposure child (m**3/yr) 3700.0 33 Inhalation exposure infant (m**3/yr) 1400.0 34 Leafy veg exposure adult (kg/yr) 64.0 35 Leafy veg exposure teen (kg/yr) 42.0 36 Leafy veg exposure ' child (kg/yr) 26.0 37 Leafy veg exposure infant (kg/yr) 0.0 38 Non-leafy veg exposure adult (kg/yr) 520.0 39 Non-leafy veg exposure teen (kg/yr) 630.0 40 Non-leafy veg exposure child (kg/yr) 520.0 41 Non-leafy veg exposure infant (kg/yr) 0.0 42 Root veg consumption rate adult (kg/yr) 0.0 43 Root veg consumption rate teen (kg/yr) 0.0 44 Root veg consumption rate child (kg/yr) 0.0

. -_ - .- _ _ - . . _ - - . _= . . _ . . - _..___--_ - _- .-

l ODCM rov. 18 Page 156 l

4/97 TABLE 2 3 (Continued)

Assumptions Used in Limerick Gaseous Effluent Dose Evaluation Index Description Value 45 Root veg consumption rate infant (kg/yr) 0.0 4G Cow milk consumption rate adult (1/yr) 310.0 47 Cow milk consumption rate teen (1/yr) 400.0 48 Cow milk consumption rate child (1/yr) 330.0 49 Cow milk consumption rate infant (1/yr) 330.0 50 Goat milk consumption rate adult (1/yr) 23.0 l 51 Goat milk consumption rate teen (1/yr) 29.0 52 Goat milk consumption rate child (1/yr) 0.0 l'

53 Goat milk consumption rate inf ant (1/yr) 0.0 54 Meat consumption rate adult (kg/yr) 110.0 55 Meat consumption rate teen (kg/yr) 65.0 56 r) 41.0 t

1 57 Meat consumptionrate Meat consumption rateinfant child (kg/y/yr)(kg 0.0 58 Fraction of year animals on pasture 0.75 59 Fraction of feed from pasture when on pasture 0.39 60 Fraction of year leafy veg grown 0.42 61 Atmosphere hydrogen concentration (gm/m**3) 8.0 L

l ODCM R'.;v. 18 Pag 3 157 4

4/97 TABLE 2 4 Nearest Gaseous Effluent Dose Receptor Distances (Meters) x Plume Ground Inhalation Vegetation Meat cow Goat Direction Pathways Pathway Pathway Pathway Pathway N 965 2574 3414 7562 0 NNE 805 805 1585 0 0 NE 1287 2414 1097 0 0 ENE '965 2896 3871 0 0 E_ 965 1770 1890 0 0 ELR 805 1931 4511 1770 1770 SE 1609 1770 7241 0 0 CSE 1609 1931 7224 7562 0 S 1287 1931 3018 3701 9 SSW 1609 2253 1433 2896 0 SW 965 965 2835 4827 0

-WSW 1287 1287 2134 4505 0 W 965 3540 4084 0 0 WNW 1126 1126 0 0 0 NW 2092 2574 6660 0 0 NNW 1449 1931 6325 0 0 1

l ODCM Rev. 18 Page 158 l 4/97 APPENDIX A

i l I l ODO4 Rsv. 18 .l Page 159.

l 4/97 TABLE A-1 Technical Specification /ODCM Matrix ODCM ODCM TGchnical .

Section I Equation Snecification* Recruiramant Section II 3.3.7.11 3.2.1 1-1 1-2 1-3 1-4 3.3.7.12 3.3.1 2-1 (or 2-9) l 2-2 (or 2-9) 2-4 (or 2-10) 2-5 (or 2-10) 3.11.1.1 3.2.2 1-1 1-2 1-3 1-4 3.11.1.2 3.2.3 1-5 1-6 1-7 3.11.1.3 3.2.4 1-8 1-9 3.11.2.1 3.3.2 2-22 2-23 3.11.2.3 3.3.4 2-26 2-27 2-28 3.11.2.2: 3.3.3 2-24 2-25 3.11.2.4 3.3.5 2-33 3.11.2.7 3.3.6 2-4 2-5 l

Parts of or the entire Tech. Spec. Section has been transferred to ODCM via T.S. amendment # d.8 for Unit 1 and 11 for Unit 2.

.-- - -. . . . - . - . . . . . . . - . . . . _ - - . . . . . . ~ . . - - - . - - - . -

l ODCM Rev.18 Page 160 l 4/97 TABLE A-1 Technical Specification /ODCN Matrix ODCM ODO!

TGehnical Section I Equation i Specification

Requirement Section II 6.9.1.8 3.6 15 16 17 2 24 2-25 2-26 2-27 2-28 3.11.4 3.3.7 3-1 3.12.1 3.4.1 Section II APP. B 6.9.1.7 3.5 1-5 3.12.3 3.4.3 1-6 1-7 2-29 2-30 2-31 2-32 3-2 i

Parts of or the entire Tech. Spec Section has been transferred to ODCM via T.S. amendment # 48 for Unit 1 and 11 for Unit 2.

i

.I i

l ODCM R v. 18 P'g3 161-l 4/97 r f

i 0

i I .

i t

4 t

t 4

i 9

APPENDIX B n

RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM -

SAMPLE TYPE, LOCATION, AND ANALYSIS i I

f 4

6 -

b 7

d e

t' a

P 4

a 4

1 e

g -inr. y -, - - + , .w . p y ,- .,, . , , , - - m--,-- -- ,.- . _ , - - ,. -- __ _ _-_ _ -

__v.,., ,

ODCM Rev. 18 l Page 162 4/97 l

l TABLE B-1 Page 1 o' 4 ODCM - Limerick Generating Station Radiological Environmental Monitoring Program Collection Method Analyses Pathway Station Code Location 1 set of four (4) TLDs Gamma dose quarterly 36S2 3,183 feet N of site I. Direct Site Boundary 3S1 2,301 feet NNE of site from each location at 2,350 feet NE of site least quarterly SS1 7S1 3,099 feet ENE of site 1093 2,648 feet E of site 11S1 2,017 feet ESE of site 13S2 2,149 feet SE of site 14S1 3,319 feet SSE of site 18S2 1,390 feet S of site 21S2 977 feet SSW of site .

23S2 2,793 feet SW of site 25S2 2,445 feet WSW of site 26S3 2,088 feet W of site 29S1 2,886 feet WNW of site 31S1 1,395 feet NW of site 3482 3,071 feet NNW cf site Intermediate 36D1 18,527 feet N of site Distance 2E1 25,112 feet NNE of site 4E1 25,221 feet NE of site 7El 22,489 feet ENE of site i 10E1 20,826 feet E of site 10F3 29,442 feet ESE of site 13E1 22,772 feet SE of site 16F1 26,608 feet SSE of site 19D1 18,439 feet S of site 20F1 27,648 feet SSW of site 24D1 20,972 feet SW of site 25D1 21,044 feet WSW of site 28D2 20,231 feet W of site 29El 26,110 feet WNW of site 31D2 20,446 feet NW of site

_ _ _ - m

ODCM Rew. 18 l Page 163 l

4/97 TABLE B-1 Page 2 of 4 Station Code Location Collection Method Analyses Pathway 34E1 24,243 feet NNW of site Distant 5H1 C 130,742 feet NE of site and 6C1 11,305 feet NE of site Special 9C1 11,377 feet E of site Interest 13C1 14,980 feet SE of site 15D1 16,877 feet SE of site l

17B1 8,462 feet S of site 20D1 16,157 feet SSW of site 31D1 15,853 feet WNW of site II. Airborne 10S3 2,648 feet E of site Approximately 1 cfm Gross beta analysis Particulates 11S1 2,017 feet ESE of site continuous flow through on each weekly 14S1 3,319 feet SSE of site glass fiber filter sample. Gamma 13C1 14,980 feet SE of site which is collected spectrometry shall be 22G1 C 93,619 feet SF of site weekly. done when gross beta exceeds ten times the I

yearly mean of control station value.

Gross beta analysis done =24 hr after sampling to allow for Radon and Thoron daughter decay.

Gamma Spec on quarterly composite.

i

l ODCM Rev. 18 Paga 164

.l 4/97 TABLE B-1 Page 3 of 4 POthway Station Code Location Collection Method Analyses Iodine 10S3 2,648 feet E of site A TEDA impregnated Iodine 131 11S1 2,017 feet ESE of site flow-through cartridge 14S1 3,319 feet SSE of site is connected to air 13C1 14,980 feet SE of site sampler and is 22G1 C 93,619 feet SW of site , collected weekly at site filter change.

P III. Water Surface 24S1 C 1,058 feet SW of site 5 .tiple collected from a Gamma isotopic 13B1 9,225 feet SE of site continuous water analysis monthly:

sampler, monthly. In l event samp'.er is H-3 on quarterly inoperable, weekJf grab composite samples will be collected until sampler returned to service.

Sediment 16C4 11,510 feet SSE of site A sediment sample is Gamma isotopic l

taken down stream of analysis each ,

discharge semi-annually sample IV. Incestion l Milk 10B1 5,725 feet E of site Sample of fresh milk is Gaaraa isotopic and 19B1 10,317 feet SSW of site collected from each I-131 analyses on ,

21B1 9,263 feet SSW of site farm biweekly when cows each sample l 9G1 C 62,304 feet E of site are on pasture (April through October),

monthly at other times.

+=--- _ _ _ . _ _ . _ _ _ . . _ _ _ _ _ _ _ _ _

l ODCM Rev. 18 Page 165 l 4/97 TABLE B-1 Page'4 of 4 1

Pathway ' Station Code Location Collection Method Analyses Drinking 15F7 33,400 feet SSE of site Sample collected from a Gross beta and gamma 15F4 45,514 feet SE of site continuous water isotopic monthly, 16C2 14,034 feet SSE of site sampler monthly. In 28F3 C 30,811 feet WNW of site event sampler in H-3 on quarterly '

inoperable, weekly grab composite sanples will be collected until sampler returned to service.

f l Fish 16CS 9,251 feet SE of site Two species of Gamma isotopic 29C1 C 13,725 feet WNW of site recreationally analyses on edible important fish portions.

(Predator and bottom !

feeder) sampled in season or semiannually _

if not seasonal.

Food Two offsite locations of highest Samples of three (3) Gamma isotopic ;

Products predicted annual average ground different kinds of analysis d level D/Q and one location (15- broad leaf vegetation 30 km distance) in the least monthly when available prevalent wind direction as if milk samplings is not t determined using the results ci performed.

the most recent annual Landuse Survey.

C = Control Location i

t e

l ODCM Rev. 18 Page 166 l 4/97 APPENDIX C O

l ODCM R;v. 18 P g2 167 l 4/97 ODCM Revision Process I. REVISION PROCESS

a. The preparer shall ensure the ODCM contains program elements described in Technical Specifications 6.8.4.d,e and f.

b. All pages affected by the change shall contain revision bars in the margin indicating the area of the page changes and the date (month and year) of the change. Revision bars from previous revisions shall be removed.

I c. Initiate an ECR in accordance with MOD-C-9.

d. In addition to the requirements of LR-C-9, the following shall also be performed:

l 1. The preparer of the proposed change shall assemble an ODCM revision package. This package should contains j a. Proposed page changes. ~

l b. Sufficient information, appropriate analysis or evaluation to support the change.

l c. A determination that the changes will maintain the level of effluent control required by 10CFR20.1301, 10CFR20.1302, 40 CFR Part 190, 10CFR50.36a and Appendix I to 10CFR Part 50.

l d. A 10CFR50.59 review prepared in accordance with administrative procedures.

l e. Other documentation as required by administrative procedures.

l 2. The preparer shall obtain review of the ODCM revision package utilizing the SQR process in accordance with administrative procedures. This review should include:

l a. Manager, Health Physics Support Staff.

l b. Cross-disciplinary review (i.e. Chem, R/W, Nuclear Eng. Div. Programs Branch, EP) , if required, and l c. Review by the Radiation Protection Manager.

l 3. Upon satisfactory completion of the SQR and responsible Superintendent reviews, the }.'eparer shall obtain PORC approval of the ODCM revision package.

.. . -. . _ . . .- . . . . -...- - -- - -~..~-. ... - - . -. ~. - ... -. . ,

1 l

ODCM Revi 18 l Page 168 l

.l 4/97 l II. APPROVAL a.- Upon satisfactory completion of PORC review and appropriate review / approval forms, the revised OD N shall be forwarded to the- Plant Manager for approval signature on the ODCN cover sheet.

l III. ISSUANCE

a. The ODCM shall be issued as a complete document. Issuing page changes is not permitted.

b. The ODQ4 shall contain a cover sheet indicating the ODCN revision number and a Table of Contents. All pages of the ODCM shall be marked with the revision ntunber and date.

c. The preparer shall forward the following to the Document Control Center:

1. Original ODCM for issuance.

2. The ODCN revis$on package.

3. 10 CFR50.59 reviews.

4. All appropriate review / approval forms.

i l IV. IMPLEMENTATION

a. Changes to the ODCM shall become effective upon approval of the Plant Manager.

I b. The Effluent. Physicist shall ensure that a copy of the i complete ODCM is submitted to the NRC with the Annual l Radioactive Release Report for the period of the report in l which the change to the ODCM was made.

l l

l 1

l ODCM Rev. 18 P :g3 169 l 4/97 i

e FIGURES 1

l LGS DILUTION vs RIVER FLOW STATION (OUTFALL)

SI 93 D i

, i--

I L

U I 1[+02

/

O /

/

N - r F

/

A /

/

g 1[+01

' T ,

O ,/

R -

_t f 11+02 1[+0$ 1[*04 1I+01 FLOW AT POTTSTOWN (CFS)

Figure f.3.f-( .

J ODCM, Rev. 18 i Page 170 4/97 l

- i-meme-unes,,summmi-mso

v4 > %

HN

v

(

m 18 O

v O

$ ~

O

.J 11..-. rn U

u.

CH O lij 2 l y "r 1 - *Z

.-- 3 '

, %n Z co < O a.

k N H" M Md

>Ww (u H e' Z !- \ g5 OS '

s O"

c.

z s a N O s<

D *O

.J

-rW N, 3

O Q# 3 ,

.J 1

(O O

.J O

s T M N e W D O O O h

Q .J D H -O Z L<OHOE ennes amies t

ll 1lIl lI l

' *!i 827 179

S~; .

. 1/

. 4 ve eg Ra

. ,P M

C D

O 4

0 I'

1 W ,

O ,

L )

F S

'3 F R )E C ELL [/ r 0

t 1

(

y VIV I

, W RIXN 3

' O1 -

, T sE i S13 vO Te r H P Tu N (P / Og i ON PF I

T!O T

/ 2 0

T A

UL / '

1 W

LS I

z O D J L F

S G

L 1

0

+

[

3 2 0 1 0 0 0 0

[ '

1 I' 1 1 1 ' 1 DI L TI ON FACTOR l l lll ll 1j

LGS DILUTION vs RIVER FLOW STATION (PHILA. SUBUTIBAN) 1[+03 D ,

I L .

U j*3 I 1l+02 /

I , y 0 -

N '

J F d A

/

C II'01 f T '

O '

/

R if .

I 11+00 l

11+01 1!+02 11+05 11+04 FLOW AT POTTSTOWN (CFS) '

Figure 1.3.f-4 .

ODCM, Rev. 18 Page 173 4/97 i

1

. . ..r

- . MNm as

W

. >0 m en C4 10

.. a b

O 4 .

l l o e O .

e s^ ~

O \

J n E

u. '

T m -

. u. -

EE ymm \ ,

o. 8 '$

% vz, .

>m

-o ,

5 m :.

Eo x 0 J. a

&a.

s

@5 @4~

>wm. b

,g H g-. ==

O5o Z S. '

Oz N s%

~~ O uH o< 2

>~h "

\ $)O

A Q t; .J 1

e O ,E O t J .

- =

0 5l m

o n

o o

oW o -

E

$ 5 $ $ $

5

=

O-JDH-OZ w<OHOW di H

O

. E.

l

- - l

Or 6 ,

ft c

a 1

Is , _

,e.

s ,l, g .

. g 4,; L -

AE

, gg -

m j }. m.

17 hhh h lIl

~

I ejg .

, w -

g I

^

G. Bl<I

.- Bl..I -

4 I

% %- r 4 *#

~ i j

. .i 25' c J A i 1 5 m

d. 1 83 ge 8E a s e + ) E W A,

Sud a is l

t 1 Bb 2" "

ik :

") .I 11 i 4g 4

5}

Aa e e I e A aj E 25 8E g e

a ; ; a e- 4

%) %D %

%'D ,

D % D x w p g g 5 ! E!! +

BI! BN! 5!

o .

J o

J q Eb-llI *

^

g o

=

^

i i -

T i f 51

.... . s .. . ,

SE $3 I $

ese en Es$ }$s a-5 5 s

, . . e N. . . .

_w _

! 1I)!\

n b pi . o

. mtn

~ 86 n oi

- i .

o Cs, e. 17 eew t ,

nr r : -- .

c.. , nm eo t s ? e 2

. , _ - i r i e e v .r =c. .

e giedi n

.E w ;_ *

~

E . , e.

.enr t

.c .

i, e gi s.s ve eg dn co _ *

m. . , r .

= O. .

., s oi i

Ra WFa AcM i _

c t

l c.

s l

e e

. C

- n r

c s =

a No u u,tre

o. ito e

,P t . pe

. :- m an s

.r M p

T

.lp nu d g t

r E

- ~ .

nc -e u = l.

dr R

ao s m i

c o

e C D

O T

g n

t P u e.

i

,. _- ; T.

, n.. ** * ; ,m 3

2

(

e.

~

g d. !

n.

J .

gT a M[ .

g

.e.

,I gI

'a s.

a e. . )

m 8

a [.

,ar m

=..

m 2

(

w w O

gI o

x%+s,

, m .

w

~

- s

~

s.

\ g/ m: " + . 4 , . e.

N/ 2 ,

/ s.

s

$ ce

~

I

.e

.a* "* c s a ii a

s. n v e. "* +~ + + , + + + *

u. -u Ac-w u3E = -

y '[

g

&f 6

. r e e m *

& 6 t l

M m o" '

, m i

F l

M/f m M l

g y g n a

F t

m t

e. , y s l

E S

, . u a

a e .

. e = t.. . . h d

e w . er 2 e . o x

. T r E m

e . .

. p

~ r . .

%, 9oN t

e .

4 n . mo ie ' . G .. ,.

E -

. y a

. En c. ~ c t d.

r

. e.

g mG e t.

i

'9 8

T

. .w n

ue r

- . 9 r

9.

c c

M8 T

I l

} (lll lj!f t11

II. n f1a j,j afl <= ic dn n a

o J

I s

{}g l I m s E

113 8

E E E

~^

}, 9 ] g 'F i

'P]g*

till 4 j

~

iill . !Ei . jEd .

s e e Illi-a le 1

I .

11 11 s,)ll

1 il 1 53 sr- p ". 7 Li"t,B&

I ij; sbi 11 1

Z l}]

e "2,

35 g l

s .

m y T) I 9, >

_r i

~ l ~

R I !s 0.3 54 en B y

Y Io n $5 E l353 I nu ewm

l ODCM R v. 18 .

P0g3 179 l 4/97 3 uilt % n, ,,

NNW NNE 4 R

NW NE 3652 3452 3S1 ENE Sp1 1

31$1

7 51 29S1

/

uS3.

g psi

/ e1053 25S2 e2 S 1151

, 1852 1352 23S2 ESE SW

~

_ +

1451 S

$ SE

+

SSE

/

2 Figure B 1 Environmental Sampling Locations On Site or Near the Limerick Generating Station

l ODCH Rev. 18 Page 180 l 4/97 100

Ut y

5 RADIUS 2,,.

NW NE

3601 4E1*

31,0 2 WN ENE 29E1

3101 6C1'

[-

29C1 W \

' 02 '

i ,0 1 ac1 E

10C1

/

16

2191 1 i 37 3

*2501 13c1

,g 3 ESE WSW

1

96 2401 1sc1 . 1 2001e p 1E 24 e- ' 0I w SE 422

\S S SE 7 s N

Figure B 2 Environmental Sampling Locations at Distances Less Than Five Miles from the Limerick Generating Station.

l ODCN R';v. 18

.P;ga 181 l 4/97 i

lI I -

I

, to f

\

5 or N 5' . \

N G I

f I ,, E N 2%

W Q bd

~

N f -b

, e 8

~

Is d_ _

N 1 , -

g n.

1 8.

\ 4* / \ n ,

Figure B 3 Environmental Sampling Locations at Dista.nces Greater Than Five Miles from the Limerick Generating Station, l

i j ODCM Rev. 18 Page 182 l 4/97 REFERENCES

1. Regulatory Guide 1.109, ' Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I,' Revision 1, U.S. Nuclear Regulatory Commission, Washington, D.C. 20555, October 1977,

2. Regulatory Guide 1.111, ' Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light Water Cooled Reactors,' Revision 1, U.S. Nuclear Regulatory Conadssion, Washington, D.C. 20555, July 1977.

3. Regulatory Guide 1.112, ' Calculation of Releases of Radioactive Materials in Gaseous and Liquid 3ffluents from Light-Water Cooled Power Reactors,' U.S. Nuclear Regulatory Commission, Washington, D.C. 20555, April 1976.

4. Regulatory Guide 1.113, ' Estimating Aquatic Dispersion of Effluents from Accidental and Routine Reactor Releases for the Purpose of Implementing Appendix 1," Revision 1, U.S. Nuclear Regulatory Commission, Washington, D.C. 20555, April 1977.

5. U.S. Nuclear Regulatory Commission, ' Calculation of Releases of Radioactive Materials in Gaseous and Liquid Effluents from Boiling Water Reactors (BWR. GALE Code)," USNRC Report NUREG 0016, Washington, D.C. 20555, April 1976.

6. U.S. Nuclear Regulatory Commission, 'X00D00, Program for the Methodological Evaluation of Routine Ef fluent Releases at huclear Power Stations,' USNRC Report NUREG 0324, Washington, D.C. 20555, September, 1977.

7. Title 10, " Energy,' Chapter I, Code of Federal Renulationg; Part 20, Appendix B, U.S. Government Printing Office, Washington, D.C.

20402, January 1, 1977.

8. Title 10, ' Energy,' Chapter I, Code of Federal Reculations; Part 100, U.S. Government Printing Of fice, Washington, D.C. 20404, January 1, 1977.

9. Title 40, ' Protection of Environment,' Chapter I, Code of Federal Renulations, Part 141, U.S. Government Printing Office, Washington, D.C. 20402, January 1, 1977.

10. Regulatory Guide 1.21, ' Measuring, Evaluating, and Reporting Radioactivity in Solid Wastes and Releases of Padioactive Materials in Liquid and Gaseous Effluents frod. Light-Water Cooled Nuclear Power Plants,' Revision 1, U.S. Nuclear Regulatory Commission, Washington, D.C. 20555, June 1974, i

l ODCM R v. 18 P go 183 l 4/97 REFERENCES

11. Title 40, " Protection of Environment,' Chapter I, Code of Federal Renulations, Part 190, Federal Register, Vol. 42, No. 9, Washington, E.C. 20402, January 13, 1977.

12. U.S. Nuclear Regulatory Commission, 'Short Term Diffusion Estimates,' Section 2.3.4, Standard Review Plan for the Review of Safety Analysis Reports for Nuclear Power Plants LWR Edition, USNRC Report NUREG 75/087, Washington, D.C. 20555, November 1975.

13. U.S. Nuclear Regulatory Commissidn, ' Preparation of Radiologica.

Effluent Technical Specifications for Nuclear Power Plants,'

USNRC Report NUREG 0133, Washington, D.C. 20555, October 1978.

14. Letter From Thonas E. Marley, Director Office of Nuclear Reactor Regulations, To Thomas E. Tipton Vice President and Director Operations, Nuclear Management and Resources Council, 6/30/93.

15. ANSI N42.14 1991 (Revision of ANSI N42.14 1978)

Calibration and Use of Germanium Spectrometers For the Measurement of Gamma Ray Emission Rates of Radionuclides', Sect. 6.2.2

16. EML Procedures Manual, H.L. Volchok and G. dePlangue, Editors, U.S. Dept. Of Energy (Revised Annually)

17. L.A. Currie, "Lindts For Qualitative Detection and Quantitative Determination Application to Radiochemistry', Analytical Chemistry, Vol. 40, pp. 586 593 (TABLE II), 1968

18. NUREG/CR 4007, ' Lower Limit of Detection: Definition and Elaboration of a Proposed Position for Radiological Effluent and Environmental Measurements", prepared by NRC by L.A. Currie (Chapter II, Sect. D.2; Chapter III, Sect. C.1), September 1984

19. Tech. Spec. Section 1.24 (Definitions)

20. USNRC Generic Letter, 89 01

21. Tech. Spet. Section 6.14.

22. Tech. Spec. Section 6.5.1.6m.

23. Tech. Spec. Section 6.5.3.

2 4. - Tech. Spec. Section 6.8.4d, e and f.

25. Tech. Spec. Section 6.9.1.8/ODCM Control I.3.6.

26. Tech. Spec. Section 6.10.3m and n.

27. UFSAR, Section 11.5.6.

I

\. ..

. .. . .. _ - - _ _ - .

ML20203H270

Text

units conversion C,

Navigation menu

Search